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About this budget analysis 
 
This analysis looks at the health and related provisions in the Australian Government’s 2015-16 Budget.  
This is done in the light of current and past strategies, policies, programs and funding, and is supported, 
where possible, by data drawn from Medicare, the Pharmaceutical Benefits Scheme, reports and 
published papers. 
 
As was the case last year, this year’s analysis has been delayed. The Budget Papers are even more 
impenetrable than those from 2014-15, provisions in the Budget have already changed as the Abbott 
Government struggles to sell its policies, and new announcements have been made in the weeks since 
the Budget was released. This delay does mean that new information about federal health expenditures 
and the impact of the proposed changes, along with such information as was obtained from Senate 
Budget Estimates held in early June,1 can be included. 
 
Indigenous affairs issues in the 2015-16 Budget have been previously analysed and this report is 
available at http://ses.library.usyd.edu.au/handle/2123/13476 
 
Budget analyses from previous years are available at 
http://ses.library.usyd.edu.au/browse?type=author&value=Russell%2C+Lesley 
 
The opinions expressed are those of the author who takes sole responsibility for them and for any 
inadvertent errors. 
 
 
 
Lesley Russell 
 
Lesley.Russell@sydney.edu.au 
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Introduction 
 
The impacts of the 2015-16 Budget must be assessed in light of the previous Budget, which casts a long 
shadow.  
 
Australians’ health and wellbeing depends not just on their ability to access quality and affordable 
healthcare services when they need them, but on a range of other services, of which education, 
employment, social justice and welfare supports are the most important.   
 
ACOSS estimates that, combined, the two budgets strip approximately $15 billion / 4 years from basic 
services and supports that affect low and middle income households.2 Analysis from NATSEM highlights 
that the Abbott Government’s Budget changes are being g made at the expense of the less well-off and 
that its second Budget has done little to reverse the unfair redistributions of its first budget.3 
The over-arching aim appears to be to improve the federal budget deficit by shifting costs off the 
Commonwealth Government’s balance sheet on to the States and Territories, service providers and 
consumers.  
The Health Budget this year sees the Government using the same methods to take savings with the 
same objectives as last year, but what leaps out is the continuing failure to develop and implement 
strategies and policies to underpin these decisions. Budget decisions smack of policy on the run, or in 
some cases, no policy at all. There is no inkling of any reformist imagination. 
In critical areas like mental health, e-health and primary care we see a common modis operandi: 
commission a report but delay acting on it; implement a few aspects of the report and ignore the 
remainder – or set up an advisory group to obtain yet more advice and further delay; rebadge anything 
named by the previous Labor Government; and finally - make sure there are no plans and no funding for 
anything beyond three years.   
The Government continues to find savings by using price signals (or co-payments) to reduce demand.  
The controversial Medicare co-payment has been abandoned but changes to Medicare reimbursements 
will see patients’ out of pocket costs grow – effectively implementing co-payments by stealth. And PBS 
co-payments remain on the table, at least until replacement savings are found. Other common methods 
for achieving savings include: tightening up eligibility and funding rules for patients’ benefits and 
providers’ incentives; cutting funds from health programs and agencies in the name of efficiency and 
rationalisation; and re-negotiating agreements with service providers, including states and territories, 
non-government providers and the private sector. 
This Budget also reinforces the Government’s intent to claw back $80 billion over the next decade from 
the States’ and Territories’ budgets for health and education, with $57 million of this to come from 
funding for public hospitals. This has service to reignite the ‘blame game’ which the previous Labor 
Government had worked hard to address (if imperfectly). At a time when cross jurisdictional and cross 
                                                          
2
 http://acoss.org.au/images/uploads/ACOSS_Budget_Analysis_2015-16.pdf 
 
3
 http://www.natsem.canberra.edu.au/publications/?publication=interim-analysis-of-the-2015-16-federal-budget  
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sector efforts and collaborations are needed to deliver integrated care and improve efficiencies, this is 
undermining the good will needed to achieve these reforms. 
The one substantial Government commitment is to the Medical Research Future Fund, which has 
become the beneficiary, even the justification, for savings from many areas in the Health portfolio. It is 
ironic that these program cuts will quickly lead to impacts on the health of individuals and the 
population as a whole – the very things that the MRFF is lauded as addressing through the research it 
will support.  
The biggest concern must be that these efforts of the Abbott Government to ensure that our 
grandchildren do not bear the burden of Government debt mean future generations will bear the 
economic and social burdens of increasing rates of illness and disability.  
The key messages from a 2012 WHO report entitled Health systems, health and wealth: Assessing the 
case for investing in health systems4are these: 
 
 Health is central to well-being and wealth.  Healthier people are more productive and better health 
reduces demands on health care now and in the future.  Health and wealth reinforce each other and 
health systems are a catalyst for both 
 
 Health systems investment brings real benefits. Appropriate investment in health systems is an 
effective way of improving health and wealth and societies can choose ‘how’ and ‘how much’ to 
invest in health systems despite all the competing demands for resources. Health systems help 
create societal wellbeing and promote equity.  
 
 Policy makers can make health systems and health system investment work better. Explicit 
strategies for improvement are key and these work best if they reflect the burden of disease and 
risk factors, combining prevention and treatment accordingly. 
 
These messages all apply to Australia’s formulation and funding of health policies and services, and 
never more so than in 2015. 
 
 
 
 
 
 
  
                                                          
4
 http://www.euro.who.int/__data/assets/pdf_file/0009/83997/E93699.pdf  
10 
 
State / Territory and Commonwealth relations 
The 2015-16 Budget highlights the Abbott Government’s renegotiation of contracts with the States and 
Territories in order to achieve savings and implement its fiscal and social ideologies. Policies and 
program cuts in the 2014-15 and 2015-16 Budgets have shifted costs from the Commonwealth to the 
States and Territories and also to consumers and to the medical profession. 
Small wonder then that, despite talk about “co-operative federalism” and “ending the blame game”, 
Commonwealth-State relations remain fraught. In particular, tensions over the roles and responsibility 
for high-cost issues like health remain unresolved and are aggravated as the Commonwealth floats ideas 
and then quickly withdraws or disowns them in the face of public opposition.  
Even as there is broad agreement about the need for better integration of healthcare services to 
manage the growing burden of chronic illnesses together with the need for a more efficient, effective 
and sustainable health system, Commonwealth-State collaborative across the systems are stifled. 
In 2015-16 the Commonwealth will provide $17.2 billion to support State and Territory health services 
(see Table 1). This is 4.8% more than in 2014-15. 
Table 1.  Payments to support state health services 
 2014-15         
$m 
2015-16       
$m 
2016-17        
$m 
2017-18      
$m 
2018-19     
$m 
National Health Reform 
funding 
15,459.4 16,440.9 17,382.4 - - 
Public hospitals funding - - - 18,103.3 18,873.1 
National Partnership 
payments 
     
-Health infrastructure 736.3 318.3 96.5 29.5 - 
-Health services 88.8 72.6 55.1 23.2 17.1 
-Indigenous health 61.0 12.9 12.9 6.2 6.4 
-Other health payments 458.6 339.1 143.3 146.3 148.1 
Total 16,804.2 17,183.7 17,690.2 18,308.5 19,044.8 
From 2015-16 Budget paper No 3 Table 2.4 
Examination of how this funding has changed over the past three Budgets highlights the cuts that have 
been made.  The 2015-16 funding in this Budget is $400 million less than that proposed for 2015-16 in 
last year’s budget, and about $1.3 billion less than proposed for 2015-16 in the 2013-14 Budget. 
Tables 2 and 3 highlight how the Budget estimates have changed since 2013-14 for National Health 
Reform payments and for National Partnership (NP) agreements. 
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Table 2.  Payments to States and Territories for public hospitals under National Health Reform 
 2013-14                
$m 
2014-15         
$m 
2015-16        
$m 
2016-17        
$m 
2017-18         
$m 
2018-19        
$m 
2015-16 
Budget 
- 15,459.4 16,440.9 17,382.4 18,103.3 18,873.1 
2014-15   
Budget 
13,884.5 + 
916.2* 
15,115.5  + 
nfp* 
16,551.3 18,094.9 18,872.1 - 
2013-14   
Budget 
14,040.0 + 
818.5* 
15,531.1 + 
99.5* 
17,164.1 + 
99.5* 
18,956.1 
+99.5* 
- - 
*NHR reward funding 
 
A direct comparison on NPs is not really possible and perhaps not even fair, given that some of these 
were for one-off initiatives and some funding once provided through NPs is now provided through 
different mechanisms.  Nevertheless such comparisons do serve to highlight the loss of the NPs on 
mental health and prevention and the significant decline in funding for the NP on Indigenous health. 
 
Table 3. Payments for States and Territories for health National Partnership Agreements 
 2013-14                
$m 
2014-15         
$m 
2015-16        
$m 
2016-17        
$m 
2017-18         
$m 
2018-19        
$m 
2015-16 
Budget 
- 1344.7 742.9 307.8 205.2 171.6 
2014-15   
Budget 
1093.8 1304.1 949.1 668.9 660.0 - 
2013-14   
Budget 
1218.5 1410.6 1208.5 974.6 - - 
 
Special assistance for Tasmania 
This Budget provides Tasmania with the last of the funding from the Tasmanian Health Assistance 
Package - $22.9 million in 2015-16, including $10.9 million to reduce elective surgery waiting lists.  This 
is in addition to the post-budget announcement of $143.7 million / 2 years for the continued operation 
of the Mersey Hospital. 
This funding is not included in the Tables above. 
See section on Hospitals and Acute Care for further information. 
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National Health Reform Funding 
 
The 2015-16 Budget confirms that the Abbott Government remains committed to its 2014-15 decision 
to cut $57 billion over the next 10 years from Commonwealth funds to States and Territories for public 
hospitals.  Semantic games are being played about savings taken over the forward estimates and those 
proposed over the next ten years and about whether changes in indexation constitute funding increases 
or budget cuts.5 (See Table 2 and Table 3 for National Health Reform / Public Hospital funding across the 
forward estimates.) 
There are very real reasons for concern that the Government’s agenda involves doing considerably less 
in terms of supporting the States and Territories in funding public hospitals.   A December 2014 issues 
paper on “Roles and Responsibilities in Health Care” prepared for the Reform of the Federation White 
Paper laid out some very sensible issues and questions for discussion.6  However a leaked proposal 
prepared by the Department of Prime Minister and Cabinet as part of the Federation reform process 
proposed handing over the full funding of public hospitals to the States. 
This would means that the loss of up to $18 billion / year which would decimate State and Territory 
budgets. States would have to raise taxes, cut back on hospital admissions or perhaps even means test 
access to public hospitals.  Meanwhile the main means of reducing hospital admissions and costs – by 
addressing shortfalls in primary care – would remain under Commonwealth control. 
Currently the States and Territories provide the majority of public hospital funding (see Table 4). 
Moreover, as Figures 1 and 2 show, this contribution is declining over time. 
Table 4. Funding of public hospitals under National Health Reform 2013-147 
Jurisdiction State/Territory 
contribution     
($b) 
State/Territory 
contribution      
(%) 
Commonwealth 
contribution    
($b) 
Commonwealth 
contribution   
(%) 
New South Wales 6.4 60% 4.3 40% 
Victoria 4.5 56% 3.5 44% 
Queensland 5.4 66% 2.8 34% 
South Australia 2.1 68% 1.0 32% 
Western Australia 2.8 65% 1.5 35% 
Tasmania 0.6 67% 0.3 33% 
Northern Territory 0.7 87.5% 0.1 12.5% 
Australian Capital Territory 0.6 67% 0.3 33% 
Total 23.1 63% 13.8 37% 
From Administrator National Health Funding Pool 
                                                          
5
 http://www.abc.net.au/news/2014-06-23/has-hospital-funding-been-cut-by-50-billion-fact-check/5486988 
 
6
 https://federation.dpmc.gov.au/sites/default/files/issues-paper/Health_Issues_Paper.pdf 
 
7
 Includes activity-based, block and public health funding.  
http://www.publichospitalfunding.gov.au/publications/annual-reports/2013-14  
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Figure 1. Funding for public hospitals8 
 
 
Figure 2.  Commonwealth share of NSW health funding 9 
 
                                                          
8 http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=60129551482  
9
 http://www.abc.net.au/news/2014-06-23/commonwealth-share-of-nsw-health-funding/5536804  
14 
 
Until June 2017 the NHR funding is linked to the level of services delivered by public hospitals: each 
State and Territory entitlement is linked to growth in public hospital activity and the National Efficient 
Price. At Senate Estimates DoH explained the 2014-15 reduction in predicted spending as due to a 
decrease in activity. From 1 July 2017 the funding will be linked to the CPI and population growth. 
The last payments made in 2014-15 under the NP in Improving Public Hospital Services, which used to 
be included here, in this Budget are shown under Other Health National Payments (as if to highlight that 
they are not part of hospital funding reform). In 2014-15 $14.5 million was paid in reward funding for 
the National Elective Surgery Target (NEST), and $45.2 million was paid in reward funding for the 
National Emergency Access Target (NEAT).  This is considerable less than was anticipated in the 2013-14 
Budget ($99.5 million), presumably because not all States and Territories qualified for reward funding 
(seeTable 5). The basis on which these payments were made is reported by the Administrator of the 
National Health Funding Pool.10 
Table 5. Reward payments to States and Territories under NHR Agreements 2014-15 
 NSW  
$m 
VIC     
$m 
QLD    
$m 
WA   
$m 
SA     
$m 
TAS   
$m 
ACT   
$m 
NT      
$m 
NEST 8.5 - - 0.9 4.1 - 0.7 0.2 
NEAT 28.6 - 16.7 - - - - - 
Lost in the debate about hospital funding is the loss post 2013-14 of funding for sub-acute beds and 
long-stay older patients which is likely to have an impact on bed availability, Length of Stay data and 
health outcomes for frail older patients.   
It is also not clear what has happened to the preventive health funds that used to make up a small part 
of this funding (given in the 2013-14 Budget as $251.9 million for 2015-16).  This represents the sum of 
amounts identified under the National Healthcare Reform agreements relating to public health, youth 
health services, and the delivery of essential vaccines.   
 
  
                                                          
10
 http://www.publichospitalfunding.gov.au/reports/national  
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National Partnership payments 
 
In 2015-16 $742.8 million will be provided to the States and Territories under four National Partnership 
(NP) agreements. 
 
NPs on Health Infrastructure 
$318.3 million is provided in 2015-16 through NPs on Health Infrastructure. 
 
 2014-15         
$m 
2015-16       
$m 
2016-17        
$m 
2017-18      
$m 
2018-19     
$m 
Health and Hospitals Fund 650.2 239.7 95.0 29.5 - 
-Hospital infrastructure & 
other projects of national 
significance 
66.4 0.6 - - - 
-National cancer system 112.4 63.1 1.5 1.6 - 
-Regional priority round 471.4 176.0 93.5 27.9 - 
Albury-Wodonga cardiac 
catheterisation lab 
- 3.5 1.5 - - 
Bright Hospital feasibility 
study 
0.1 0.1 - - - 
Cancer support clinic, 
Katherine 
0.5 - - - - 
Construction of 
Palmerstone Hospital 
20.0 20.0 - - - 
Improving local access to 
care, Phillip Island 
- 2.5 - - - 
Oncology day treatment 
centre, Frankston Hospital 
0.7 - - - - 
Redevelopment of Royal Vic 
Eye & Ear Hospital 
50.0 50.0 - - - 
Upgrade, Ballina Hospital 1.9 2.6 - - - 
Upgrade, Casino & District 
Memorial Hospital 
3.0 - - - - 
Warrnambool Integrated 
Cancer Care Centre 
10.0 - - - - 
Total 736.3 318.3 96.5 29.5 - 
From 2015-16 Budget Paper No 3 
These NPs comprise the Health and Hospitals Fund (HHF) (which has cease making new disbursements 
and the remaining $1 billion will go to the MRFF) and a series of small grants which represent local 
election commitments.  The funding to be provided over the forward estimates for the HHF regional 
priority round is $34.2 million less than in the 2014-15 Budget. 
16 
 
NPs on Health Services  
$72.7 million will be provided in 2015-16 for NPs on Health Services. 
 
 2014-15         
$m 
2015-16       
$m 
2016-17        
$m 
2017-18      
$m 
2018-19     
$m 
Canberra Hospital – 
dedicated paediatric 
emergency care 
5.0 - - - - 
Expansion of BreastScreen 
Australia 
12.4 13.6 15.8 - - 
Health care grants for 
Torres Strait 
4.5 4.6 4.7 - - 
Hummingbird House 15 0.8 0.8 0.8 0.8 
Improving Health Services 
in Tasmania  
27.6 14.8 - - - 
-Better access to 
community based palliative 
care services 
1.7 1.7 - - - 
-Cradle Coast Connected 
Care clinical repository 
0.3 0.3 - - - 
-Improving patient 
pathways through clinical 
and system redesign 
5.3 9.0 - - - 
-Innovative flexible funding 
for mental health 
1.0 1.0 - - - 
-Reducing elective surgery 
waiting lists 
19.3 10.9 - - - 
National Bowel Cancer 
Screening Program  – 
participant follow-up 
1.9 2.4 4.7 6.4 - 
National Perinatal 
Depression Initiative 
8.3 nfp nfp nfp nfp 
OzFoodNet 1.7 1.7 1.7 nfp nfp 
Royal Darwin Hospital – 
equipped, prepared, ready 
15.3 15.5 15.7 16.0 16.3 
Torres St health protection 
strategy – mosquito control 
1.0 1.0 1.0 - - 
Vaccine preventable 
diseases surveillance 
0.8 0.8 0.8 - - 
Victorian cytology service 8.9 9.3 9.8 - - 
Total 88.8 72.6 55.1 23.2 17.1 
From 2015-16 Budget paper No 3  
The only new NP under Health Services is for the provision of $4.7 million / 5 years for the construction 
and operation of a dedicated respite and hospice care facility for children in Queensland. 
17 
 
This Budget provides the last of the funding to Tasmania that was part of the Tasmanian Health 
Assistance Package ($14.8 million).  It is amusing to note that the only reference to this on the DoH 
website is a curt note that this was a provision established by the previous Government!11 
$63.5 million / 4 years is provided through a new NP with the Northern Territory for the continued 
operation of the National Critical Care and Trauma Response Centre (NCCTRC) at Royal Darwin Hospital.  
The Budget Papers say this funding has already been provided by the Government – meaning it is 
continued funding in the forward estimates. Only about $32 million of this is new funding as the current 
NP provides funding of $31.3 million for 2015-16 and 2016-17. (This provision is discussed further in the 
Miscellaneous Section). It is not clear why the Government considers it necessary to sign a new 4 year 
NP when the current NP still has 2 years to run. 
Considerable concern has been generated by the failure to provide future funding for the National 
Perinatal Depression Initiative (NPDI).  To date no explanation has been forthcoming from the 
Government.12 
The NDPI was created in 2008, when State and Territory Governments, together with the Federal 
Government, agreed to collaborate on the development of a five year national initiative to improve the 
prevention and early detection of antenatal and postnatal depression and to provide better care, 
support and treatment for expectant and new mothers  
The Commonwealth committed $55 million / 5 years towards the NPDI – $30 million to the states and 
territories, $20 million to the Access to Allied Psychological Services (ATAPS) component of the Better 
Outcomes in Mental Health Care program, and $5 million to beyondblue. The states and territories 
committed an additional $30 million / 5 years, bringing the total funding to $85 million nationally. 
Although the funding for this program expired in June 2013, the 2014-15 Budget provided future 
funding ($8.2 million / year) for the three years 2014-15 to 2016-17, so the money is in the forward 
estimates.  The apparent loss of this program might be linked to the apparent loss of the ATAPS program 
and the huge delay in doing anything about mental health reform. 
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NP on Indigenous Health 
Funds for Indigenous health provided through NPs have declined precipitously in recent years. In 2015-
16 only $12.9 million will be provided and all of this is for programs in remote areas – mostly in the 
Northern Territory. 
 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18   
$m 
2018-19   
$m 
Accommodation, 
infrastructure for renal 
services in NT 
10.0 - - - - 
Improving trachoma control 4.1 .4.2 4.2 - - 
Early childhood 
development –antenatal 
and reproductive health 
31.5 - - - - 
NT remote Aboriginal 
investment - health 
- 5.6 5.9 6.2 6.4 
Renal dialysis services in 
Central Australia 
1.7 - - - - 
Rheumatic fever strategy 3.0 3.1 2.7 - - 
Stronger Futures in NT - 
health 
10.3 - - - - 
Torres Strait health 
protection strategy – Sabai 
Is clinic 
0.5 - - - - 
Total 61.0 12.9 12.9 6.2 6.4 
From 2015-16 Budget paper No 3 
 
Funding previously provided to the Northern Territory via the NP on Stronger Futures is replaced from 
2015-16 by a new NP on Northern Territory remote Aboriginal investment. The only changes seem to be 
the name of the NP and a decrease in funding from around $10 million / year to $5-6 million / year.   
It is not clear whether the Government’s strategy in future years is increasing to require Indigenous 
Australians to use mainstream services, or whether new NPs will be established once the ATSI Health 
Plan is implemented.   
This provision is discussed in greater detail in my analysis of the impact of the 2015-16 Budget on 
Indigenous Affairs.13 
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Other Health NPs 
$339.1 million is provided in 2015-16 for adult public dental services, essential vaccines and funding for 
mental health services. 
 
 2014-15         
$m 
2015-16       
$m 
2016-17        
$m 
2017-18      
$m 
2018-19     
$m 
Treating more public dental 
patients 
135.8 - - - - 
Adult public dental health 
services 
- 155.0 nfp nfp nfp 
Essential vaccines 211.1 138.8 143.3 146.3 148.1 
National Coronial 
Information System 
0.4 - - - - 
Supporting National Mental 
Health Reform 
51.6 45.3 - - - 
Total 398.9 339.1 143.3 146.3 148.1 
 
The Budget provides funding for the NP on Adult Public Dental Services, the commencement of which 
was deferred for 12 months in the 2014-15 Budget, but then cuts by nearly 25% the funds previously 
allocated for 2015-16 (from $200 million to $155 million).  Moreover there is no certainty provided for 
future funding. Budget Paper 3 indicates that “Funding arrangements beyond 2015-16 are subject to 
negotiations with the states” – the usual modus operandi of the Abbott Government.  The statement 
from the Minister for Health, Sussan Ley, released two days before the Budget, stated that “more than 
$200 million” would be provided in the Budget for dental services in 2015-16.14 Her statement also 
referenced the Government’s White Paper on Reforming the Federation as providing an opportunity to 
greater co-ordination with less duplication. In this political environment that could well be read as the 
Abbott Government looking to divest itself of responsibilities for public dental services. 
This provision is discussed further in the section in Dental Health. 
The NP on Essential Vaccines provides funding to the States and Territories for the purchase of essential 
vaccines that are provided through the National Immunisation Program (NIP) and have not yet 
transitioned to centralized purchasing arrangements. 
Under a COAG agreement, starting in 2009-10 the funding for the NIP changed from a Specific Purpose 
Payment (SPP) to a Commonwealth Own Purpose Expense (COPE) arrangement. The Commonwealth is 
responsible for the procurement and payment of NIP vaccines and the functions associated with 
implementation of the NIP remain the responsibility of the States and Territories. Funding for this is 
provided as part of the National Health Reform / Public Hospitals funding (see Table XX) but is no longer 
specifically stated. The 2013-14 Budget gave the total funding for the public health component of the 
NHR funding (this includes more than the vaccine service delivery function) as $365.3 million. 
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The Budget Paper state that over $400 million in funding has been transferred to Commonwealth 
centralized purchasing arrangements since the 2014-15 MYEFO.  It appears from this statement and a 
comparison of funding for this provision over the years since 2009-10 that little progress has been made 
to date in implementing the COAG agreement, which should enable significant price savings. 
It is not clear what has happened since June 2015 to the NP for the National Coronial information 
System. This is paid to Victoria and has been in operation since at least 2008-09. 
Like all the mental health programs, the NP on Supporting National Mental Health Reform and the 
programs and services it supports is without a known future. The Budget Papers make no comment on 
this. 
The agreement documents for this NP highlight that the focus is to be on delivering improved health, 
social, economic and housing outcomes for people with severe and persistent mental illness by 
addressing gaps in services and preventing cycling through state mental health systems.15 
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Hospitals and acute care 
 
As previously noted (see section on State and Territory and Commonwealth relations), the Abbott 
Government is withdrawing from the Commonwealth commitment to sustainable public hospital 
funding, and to meeting an equal share of growth in public hospital costs. 
 
While reports from the National Health Performance Authority16highlight improvements in the targets 
set as part of the National Health Reform Agreements, this is still some considerable way to go before 
these targets are met by all hospitals in all jurisdictions, as the 2015 AMA Public Hospital Report card 
highlights.17 The likelihood of these targets being met is reduced by Commonwealth actions that reduce 
hospital funding and make access to primary care and specialist care and many PBS drugs more 
expensive. 
It is ironic that the Independent Hospital Pricing Authority (IHPA) an independent government agency 
established by the Commonwealth as part of the National Health Reform Act 2011 , to implement 
Activity Based Funding (ABF) for Australian public hospitals, has recently released a draft Pricing 
Framework 2016-17 for consultation.18  The expectation is that this will be implemented in 2016-17 as 
proposed by the previous Labor Government, only to be withdrawn in 2017-18 as proposed by the 
Abbott Government, which will also then abolish the IHPA. 
 
Mersey Hospital - Tasmania 
 
On 28 May 2015, a joint statement from the Federal Health Minister Sussan Ley and the Tasmanian 
Health Minister Michael Ferguson announced the Abbott Government would provide the Mersey 
hospital with operational funding of $148.5 million / 2 years.19  
Funding for the Mersey Hospital was due to run out on June 30. This statement leaves unresolved the 
issue of the future of this hospital, and whether it will return to state funding. 
This is the only federally owned hospital in Australia, although it is operated by the Tasmanian 
Government. As the Howard government's health minister in 2007, Mr Abbott took over funding for the 
hospital from the Tasmanian Government. It followed public outrage at an announcement that the 
hospital would be downgraded to a day procedure centre, with only a limited overnight emergency 
facility. 
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The State Government has stated an intention to turn the Mersey into a state centre for elective day 
surgery but the local community wants to maintain a 24/7 emergency department and high dependency 
unit and maternity services.20 While ever the future of the hospital remains firmly in the political cycle 
there will be doubts about its long-term future. 
 
Royal Darwin Hospital 
 
The 2015-16 Budget provides  $63.5 million / 4 years is provided through a new NP with the Northern 
Territory for the continued operation of the National Critical Care and Trauma Response Centre 
(NCCTRC) at Royal Darwin Hospital.  The NCCTRC was announced after the 2002 Bali bombings and 
formally established in 2005.  Its function is to ensure enhanced surge capacity for Royal Darwin Hospital 
to provide a rapid response in the event of a mass casualty incident in the region. To achieve this 
objective the NCCTRC has provided significant financial support (around $15 million / year) to Royal 
Darwin Hospital to enhance the capability of the hospital’s surgical and trauma divisions. 
This provision is discussed in more detail in the Miscellaneous Section. 
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Medicare 
 
The Budget Papers show that Medicare expenditure is expected to exceed $21.1 billion in 2015–16, an 
increase of 1.6% from 2014-15. Growth in Medicare expenditure to 2018–19 is expected to be 6.7% in 
real terms, which is below forecast growth in expenditure on the private health insurance rebate (7.0%), 
but higher than PBS growth (3.8%) over the same period 
The Abbott Government’s policy on Medicare continues to be unknown and unknowable.   
The 2014-15 Budget introduced co-payments for most GP visits and for out-of-hospital diagnostic 
imaging and pathology tests.  This would for the first time remove bulk billing for these items. That this 
was a decision based on ideology rather than policy was indicated by the varying explanations provided 
for this action.  It was variously sold as helping to address the budget emergency, ensuring the 
sustainability of Medicare, sending a price signal and reducing unnecessary health services. 
In the 2014-15 MYEFO the Government moved to modify their proposal, with changes to rebates for 
Level A and B GP consultations and a $5 reduction in rebates for GP consultations for non-concessional 
patients. This essentially placed the responsibility for a co-payment (or not) on doctors by diminishing 
their fees via the reduction in rebates and a freeze on rebate indexation and then allowing them to 
charge an optional patient co-payment. Not surprisingly, there was major opposition from doctors and 
patients alike. 
Now, the Government has decided not to proceed with these measure (although the pause on 
indexation for doctors, allied health professionals and optometrists remains and is extended to 2018) – 
a decision that is expected to cost the Budget $2.9 billion over the forward estimates, but will still 
achieve savings of $1.3 billion.  
A paper published in the Medical Journal of Australia in March21 found that the indexation freeze will 
cost GPs $384.32 per 100 consultations in 2017–18 dollars, requiring an $8.43 copayment per non-
concessional patient consultation to maintain their current incomes. It predicted that even though the 
rebate reduction has been retracted, the freeze will have greater impact with time — nearly double the 
amount of the rebate reduction by 2017–18 – and the freeze may still force GPs who currently bulk bill 
to charge copayments  as their practice costs rise. More recently, the second interim report from the 
Senate Select Committee on Health published similar findings and quoted the AMA as calling the 
indexation freeze ‘co-payments by stealth’.22  
 
There is some hope that Health Minister Sussan Ley’s recently announced review of all items on the 
Medicare Benefits Schedule (MBS) represents a new approach that will be more grounded in evidence 
and deliver some improved quality, safety and health outcomes. However there are also concerns about 
this review. It is required to review the 5,500 items currently on the MBS within a very short time frame, 
and while there is no savings target attached to the review, the Minister has indicated that any savings 
would go to the MRFF rather than to a restructure of MBS items (for example, to better reward 
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coordinated care).23 There needs to be an ongoing review of the MBS that considers items and their 
reimbursement in the light of new evidence and medical and technological progress. There is growing 
recognition through publications and the recently launched Choosing Wisely Australia program24 that 
the MBS25 and the PBS currently have many low- value items. 
 
The AMA and others have spoken out about how current funding arrangements for general practice do 
not adequately encourage and reward team and community-base care and coordinated care and need 
to be overhauled.  There is growing support for alternatives to the current fee-for-service model. Some 
GPs have acknowledged the tension between their professional aspirations to provide quality care, 
especially for patients with multi-morbidities and the demands of running a business.26  Many of these 
issues could be addressed by apply savings achieved by disinvestment from low-value services to the 
proposals that will be developed by the Primary Health Care Advisory Group.   
 
It remains to be seen if the Abbott Government is willing to embark on these initiatives which have the 
potential to deliver savings and needed reforms and make Medicare sustainable into the future. 
 
 
Out of pocket costs 
 
The issue of growing out-of-pocket (OOP) costs and their impact on the ability of Australians to access 
needed health care is undermining the universality of Medicare, widening health inequalities and 
arguably leading to increased hospital costs. 
Currently, individual co‐payments comprise around 17% of total health care expenditure in Australia – 
the largest non‐government source of funding for health goods and services.27 This includes where 
individuals meet the full cost of goods and services ‐for example, medications that are not subsidised by 
the PBS, health services not subject to a Medicare rebate ‐ and where individuals share the cost of 
health goods and services with third party payers such as Medicare and private health insurance funds. 
 
This contribution by individuals represents a higher proportion of health care funding than in most other 
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OECD countries and equates to $1,078 per capita. Moreover, in most OECD countries over the last 
decade the proportion of total expenditure coming from individual co‐payments has been decreasing, 
while in Australia out‐of‐pocket expenditure on health per capita continues to grow at a faster rate than 
the broader economy, average incomes and overall household expenditure.28  
 
Measured in current prices, out‐of pocket expenditure on health per capita has grown by 89.0% over the 
decade to 2011–12. In particular, total patient out‐of‐pocket expenses for primary and specialist care 
have significantly increased over the past 10 years, rising from $9.7 billion in 2001–02 to $17.1 billion in 
2011–12, a 76% increase.29 The average cost of a GP visit in 2013-14 was $47 from Medicare plus $5 
from the patient.  For a private specialist, the average visit cost $82 from Medicare plus $38 from the 
patient.30  
 
About one-third of individuals’ out-of-pocket costs go for medicines, and although this includes 
nutritional supplements and ‘complementary’ and ‘alternative’ medicines, the out-of-pocket costs of 
essential over-the-counter and prescription medicines is also rising.31   
 
While these figures give a general guide to medical OOP costs, it is important to understand that in 
health care there are few ‘average’ patients.  That is because health care usage (and health care costs) 
are not evenly distributed across the population.  Increasing numbers of Australians are incurring high 
OOP costs on a regular basis, due to factors such as their location, type of illness and the availability of 
public health care services.   
 
People with chronic illnesses and disabilities use health care much more often than the rest of the 
population and the increase in out-of-pocket costs falls disproportionately on this group, which already 
has a lower average income, thus compounding their financial disadvantage. So begins a vicious cycle, 
where those with poor health and fewer financial resources must pay proportionately more out-of-
pocket for their needed care, meaning they often go without. 
 
The Abbott Government has pushed to introduce or increase co-payments, claiming variously that 
growth in health care costs is unsustainable, price signals are need to reduce GP visits, budget deficits 
must be addressed and increased funding is needed for medical research. But targeting primary care for 
cost savings will quickly backfire. Research shows that while the number of GP visits has increased, these 
services are cost-effective; if the same services were performed in other areas of the health care system, 
they would cost considerably more.32 
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The World Health Organisation has highlighted some of the potential negative consequences of co-
payments, including the fact that they are the least equitable form of health funding because they are 
regressive (the rich pay the same amount as the poor for any particular service).33 There is now a raft of 
Australian reports highlighting the adverse impacts of co-payments.34 
It is clear that whether the policy focus is on economic, health or social equity outcomes, greater 
attention needs to be paid to tackling rising out-of-pocket costs. With our ageing population and rising 
rates of chronic conditions, we can expect that there will be increasing numbers of Australians requiring 
long-term health and medical care from a range of different providers and in both hospital and 
community settings. Our current health care financing systems and safety-net arrangements are 
inadequate in meeting the needs of this group to ensure they can manage their health care costs and 
afford the services they need.   
This is a difficult topic – it involves a potent mix of evidence, ideology, consultation and leadership.  
There is no silver bullet and effective solutions are unlikely to be found through simple ‘add ons’ to our 
current health funding system, developed in an age where the majority of health care was for short-
term, acute problems. They are more likely to involve a multi-faceted approach and require a re-thinking 
of the ways in which we generate and allocate our health care resources and ensure health care funding 
decisions reflect our society’s underlying values. 
Work in this important area has barely begun, probably because in the absence of truly universal health 
care, it’s a wicked problem to solve, involving a potent mix of evidence, ideology, consultation and 
leadership. There is no silver bullet and effective solutions are unlikely to be found through simple ‘add 
ons’ to the current health funding system, developed in an age when the majority of health care was for 
short-term, acute problems.  A multi-faceted approach is required, based on evidence and need and 
reflecting our society’s underlying values. 
It is important that policies target those with the largest out-of-pocket costs and those who have 
problems affording their essential health care expenses. These are not necessarily people on the lowest 
incomes or people with concession cards. The increasingly high thresholds mean many people with 
complex medical needs can’t afford to reach the protections of the safety nets. Simply carving out 
exclusions on the basis of age or concessional status risks shifting costs to other vulnerable groups, thus 
widening inequalities and increasing preventable health problems.   
 
In addition, tackling over-testing, inappropriate prescribing and unwarranted variation in health care 
services is needed, together with a concerted effort to identify low-value health care practices and 
incentives to encourage disinvestment in these. These efforts will not necessarily address patients’ out-
of-pocket costs directly, but will ensure better value for the health care budgets of both individuals and 
governments.  
 
If new policies are to be sound and publicly accepted, they must be underpinned by work to establish 
what the public wants and to better engage Australians in the current debate over health care costs, by 
establishing who bears the burden of unmanageable out-of-pocket costs, and by consultation with 
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health care professionals at the coal face about how they see this issue from both a business and a 
health outcomes perspective. 
 
It is ironic that the last time an Australian government moved to tackle out-of-pocket costs was when 
Tony Abbott was Minister for Health and introduced the Extended Medicare Safety Net to cover rising 
specialists’ fees.  However this approach was recognisably flawed from the beginning and quickly led to 
inappropriate fee increases by some specialists. Successive governments have been forced to tinker with 
the policy to limit cost blow-outs; none has been willing to address the fact that the majority of safety 
net benefits flow to the most well-off Australians. It was no surprise that this policy failed to deliver on 
the expected outcomes and had unintended negative consequences and it serves as a lesson for future 
policy-makers. 
To kick-start the necessary analyses, debates and policy formulations, Jennifer Doggett and I have 
developed a discussion paper which lays out the issues, as we see them. 35  
Solutions might be drawn from initiatives that make better, more cost-effective use of the various skills 
of the health care workforce, by a reconsideration of when the GP gatekeeper role is essential, by 
transparency around specialist fees, perhaps even shaming those whose fees are significant outliers, and 
through the establishment of community health centres with salaried staff in areas of need. For people 
who are recognised as having ongoing high health care costs, reduced co-payments and out-of-pocket 
costs could be linked to voluntary registration with a general practice and a pharmacy, thus also 
ensuring greater coordination and continuity of care. 
 
We are well aware that these proposals for addressing out-of-pocket costs will be seen as controversial 
by some.  The paper is admittedly short on solutions, but we are hopeful these will come.  Our purpose 
is to galvanise thought, evidence and action to address this key issue of fairness and equity.  There is no 
shortage of collated evidence and expert advice available to drive policy development – all that is 
needed is leadership. 
 
Budget provisions 
 
Medicare Benefits Schedule – reversal of changes to GP rebates 
Savings of $2.99 billion / 5 years are foregone by the Abbott Government’s decision not to proceed with 
the changes to rebates proposed in December 2014 and costed in the 2014-15 MYEFO. 
 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DoH 182.7 657.8 699.0 726.5 762.8 
DVA 3.5 6.4 6.0 5.7 5.4 
DHS -4.7 -18.3 -13.4 -13.9 -14.2 
Total 181.4 645.9 691.6 718.3 754.1 
Related capital DHS -0.3 -0.2 - - - 
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However it appears that the Government is still achieving savings of some $1.3 billion over the years 
2014-15 to 2017-18. This may be explained by inclusion of the savings from the freeze on Medicare 
rebates – although these were costed separately in previous budgets. 
As originally proposed in the 2014-15 Budget this policy – then touted as a patient copayment  - was set 
to save $3.5 billion / 5 years. 
 
 2013-14           
$m 
2014-15       
$m 
2015-16      
$m 
2016-17     
$m 
2017-18     
$m 
DoH - 1.4 -1,164.4 -1,181.6 -1,226.8 
DHS 0.2 7.4 34.2 28.6 26.0 
Total 0.2 8.8 -1,130.2 -1,153.0 -1,200.8 
Related capital  DHS - 5.4 2.4 - - 
From 2014-5 Budget 
 
In the face of major opposition to this proposal, in December 2014 the Prime Minster announced that 
the $7 Medicare co-payment would not proceed.36 Under the new proposal Medicare rebates for 
common GP consultations would be reduced by $5 for non-concessional patients aged 16 and over from 
1 July 2015. The Government stated that “Doctors may choose to recoup the $5 rebate reduction 
through an optional co-payment or continue to bulk bill non-concessional patients over the age of 16” , 
describing this as an ‘optional copayment’.  
At the same time, changes were made to the standard GP consultation items and Medicare fees for all 
services provided by GPs, medical specialists, allied health practitioners, optometrists and others will 
remain at their current level until July 2018. 
 
It was stated that these changes would contribute more than $3 billion to the Medical Research Future 
Fund. 
MYEFO 2014-15 provided new costings for this policy over the forward estimates. 
 
 
 
2013-14   
$m 
2014-15    
$m 
2015-16   
$m 
2016-17    
$m 
2017-18   
$m 
DoH -  -183.1 375.9 50.9 -248.7 
DHS -  2.1 -12.9 -12.7 -11.5 
Total - -181.1 363.0 38.2 -260.2 
From MYEFO 2014-15 
 
It is assumed then that the total savings from this policy are derived by subtracting the MYEFO figures 
from the Budget figures.  This would deliver savings of the order of $3.5 billion. 
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2013-14   
$m 
2014-15    
$m 
2015-16   
$m 
2016-17    
$m 
2017-18   
$m 
Total  0.2 -172.3 -767.2 -1115.0 -1461.0 
Derived by subtracting MYFO expenses from 2014-15 Budget expenses 
 
Medicare Benefits Schedule – modification of health assessment items 
Savings of $144.6 million / 4 years are made by removing the current duplication between health 
assessments under MBS and health assessments provided by the States and Territories. The savings are 
directed to fund other heath policy priorities or to the MRFF. 
 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DHS - 0.1 -0.2 -0.2 -0.2 
DoH - -20.0 -36.2 -41.3 -46.7 
Total - -19.9 -36.3 -41.4 -46.9 
 
Medicare currently funds the Healthy Kids check for children who have received, or are receiving their 
four-year-old immunisation.  A number of States offer similar child health checks. For example, the 
Victorian Government funds free regular health and development checks at Maternal and Child Health 
centres for children up to the age of three and a half.  
A child health check is required in order to qualify for the FTB Part A Supplement.37Both the Medicare 
Healthy Kids check and State and Territory child health checks meet this requirement.  
Details of what the revisions to health assessments will be are not provided in the Budget, but some 
information was provided in Senate Estimates.  The ability to bill for a Health Check for kids aged 0-4 
under MBS items 701 (brief), 703 (standard), 705 (long), and 707 (prolonged) will be removed on the 
assumption that most services provided under these items for this age group are Healthy Kids checks. 
GPs who continue to provide these services must bill for a standard GP consult. The current 
reimbursement for item 703 (the most popular) is $137.90 and the reimbursement for a standard GP 
consult is $37.05. This will likely mean additional costs for parents who cannot access State and Territory 
services.  
Indigenous children will continue to be eligible for the Aboriginal and Torres Strait Islander health 
assessment every nine months under MBS item 715. It is not clear what happens to item 10986 
(provision of a health check by a Practice Nurse or an Aboriginal Health Worker).   
Senate Estimates was told that State and Territory child health checks provided a more comprehensive 
health assessment (this could not be verified) and that the Government only has payments data for the 
provision of these checks, and does not have any information about subsequent referrals. DoH gave the 
following data: in 2008-09 37,924 services were provided at a cost of $1.73 million; in 2013-14 157,680 
                                                          
37
 http://www.humanservices.gov.au/customer/enablers/centrelink/family-tax-benefit-part-a-part-b/healthy-
start-for-school-health-check  
30 
 
services were provided at a cost of $20.52 million.  The estimate was that 53% of the eligible population 
had received a Healthy Kids check (it is not clear if this applies to Medicare data or to FTB-A Supplement 
data, but presumably the former). 
Medicare Australia data show that for children aged 0-4 years in 2013-14 137,004 services were 
provided at a cost of $17.65 million. This includes services provided under item 10986.  The differences 
between these data and DOH are not known.  Also it is not clear why savings over the forward estimates 
makes the bold assumption that 100% of eligible kids would get this service over the next 4 years when 
uptake of this item has been relatively slow. 
 
New and amended listings on the Medicare Benefit Schedule 
The addition of new and amended items to the MBS and to Veterans’ Benefits will cost $39.8 million / 4 
years. 
 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DoH - 8.4 11.3 9.9 8.4 
DVA - 0.3 0.4 0.3 0.3 
DHS - 0.2 0.1 0.1 0.1 
Total - 8.8 11.8 10.3 8.8 
 
The new and amended listings include: 
 Rebates for second expert opinions for diagnoses related to the testing of bone marrow specimens, 
tissue pathology and cytopathology/ 
 New items for the treatment of early stage breast cancer using targeted intraoperative 
radiotherapy. 
 New items to enable routine monitoring of implanted cardiac devices to be provided remotely. 
 Extended eligibility for the use of telehealth services to optometrists, to support patients use of 
video consultations with specialist ophthalmologists. 
Revised listings include: 
 Paediatric surgical services  
 Computed tomography colonography 
It is assumed that these revised listings generate savings. 
The total cost of these items is more than offset by savings of $287.80 / 4 years taken in MYEFO from 
new and amended MBS items. 
 
 
31 
 
Review and reform of the Medicare Benefits Schedule 
$34.3 million / 2 years is allocated for review of the MBS items and to continue the activities of the 
Medical Services Advisory Committee (MSAC). 
 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DoH - 17.0 17.3 - - 
 
The current funding levels for MSAC for MBS review work is of the order of $9.5 million / year. 
Currently, the MBS has more than 5,500 services listed, not all of which reflect contemporary best 
clinical practice. Health Minister, Sussan Ley, has announced an MBS Review Taskforce that will consider 
how MBS services can be aligned with contemporary clinical evidence and improve health outcomes for 
patients.38 The Health Minister has said the Government’s proposed reforms would be “an ongoing 
process”  (although funding is only provided for two years) and that the taskforce is expected to report 
back “with key priority areas for action” in late 2015. Barely 3% of items on the MBS have been properly 
assessed against contemporary evidence for safety, effectiveness and cost effectiveness so this is a large 
task.  
In the 2009-10 Budget, Labor initiated an independent systematic review of MBS items via an MBS 
Quality Framework and $9.3 million / 2 years was provided for this work. In 2011 the decision was made 
to refer all applications for new MBS items, as well as significant amendments to existing items, to MSAC 
as the sole source of expert appraisal and advice to ensure consistency and administrative efficiency. 
The 2011-12 Budget provided funding of $11.4 million / 2 years and further funding of $19.6 million / 2 
years was provided in 2013-14 to enable MSAC conduct rolling reviews of the quality, safety and fee 
levels of items listed on the MBS.  
The work of experts under this Framework is complicated and protracted 39 but has resulted in changes 
to MBS item rebates. Some occurred with little notice such as changes to Vitamin D testing, while others 
attracted significant attention, as was the case with changes recommended to the rebate paid for 
cataract surgery.  
Labor has supported this review, with Shadow Minister for Health, Catherine King saying; “ This is good, 
and smart health reform, based on evidence, quality and safety in healthcare. It is not about rationing 
healthcare but ensuring informed decisions on the part of both doctors and patients about the best 
approaches.”40 
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 http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2015-ley045.htm  
 
39
 https://www.chf.org.au/pdfs/chf/Presentation-DoHA-MBS-Quality-Framework-workshop-25May2010.pdf 
 
40
 http://www.theguardian.com/commentisfree/2015/apr/16/reviewing-medicare-benefits-should-be-an-act-of-
reform-not-saving-for-savings-sake 
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The linking of MBS item review and reform to a complimentary review of primary care and the 
development of clearer Medicare compliance rules and benchmarks41, combined with the independent 
work of Choosing Wisely Australia, offers exciting possibilities for meaningful reforms. However there 
remain concerns that the Abbott Government will use the review as a mechanism to cut Medicare 
funding rather than an opportunity for needed reform. 
 
Medicare After Hours Practice Incentive Program 
More than $410 million / 4 years, including $98.8 million in 2015-16 are provided for a new After Hours 
Practice Incentive Program (AH PIP).  These funds are redirected from the After Hours GP Helpline which 
is cancelled and the Medicare Locals After Hours Program.   
 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DoH - -1.8 -0.2 -0.3 -0.3 
DHS 1.5 0.2 0.2 0.3 0.3 
Total 1.5 -1.5 .. .. .. 
 
It is not clear if this funding also covers the provision of After Hours care by PHNs where this is needed. 
The new PIP is based on recommendations from the After Hours Primary Health Care Review.42 It 
provides five separate payment levels, with quarterly payments:43 
 Tier 1 -  $1 per Standardised Whole Patient Equivalent (SWPE) for a formal arrangement to ensure 
that practice patients have access to care in the complete after-hours period (eg a phone 
arrangement with a locum service).  
 Tier 2 - $4 per SWPE for participating in a cooperative arrangement with other practices cover the 
sociable after-hours period (6pm–11pm weeknights) and making formal arrangements for patients 
at other times.  
 Tier 3 -  $5.50 per SWPR for the provision of direct care of practice patients during the sociable 
after-hours period of 6pm–11pm weeknights, with formal arrangements for a substitute service in 
place for other times.  
 Tier 4 - $5.50 per SWPE for practices that cooperate to provide after- hours care to practice patients 
for the complete after hours period (hours outside of 8am to 6pm weeknights; hours outside of 8am 
to 12pm Saturdays; and all day Sundays and public holidays).  
 Tier 5 - $11 per SWPE for practices directly providing round-the-clock care. 
The new after-hours regime allows more flexibility by including GP telephone advice and telehealth 
services, as well as home visits and in-practice consultations. 
                                                          
41
 http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2015-ley045.htm 
 
42
 http://www.health.gov.au/internet/main/publishing.nsf/Content/primary-ahphc-review 
 
43
 http://www.health.gov.au/internet/main/publishing.nsf/Content/primary-ahphc#pip  
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The top payment under the new AH PIP for round-the-clock coverage that is more than five times the $2 
flat rate (per weighted average patient) offered under the previous PIP.  It remains to be seen if this 
more generous incentive will encourage more GPs to provide full after hours services. 
The DoH website says that PHNs will receive funding to work with key local stakeholders to plan, 
coordinate and support after- hours services and ensure these are targeted to the specific needs of 
different communities. It is not clear if this applies to all PHNs or to those where there are gaps in after-
hours service provision. 
The Jackson After-Hours Review found that the main factor driving the increase in after-hours MBS 
claims over the four-year period to 2013 was non-urgent consultations on practice premises on 
weeknights, mostly in urban areas in the country’s east and southeast. Another conspicuous driver of 
growth was in services by medical deputising services, in many cases backed by Medicare Locals. There 
was considerable opposition to these services from the AMA. 
The After Hours GP Helpline (AHGPH) will cease operations June 30, 2015. The Jackson review identified 
a number of issues with the AHGPH but acknowledged that a full cost-benefit analysis of the Helpline 
had not been conducted. Now all the efforts put into public awareness of this service will be lost, leaving 
some consumers bewildered. 
Many PHNs are not yet functional, and uptake of the new PIP is likely to be slow initially: this could leave 
a gap period where many communities are without functioning after- hours services. The impending 
transition from MLs to PHNs may stifle opportunities for collaboration in the establishment or expansion 
of after-hours services, especially in the initial period of operation.   
 
Other Medicare issues 
 
Medicare indexation freeze 
The Government is freezing the indexation of Medicare rebates for four years from 1 July 2014 until July 
2018. GP and specialist fees have been frozen since 1 November 2012, except for the on-off indexation 
of GP consultations by 2% on 1 July 2014. Medicare rebates for pathology and diagnostic imaging 
services have not increased for more than 15 years. 
 
As previously noted, this cut to health professionals’ reimbursements will inevitably be passed on to 
patients and private health insurers, ensuring that increases in out-of-pocket costs and higher private 
insurance premiums. It will also act to reduce bulk billing rates.   
  
 Medicare compliance rules 
The Minister for Health has indicated, as part of the announcement on MBS review and the Primary 
Health Care Advisory Group, the intention to develop clearer Medicare compliance rules and 
benchmarks.44 These will be developed in consultation with representatives from the medical 
profession, clinical leaders and patient representatives.  
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 http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2015-ley045.htm 
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The aim is to ensure that medical practitioners are not providing inappropriate services. The Minister for 
Health has indicated that the government is determined to prevent over-testing, duplication in service 
provision and “unnecessary referrals, duplication, inefficiencies and systemic waste.” 
 
Alternative funding models 
 
The  Royal Australian College of General Practitioners (RACGP) has put forward an alternative funding 
model to standard fee-for-service that would reward GPs for treating  complex patients, providing 
comprehensive services, and co-ordinating care between different healthcare providers.45 
While fee-for-service would be retained for ‘every day’ care, a range of new payments that are patient-
focussed not disease and process focussed would replace existing Practice Incentive Payments and 
Service Incentive Payments.  
The aim is for an Australian version of a patient-centered medical home, with patient enrolment to 
formalise relationships between patients and their GP. 
 
Practices would receive a payment for each patient enrolled with it, based on their patients’ age, socio-
economic status, whether they were Indigenous, and the local community’s health profile. There would 
also be rewards for working in rural and remote areas.  These payments would address complexity, 
coordination of care and help reduce health inequalities. 
Those practices that delivered a wide range of services, such as after-hours services, home care, 
palliative care and aged care in the community would be eligible for a new "comprehensiveness 
payment". GPs or practices could also receive payments to co-ordinate the care of their patients 
between different health providers, to employ nurses, teach students, conduct research, and upgrade or 
maintain IT and infrastructure.46 
The plan does not identify the cost of the changes. 
  
                                                                                                                                                                                           
 
45
 http://www.racgp.org.au/download/Documents/advocacy/Consultation-paper-RACGP-Vision-for-a-sustainable-
health-system-14-A.pdf 
 
46  
http://www.racgp.org.au/download/Documents/advocacy/Executive-Summary-RACGP-Vision-for-a-sustainable-
health-system-14-Ap.pdf  
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Pharmaceutical Benefits Scheme 
 
The Australian Government provides subsidised medicines through the Pharmaceutical Benefits Scheme 
(PBS).  In 2015-16 the PBS is expected to cost $9.77 billion and to dispense approximately 298 million 
scripts. 
Budget paper 1 outlines the trends in major components of the PBS over the forward estimates (see 
Table 6). However this table does not include the costs of the 6th Community Pharmacy Agreement (6th 
CPA)47and the costs and savings of the PBS Access and Sustainability Package48which were announced 
shortly after the Budget.49  
 
Table 6:  Spending on Pharmaceutical Benefits Scheme 2014-15 to 2018-19 
 Estimates Projections 
2014-15   
$m 
2015-16    
$m 
2016-17    
$m 
2017-18    
$m 
2018-19    
$m 
Pharmaceutical benefits 
(concessional) 
5,657 5,735 5,957 6,137 6,315 
Pharmaceutical benefits 
(HSD, other hospital drugs) 
2,213 2,601 2,809 2,965 3,072 
Pharmaceutical benefits 
(general) 
1,414 1,434 1,489 1,534 1,580 
Pharmaceutical benefits 
(targeted medicine prgms) 
148 114 106 113 115 
Immunisation 180 273 309 315 314 
Pharmaceutical benefits 
(Veterans) 
388 369 376 389 402 
Payments for wholesalers 
and pharmacy prgms 
342 344 347 350 354 
Other 265 268 272 278 284 
Total 10,607 11,138 11,667 12,081 12,439 
From 2015-16 Budget Paper 1 Table 8.2 
 
Comparison of this Table as presented with 2014-15 Budget data shows projected increases in spending 
(see Table 7).  The main variations seem to be significant increases in the cost of drugs dispensed 
through hospitals and payments to wholesalers and pharmacists.   
This latter issue bears some investigation. This covers funds initially provided as part of the 2007 PBS 
Reform package when both pharmacists and wholesalers were given significant compensation 
                                                          
47
 http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2015-ley053.htm 
 
48
 http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2015-ley063.htm 
 
49
 2015-16 Portfolio Budget Statements, Health portfolio page 57 
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arrangements. Pharmacists receive a payment (initially $1.53 and indexed annually) for dispensing of 
‘premium free’ medicine. As pointed out in a brief from the Parliamentary Library, this payment 
essentially provides pharmacists additional income for a task which is already remunerated by the 
dispensing fee.50  (Note: as described in the following section, savings have subsequently been taken 
from this payment by a measure in the proposed PBS Access and Sustainability Package).  This funding 
likely also includes the wholesaler Community Service Obligation (CSO) pool. 
There is a projected decrease in the cost of targeted medicine programs.  This includes the Special 
Access Program for Herceptin and the Life Saving Drugs Program which is currently under review.  This 
review is expected to be completed in late 2015. 
 
Table 7:  Spending on Pharmaceutical Benefits Scheme 2014-15 to 2018-19 
 Estimates Projections 
2013-14   
$m 
2014-15    
$m 
2015-16    
$m 
2016-17    
$m 
2017-18    
$m 
Pharmaceutical benefits 
(concessional) 
5,641 5,512 5,564 5,852 6,040 
Pharmaceutical benefits 
(HSD, other hospital drugs) 
2,208 2,358 2,452 2,595 2,715 
Pharmaceutical benefits 
(general) 
1,410 1,378 1,391 1,463 1,510 
Pharmaceutical benefits 
(targeted medicine prgms) 
138 148 154 158 163 
Immunisation 156 154 159 160 164 
Pharmaceutical benefits 
(Veterans) 
406 390 368 376 390 
Payments for wholesalers 
and pharmacy prgms 
368 406 402 401 401 
Other 192 201 204 204 206 
Total 10,519 10,547 10.693 11,209 11,589 
From 2014-15 Budget Paper 1 Table 8.2 
 
Since 2005, when PBS copayments were substantially increased, the average rate of growth of the PBS 
has slowed substantially (see Figure 3).  Between 1994–95 and 2004-05, the cost of the PBS grew by 
nearly 13% each year but the average annual growth rate from 2005–06 to 2013–14 was  4.86% and 
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http://www.aph.gov.au/About_Parliament/Parliamentary_Departments/Parliamentary_Library/pubs/rp/BudgetRe
view201011/HealthPharmaceuticals 
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future growth rates appear to be of this order or less. This slowing of growth in PBS expenditure has 
been attributed to the impact of various pricing policies introduced since 2005.51 
 
Figure 3: PBS costs and services 2005-06 to 2013-14 
 
Data from Medicare Australia 
 
Every Budget the Government of the day makes much about the new medicines listed on the PBS and 
uses this as the rationale for continuing budget cuts and copayment increases in this area.  Many of the 
new drugs listed are very expensive and often quite specialised medicines.  The therapeutic category for 
anti-neoplastics and immuno-modulators (which includes cancer drugs is the fastest growing category of 
the PBS.  This is highlighted in Figure 4. 
Since 2005-06 the cost of this category of drugs has increased by over 260% compared to 59% for the 
PBS as a whole. In this time frame the average cost of a prescription for these drugs has risen from 
$478.30 to $768.80.  
In December 2014, the Senate referred the matter of the availability of new, innovative and specialist 
cancer drugs to the Senate Community Affairs References Committee for inquiry and report.52 The 
report is due June 2015. 
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http://www.aph.gov.au/About_Parliament/Parliamentary_Departments/Parliamentary_Library/pubs/rp/rp1415/E
xpendCostDrugs 
 
52
 http://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/Cancer_Drugs  
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Figure 4.  Cost of cancer drugs to the PBS  
 
Data from Medicare Australia 
 
The Portfolio Budget Statements indicate that, beginning 1 July 2015, the Government will introduce a 
“balanced range of measures” that have been developed through consultation with PBS stakeholders to 
support the sustainability of the PBS. Media reports prior to the budget indicated that the Abbott 
Government would seek up to $5 billion of savings over four to five years from reimbursements paid to 
pharmaceutical companies and pharmacies. 53  
However these savings are not included in the Budget Papers. The major PBS savings in the Budget come 
from the retention of the provisions to increase PBS copayments and the threshold for the PBS safety 
net which were proposed in last year’s Budget. However within a few days of the Budget release ,Health 
Minister Sussan Ley announced that she would not proceed with these changes, leaving a $1.3 billion 
hole in the budget (and in funding for the MRFF).  
The actual status of these savings as Government policy remains uncertain. At Senate Estimates 
Assistant Health Minister Fiona Nash said that these savings remained on the table until other, 
comparable savings could be found. 
                                                          
53 Tingle L Abbott set for war with pharmacists. Australian Financial Review, 5 May 2015, p. 6. 
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The Pharmaceutical Benefits Access and Sustainability Package 
On May 27 Health Minister Sussan Ley announced the promised Pharmaceutical Benefits Scheme (PBS) 
Access and Sustainability Package of reforms that the Government estimates to achieve $6.6 billion / 5 
years  in PBS savings.54 
This Package encompasses: 
 The $18.9 billion 6th Community Pharmacy Agreement, which had been previously announced on 18 
May 2015. 
 $6.6 billion in savings from what are described as “efficiencies throughout the PBS supply chain”. 
 $2.8 billion in additional funding support for the pharmacy sector 
 A Strategic Agreement with the Generic Medicines Industry Association (GmiA) 
 A Strategic Agreement with Medicines Australia was heralded ‘in principle’. 
 
Key measures in the package include: 
 Reduction by as much as 50% in prices of generic medicines made by removing  the orginator brand 
from pricing calculations ($2 billion in savings). 
 Allowing pharmacists to offer consumers a discount of up to $1 per script on the price of the PBS co-
payment ($360 million in savings).55 
 Reworking the premium-free dispensing incentive so it only applies when there is a premium 
charged for another brand of the same medicine.  This should support the better uptake of generic 
medicines. ($560 million in savings). 
 Price reductions on F1 formulary medicines (those protected by patents), with a 5% reduction in the 
price of on-patent medicines that have been listed for five years or more on the PBS ($1 billion in 
savings). 
 Extension of the existing safety net 20 day rule to a broader range of PBS medicines to discourage 
waste ($475 million in savings). 
 $20 million awareness campaign to support the increased use of biosimilars ($880 million in 
savings). 
 Closing loopholes around the way combination drugs are subsidised under price disclosure 
reductions ($610 million in savings). 
 Removal of some comparatively low-cost over-the-counter medicines from the PBS, as 
recommended by the PBAC ($500 million in savings). 
 A new handling and infrastructure fee to pharmacists that will restore pharmacist remuneration to 
average levels provided under the previous 5th Community Pharmacy Agreement ($1.5 billion in 
costs).56 
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 http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2015-ley063.htm 
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 This was announced as part of the 6
th
 CPA. 
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 This was announced as part of the 6
th
 CPA. 
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 A doubling of investment in pharmacy-run primary care programs, which must be ‘scrutinised’ by 
MSAC to ensure they are evidence-based and cost-effective (up to $1.23 billion in costs).57 
 An independent review of pharmacy remuneration and location rules to be undertaken during the 
first two years of the 6th CPA.58 
The hit to the pharmaceutical industry ($6.6 billion) is in stark contrast to the funding going to pharmacy 
which now totals some $20 billion.59   
The legislation to enact this package was enacted by the Australian Parliament on 23 June 2015.  
Strategic Agreement with Medicines Australia 
The Government’s proposed Strategic Agreement with Medicines Australia has collapsed. Medicines 
Australia put forward a proposed Strategic Agreement which met all aspects of the Letter of Intent 
signed by the Minister for Health on 27 May.60 However on June 23 it was announced that, the Minister 
had closed down the negotiations and would not sign the proposed Agreement.61 An alternate view is 
that Medicines Australia rejected the Agreement.62 It is assumed that the disagreement is because the 
Minister needs to find additional savings over the $6.6 billion agreed to, and that would mean a 
different approach to the prices of F1 drugs and the approval of biosimilars than that on the table.63 
 
6th Community Pharmacy Agreement 
Since 1990 Commonwealth Governments have entered into and funded successive five year community 
pharmacy agreements, at a cost to date of over $45 billion.  These ensure a network of approximately 
5460 retail pharmacies which are the primary means of dispensing PBS medicines to the public. These 
agreements are also used to fund professional programs and to provide a funding pool for the 
pharmaceutical wholesalers that supply PBS medicines to retail pharmacies. 
On average Australia’s 5371 pharmacies each earn $650,000 a year from dispensing medicines under 
the Pharmaceutical Benefits Scheme. This compares to the $195,000 GPs earn on average from 
Medicare. 
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 This was announced as part of the 6
th
 CPA. Only $600 million of this is new funding. 
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 This was announced as part of the 6
th
 CPA. 
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 Note: CHF says total is $23 billion. See https://www.chf.org.au/pdfs/chf/Media-Release---Pharmacy-agreement-
offers-pills-with-a-sugar-coating.pdf 
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 https://medicinesaustralia.com.au/wp-content/uploads/sites/52/2015/03/20150527-SIGNED-FINAL-Letter-of-
Intent-Medicines-Australia-260515.pdf 
 
61
 http://www.aph.gov.au/Parliamentary_Business/Bills_LEGislation/Bills_Search_Results/Result?bId=r5462 
 
62
 http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2015-ley077.htm 
 
63
 https://medicinesaustralia.com.au/media-release/health-minister-abandons-strategic-agreement-with-
medicines-australia/  
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The recently announced 6th Community Pharmacy Agreement (CPA) costs $18.9 billion / 5 years, an 
increase of $3.5 billion over the cost of the previous CPA. As shown in Table 8, all of this increase in 
funding goes to pharmacy for increases in dispensing and handling fees and new programs to deliver 
primary care services. 
 
Table 8.  Spending in Fifth and Sixth Community Pharmacy Agreements 
Provision 5th CPA 6th CPA 
Pharmacy remuneration $13.8 billion $16.7 billion 
Professional programs $663 million $613 million 
Pharmacy Trial program  $50 million 
Additional funding for primary 
care programs 
 Up to $600 million 
Wholesalers CSO $950 million $950 million 
Total $15.4 billion $18.9 billion 
 
Key provisions include: 
Fees 
 Introduction of an Administration, Handling and Infrastructure (AHI) fee to replace the existing 
pharmacy mark-up system. This delinks pharmacy remuneration from the variability in medicines 
prices brought about by price disclosure. (Cost $1.5 billion). 
      The value of this fee from 1 July 2015 will be: 
 Where the approved price to pharmacist (wholesaler PBS list price) is up to $180.00: $3.49 per 
prescription 
 Where the approved price to pharmacist is between $180.00 and $2,089.71: $3.49 plus 3.5% of 
the amount by which the price exceeds $180 
 Where the approved price to pharmacist is $2,089.71 or above: $70.00 
 The Premium-Free Dispensing Incentive (PFDI) will increase by 4 cents to $1.72 but will apply to a 
smaller number of prescriptions than it does currently.  The PFDI will no longer apply when there is 
not a brand premium on any substitutable brand of the item but the funding removed from the PFDI 
as a result of this change has been transferred into the new AHI Fee.  
 The Dangerous Drug Fee will increase by 20 cents to $2.91. This is the first increase in this fee since 
2006.  
 For prescriptions where the cost is under the co-payment (primarily for non-concessional patients), 
the AHI fee will apply.  In addition, pharmacists may charge (at their discretion) the following 
allowable fees: 
 Safety Net Recording Fee: $1.17 (up from $1.15 currently)  
 Additional allowable fee: $4.27 
 Once systems are established, pharmacies will be required to transmit through PBS Online the price 
charged for under co-payment prescriptions. 
 In addition to all fees that apply to ready-prepared items (including the new AHI Fee), an additional 
fee of $2.04 will apply for extemporaneously prepared dispensing. 
 All fees will be indexed annually by the official Consumer Price Index.  Previously fees were indexed 
by the lower WCI9.  
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  DoH and the Pharmacy Guild will conduct an annual reconciliation of total actual versus estimated 
total community pharmacy and wholesaler remuneration, comparing actual PBS and RPBS 
prescription volumes with the estimates included in the 6th CPA document. If there is a material 
difference between actual volume and estimated volume, a risk sharing arrangement may be 
implemented to address the variance. 
 
Option to discount consumer copayment 
Pharmacies will have the option to discount the patient-co-payment by up to $1. The intent is that this 
measure will deliver pharmacists greater flexibility to be able to compete on price and quality, while 
saving taxpayers a potential $360 million / 5 years.  It remains to be seen if these savings will result.  
Chemotherapy 
Changes will be made to the structure of remuneration for chemotherapy infusions. This is intended to 
include some payments being made direct to compounders, with a different fee applying depending on 
whether the compounder holds a TGA licence.  
National Diabetes Services Scheme (NDSS) 
The supply and delivery of NDSS products will be redirected through the established CSO distribution 
network to community pharmacies from June 2016. There will be a payment of $1 (not indexed) to 
pharmacies for each product supplied.  CSO wholesalers will also be entitled to receive $1 for each unit 
they distribute. 
 
Reviews  
A Remuneration Review will be conducted to inform pharmacy and wholesaler remuneration 
arrangements for the 7th CPA (July 2020 onwards). The review will not be able to be used to change 
pharmacy remuneration during the 6th CPA.  Remunerations have not been formally reviewed since 
1989. 
During the 6th CPA there will be a public review of the Location Rules and their role in supporting access 
to PBS medicines. The Location Rules cannot be changed during the 6CPA based on the outcomes of this 
review except with the agreement of both the PGA and Government. 
Wholesalers Community Service Obligation (CSO) 
The current wholesaler mark-up arrangements will continue to apply under the 6th CPA and there will be 
no indexation of the CSO funding pool. Wholesalers will still be required to supply section 85 medicines 
under CSO arrangements at or below the official PBS price to pharmacists, and will not be permitted to 
impose new or additional fees where the supply is covered by the CSO requirements.  
A role for pharmacy in primary care 
$1.2 billion / 5 years is provided to double the current investment in support programs for patients, 
with a focus on regional and rural areas. It appears this includes $50 million for the for the Pharmacy 
Trial Program which expands the role of community pharmacists in the delivery of health care services 
to Indigenous Australians living in rural and remote areas (see Table 8). 
 
This could include vaccinations, wound care and the management of chronic conditions such as arthritis. 
Pharmacists have previously proposed offering checks for weight, blood pressure, blood sugar and 
cholesterol . All such pharmacy programmes - new and existing – will be scrutinised and approved by 
MSAC  to ensure they are evidence-based. 
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This increased investment has not been welcomed by organised medicine.  It appears to be based on a 
discussion paper produced by the PSA.64 
 
ANAO report on Administration of Fifth Community Pharmacy Agreement 
The ANAO report in the administration of the 5th CPA was released in March 2015.65 It found that overall 
DoH’s administration of the 5th CPA was mixed, and there is a limited basis for assessing the extent to 
which the 5CPA met its key objectives, including the achievement of $1 billion in expected savings. 
There is no straightforward means for stakeholders to be informed of the expected or actual cost of key 
components. Specifically, the agreement does not document that some $2.2 billion of pharmacy 
remuneration is sourced from patient co-payments and is not a cost to government. 
The 5th CPA, costing $15.4 billion / 5 years, was promoted as delivering $1 billion in government 
savings. The major savings initiatives were:  
 Cessation of the PBS Online incentive payment ($417.7 million). 
 Freezing the dispensing fee for two years ($281.5 million). 
 Cessation of under-performing professional programs ($226.4 million). 
 Reduction in private hospital pharmacy remuneration ($35.3 million). 
 Freezing the CSO Funding Pool for one year ($19.2 million). 
The 2010–11 Budget Papers clarified that the $1 billion in savings was a gross figure, and after taking 
into account approved additional expenditure of $0.4 billion, net savings were estimated to be 
$0.6 billion.  However, ANAO analysis indicates that the net savings estimated before the agreement 
was signed were closer to $0.4 billion, due to shortcomings in DoH’s 5CPA estimation methodology. The 
principal issues relate to: unexplained increases in the baseline cost of professional programs; the 
application of inappropriate indexation factors; and the treatment of patient co-payments. 
The audit report found 941 pharmacy businesses received over $1 million in remuneration under the 
community pharmacy agreements that enshrine their monopoly-like status. The audit also exposed how 
pharmacists can rort the system. For example, some pharmacists claim a $1.50 per script government 
incentive for substituting cheaper generic medicines when sometimes no substitution is actually made. 
The cost of this Premium Free Dispensing Initiative, estimated at $620 million / 5 years, blew out to 
$912 million. 
In addition to the shortfall in anticipated savings, a number of the Government’s other strategic 
negotiating objectives were only partially realised. These included: 
 The structure of pharmacy remuneration, based on defined mark-ups to the base price of 
pharmaceuticals with the addition of a variety of fees, remained essentially unchanged from the 4th 
CPA to the 5th CPA, despite the intention to restructure pharmacy remuneration arrangements by 
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shifting financial incentives from the volume driven sale of medicines to the delivery of value-adding 
professional services.  
 A ‘non-negotiable’ aspect of the 5th CPA related to obtaining access from pharmacies to the full 
range of PBS data, including information relating to prescriptions that cost less than the general 
patient co-payment. This objective was only partially realised – prescription numbers but not cost 
information was obtained.  
 Another key government negotiating objective for the 5CPA was to support information technology 
systems that are fully interoperable with broader e-health systems. However, the two Prescription 
Exchange Services (PESs) that were approved by Health for downloading electronic prescriptions by 
pharmacies did not have systems that were interoperable. Government funding for the Electronic 
Prescription Fee (EPF) was subsequently re-allocated to pay the PESs directly to make their systems 
interoperable. 
 
 
Biosimilars 
 
Biosimilars are biological products that are similar, but not identical, to an innovator product that is 
already marketed and whose patent has typically expired.  Biologics are some of the most expensive 
drugs on the PBS; they have grown from about 4% of the PBS budget 10 years ago to about 25% 
currently. Biologics cost the Government about $2.3 billion in 2013-14.66   
Biosimilars cannot be considered 'generic' equivalents of innovator products as they are not necessarily 
clinically interchangeable and in some cases may exhibit different therapeutic effects.  The clinical 
performance and immunogencity of biological drugs is highly dependent on the method of production 
and purification. Verifying similarity or comparability of a biosimilar with an innovator product therefore 
requires much more than demonstrating bioequivalence, which is sufficient for conventional generic 
drugs. 
On 18 June 2015 the Pharmaceutical Benefits Advisory Committee (PBAC) issued a statement stating 
that if a biosimilar is approved by the Therapeutic Goods Administration (TGA) it will assess whether it 
should be listed on the PBS. Assessments will be done on a case-by-case basis and will potentially allow 
a pharmacist or clinician to substitute a biosimilar.67 PBAC says the move was prompted by a number of 
biologic drugs coming off patent. 
Aside from the concerns over the safety of biosimilars, this is an issue driven by the US pharmaceutical 
industry in the controversial Trans Pacific Partnership (TPP). The industry wants extended patent 
provisions and test data protection that will prolong monopolies over new medicines and delay 
competition from biosimilars. It has been estimated that if biosimilars had entered the market prior to 
July 2013 for each of the ten biologics accounting for the highest government expenditure, this would 
have resulted in over $205 million in savings through public subsidies alone in the year 2013-14.68 This 
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figure illustrates the magnitude of the annual costs that would result for taxpayers from prolonging 
monopolies on biologic medicines. 
 
Delisting medicines from the PBS 
 
The Abbott Government will push ahead with efforts to delist from the PBS those items which are 
already available over the counter (OTC).  There are currently 352 such items.  Of these, the DoH, in 
consultation with the PBAC, is looking to delist  47.  There will be a 5 month notification period of the 
intention to delist. 
 
Impact of PBS and pharmacy changes on patients 
 
The Abbott Government has touted recent PBS decisions and agreements as “landmark deals benefiting 
consumers”. However the extent to which these changes, if enacted as proposed, will help consumers is 
not clear and savings may be offset by increased charges and changes to the safety net thresholds.  
Recent media reports69 indicate that the decision to replace the 15% mark up component of a chemist’s 
fee with a flat $3.49 “administration and handling fee” will drive up the price of low cost drugs by over 
40%. This is a cost for both government and non-concession patients. General consumers will pay the 
extra out of their own pocket but when a pensioner buys the medicine the taxpayer will pick up the 
extra tab. 
Consumers Health Forum has calculated that this will mean consumers will directly contribute an 
estimated $8.2 billion / 5 years to pharmacy owners’ remuneration.70 That amounts to 34% of the 
estimated $23.6 billion in total payments for PBS medicines to pharmacies. 
The delisting from the PBS of medicines such as pain medications will mean that pensioners and 
concession card holders will pay more for these over the counter. 
The redirection of product supply and delivery funding from the National Diabetes Services Scheme run 
by Diabetes Australia to pharmacies and wholesalers is also an issue of significant concern. It is not clear 
how the patient support and education services currently provided by Diabetes Australia and other 
services which cannot be provided within pharmacy will be maintained under the new arrangements. 
 
. 
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Budget provisions 
Ceasing the Alternative Arrangement Transfer to Pharmaceutical Benefits Program 
The Government will cease, effective 1 December 2015, the arrangement which allowed Cohealth Ltd to 
provide PBS medicines and pharmacy services to their clients. 
Cohealth is an integrated pharmacy - a one-stop-shop where GP, pharmacy and other health services 
are located together under the one roof – located in Collingwood, Victoria. It is the only integrated 
service of its kind in Australia and has existed for several decades.71 Having the pharmacy next to 
doctors’ offices improves health and reduces pharmaceutical-related hospital admissions.  It serves an 
older, disadvantaged community where many people have complex health issues.  
Cohealth’s clients pay an annual prescription fee to fill their subscriptions rather than pay a PBS 
copayment each time they fill a prescription. The amount paid is equivalent to the PBS Safety Net. 
Cohealth’s clients will now pay on a per prescription basis. 
 
Increase in the Pharmaceutical Benefits Scheme safety net thresholds 
Savings of an additional $5.1 million are achieved by pushing back to 1 January the start date for the 
increase in safety net thresholds announced in the 2014–15 Budget.  The savings taken by this measure 
will go to fund other Health priorities or to the MRFF. 
 
 2014-15 2015-16 2016-17 2017-18 2018-19 
DoH - - - - -5.0 
DVA - - - - -0.1 
Total - - - - -5.1 
 
The savings achieved under this provision were not specifically broken out in the 2014-15 Budget but 
were combined with those achieved through the increases in PBS payments. It is not clear if the figure in 
this year’s budget is offset by the loss of savings in 2015 caused by the 12 month delay in 
implementation. 
Table 9.  Changes in PBS Safety Net thresholds over time 
 
 2014 2015 2016 2017 2018    
General  (does not include 
CPI increase) 
$1,452.50 $1,597.80 $1,798.00 $2,029.20 $2,287.90 
Concession 60 scripts 62 scripts 64 scripts 66 scripts 68 scripts 
From June 2014 Senate Estimates 
 
Legislation is needed to enact this provision. 
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New and amended listings on the Pharmaceutical Benefits Scheme 
$1.6 billion / 5 years is provided for new and amended listings on the PBS and RPBS based on decisions 
made since the 2014-15 MYEFO. 
 
 
 2014-15 2015-16 2016-17 2017-18 2018-19 
DoH 5.9 375.4 381.6 391.2 377.7 
DVA .. 7.5 8.2 8.1 7.9 
DHS 0.7 5.3 1.7 1.8 1.9 
Total 6.7 388.2 391.4 401.1 387.5 
Related revenue               
DoH 
nfp nfp nfp nfp nfp 
 
The drugs listed are, with one exception, biologics, mostly for the treatment of cancer.  These drugs are 
very expensive and quite targeted in their effects. For such drugs it is usual for the Government to strike 
risk sharing agreements, so the full expenditure for these drugs will be less than that indicated over the 
forward estimates. 
It should be noted that the listing of Herceptin for the treatment of metastatic breast cancer makes the 
Herceptin program unnecessary. The special program was established in 2001 after the PBAC has 3 
times rejected the listing of Herceptin for late-stage breast cancer and following intense media 
attention.72 
It is interesting to note that Keytruda, for the treatment of melanoma, is not part of this list, even 
though it was approved by the PBAC in March 2015.  Its listing on the PBS, effective 1 September 2015, 
was announced in June, after heavy lobbying and with much fanfare.73 
Pharmaceutical Benefits Scheme price changes 
Savings of $252.2 million / 5 years are taken for price amendments to certain medicines listed on the 
PBS. The savings are to be directed to fund other health priorities or the proposed Medical Research 
Future Fund 
 
 2014-15 2015-16 2016-17 2017-18 2018-19 
DoH -13.3 -55.2 -55.6 -60.8 -66.9 
DVA -0.5 -1.8 -1.6 -1.7 -1.8 
Treasury 0.1 0.4 0.5 0.5 0.5 
Total -13.7 -55.2 -50.6 -60.8 -66.9 
These changes were made on the basis of PBAC recommendations.  Several seems to relate to the cost 
of combination medicines. It appears that these changes were made possible by the expiry of the 2010 
Memorandum of Understanding with Medicines Australia which dealt with such issues.74 
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 Proposal on the role of pharmacists in the general practice health care team. 
 
The AMA has released a proposal to make non-dispensing pharmacists a key part of the future general 
practice health care team, supporting GPs to deliver high quality care for their patients.75 This proposal 
is supported by the Pharmaceutical Society of Australian (PSA). 
 
The proposal calls for the establishment of a new (Medicare funded?) program to support general 
practices to employ pharmacists - the Pharmacist in General Practice Incentive Program (PGPIP).  
 
Under this plan, non-dispensing pharmacists would work in general practices to assist in areas such as:   
 Medication management reviews conducted in the practice, an Aboriginal Health Service, the 
 home or a Residential Aged Care Facility (RACF). 
 Patient medication advice to facilitate increased medication compliance and medication 
 Optimization. 
 Supporting GP prescribing. 
 Liaising with outreach services and hospitals when patients with complex medication regimes 
 are discharged from hospital. 
 Updating GPs on new drugs, 
 Quality or medication safety audits. 
 Developing and managing drug safety monitoring systems. 
 
Supplementary activities, depending on the needs of individual practices, could include activities such as 
patient education sessions, mentoring new prescribers and teaching GP registrars on pharmacy issues. 
 
The AMA backs up their proposal with data developed by Deloitte Access Economics that shows that the 
program (which, if taken up by 3,100 practices would cost $969.5 million / 4 years) would deliver 
savings of $1.56 in the health care system as a whole for every $1 invested. Most of the expected 
savings would result from reduced hospitalisations as a consequence of Adverse Drug Events. 
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Primary Care  
 
Although the Abbott Government says all the right things about the centrality of primary care in 
Australia’s health care system, it has done little to cement that centrality.  The focus is on general 
practice rather than primary care and even that is not well served by changes to Medicare. 
The implementation of Primary Health Networks offers some interesting possibilities, but this has been 
delayed and still lacks clear guidance. 
The establishment of a Primary Health Care Advisory Group, alongside the review of MBS items, also 
offers possibilities to real reform – for the new models of service delivery and financing that are so 
needed. 
 
Primary Health Care Advisory Group 
 
The Minister for Health, Sussan Ley, has established a Primary Health Care Advisory Group to identify:  
 Ways to provide better care for people with chronic and complex conditions. 
 Innovative care and funding models and improved treatment options for mental health conditions. 
 Ways to improve integration between the primary and acute care sectors.  
 
Dr Steve Hambleton, former President of the Australian Medical Association (AMA), will chair this new 
group.  The remit of the Advisory Group offers so much scope for real and needed reform  so it will be 
very interesting to see if the Group’s members accept this challenge and – if they do – what the Abbott 
Government’s response will be. 
The AG is required to report back with priorities by the end of the year. 
 
Primary Health Networks 
 
As of 1 July 2015 the DoH planned for the 61 Medicare Locals (MLs) to be replaced by 31 Primary Health 
Networks (PHNs).  The Minister for Health announced the preferred providers for 28 PHNs in April and 
the remaining three in June.76 At the time of Senate Estimates only 11 of these had signed contracts.  
There will clearly be an extended transition period in some areas: it is not known if MLs will be provided 
with continued funding for this. 
The majority of the successful consortia involve MLs, some also include universities and hospitals. Four 
also involve private health insurance funds. These are: 
 South-eastern NSW has partnered with Peoplecare, a national member-owned, not-for-profit health 
fund 
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 Grampians and Barwon south-west in Victoria partnered with GMHBA, a private health insurer 
 Brisbane North partnered with HCF and Bupa 
 Perth North/Perth South/country WA partnered with HCF and Bupa 
 
The cost of these PHNs is of the order of $900 million.77 The transition from MLs will cost the 
Government  $112 million.  The actual cost to the MLs is expected to be higher than this. The constant 
changes have created very large costs in staff redundancies, discontinuity and disruption in activity. 
PHNs will have six priority areas for targeted work: mental health, Indigenous health, population health, 
health workforce, e-health and aged care.  However there are currently no performance measures for 
these priority areas.  However DoH guidance for PHNs can best be described as thin; the key objectives 
are improving effectiveness, efficiency and coordination.78  They will function predominantly as 
facilitators and purchasers of care.  
There is little Australian evidence to guide effective commissioning and ensure it is focused on outcomes 
rather than outputs.  Key lessons Australian might learn from the UK National Health Service are that 
getting commissioning right is not easy and will require time and a number of iterations, and that 
achieving the desired objectives is made more complicated and more fraught by changes wrought 
simply as a consequence of changes in government and ideology. 
At this early stage there are many questions about PHNs will commission and / or deliver programs such 
as those to provide services for Indigenous Australians, ATAPS and other mental health services such as 
Partners in Recovery. Some of these programs that might be best placed to deliver commissioned 
services to special population groups have been adversely impacted by the Government’s funding cuts. 
It remains to be seen whether these new organizations will deliver the efficiencies, innovation and 
improved health outcomes that was the intent of the new policy direction. This will be particularly 
important for rural and regional Australians who carry a higher burden of disease than their 
metropolitan counterparts. 
 
A role for private health insurers in primary care 
 
Private health insurers are confronted with the same problems as Medicare.  About 35% of all 
Medibank’s hospital and medical expenditure is generated by 2% of its members and about 70% of 
these patients suffer from chronic illnesses. 
As the ageing population starts to jeopardise the sustainability for private health insurers, they have 
been looking for more efficient ways of delivering care and reducing the need for care.  They have been 
encouraged in this approach by the Abbott Government, indirectly through the recommendations that 
have emerged from the National Commission of Audit and the Harper Competitiveness Review, and 
directly through the Coalition’s ideological approach to means testing and healthcare financing.  
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In late 2013 Medibank Private began a trial called GP Access with medical centre manager IPN in which 
six of its 79Brisbane medical centres provide Medibank members with enhanced GP services, including a 
guaranteed appointment within 24 hours and after hours home visits, for no out-of-pocket costs.  In 
April 2014 the trial  was expanded to 26 medical practices run by the firm in Brisbane, the Gold Coast, 
Ipswich and Cairns. Medibank got round the current restrictions on PHI role in out of hospital medical 
care by not paying IPN for the services directly but contributing to ''administrative and management 
costs''. 
 
Other examples of this move into the primary care space include HCF providing an after-hours home GP 
service for their members and Bupa providing members with discounts in Healthscope’s national 
network of medical centres, skin clinics and pathology services. 
 
These programs raise concerns that people with private health insurance are likely getting services 
ahead of people without insurance but with greater need. These issues were discussed in detail in a 
series run by The Conversation.80 
However in June Medibank announced that an evaluation of the trial showed that  the 13,000 members 
who used the service were pleased with it,  but they didn't feel it added additional value to their private 
health insurance.  Medibank will continue with separate trials to improve primary care for patients with 
chronic disease. 
It appears the insurer was worried about public concerns and backlash.81 However Medibank Private’s 
Medical Officer stated that the insurers was "of the view that there are better ways we can support 
primary care".  This is likely through arrangements such as consortia to run PHNs. 
These approaches signal the possibility of major changes to Australia’s iconic Medicare system – and 
these should not happen by stealth. They require full analysis and debate about whether a more 
integrated public-private system is a feasible option that fits with Australian values and can improve 
efficiency in health care financing.82 
 
GP SuperClinics 
 
The Abbott Government is no fan of GP SuperClinics.  The 2014-15 Budget made the decision not to 
proceed on three SuperClinics – in Darwin, Rockingham and Wynnum – at a savings of $16.5 million.  
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At that time the then Minister for Health, Peter Dutton, said the program had been a complete failure. 
He indicated that the Government was looking to retrieve money from SuperClinics where contracts had 
been signed on a case-by-case basis.83 That approach appears to have foundered, likely on legal advice 
and / or the fact that many of these were located in marginal electorates. 
Senate Estimates was told that of the originally planned 64 GP SuperClinics, 55 are now operational and 
6 are still under construction, and 3 will not proceed. Interestingly the DoH page listing the location and 
operationability of the GP SuperClinics has not been updated since 2012.84 
Around $650 million has been committed to build more than 60 GP SuperClinics around Australia and 
for Primary Care Infrastructure Grants to upgrade and extend around 425 existing general practices, 
primary care and community health services, and Aboriginal Medical Services. 
 
The primary, and in many cases, sole use of the program funding is for capital infrastructure that 
provides an environment where the operators of the GP SuperClinics are then required to provide 
services to meet the ten objectives of the programme for a 20 year period.  The GP SuperClinics Program 
does not fund the ongoing service provision and the Australian Government does not own or operate 
the clinics.  
There has been no evaluation of the GP Superclinics program since that undertaken in 2011 when many 
Superclinics were still barely operational.85 
 
Diabetes 
The Diabetes Care Project 
The genesis of the Diabetes Care Project was much grander than the final result: the 2010-11 Budget 
provided  $449.2 million / 4 years to improve the quality and coordination of primary care services for 
people with diabetes.  At the same time the COAG Diabetes Grants, set up in 2007-08,86 were abolished 
– with no information about their effectiveness.  Under the new proposed program, patients wishing to 
take part would be required to register with a GP practice.  The practice would be required to develop a 
personalised care plan and coordinated access to other health providers such as dieticians and 
physiotherapists. 
Patients who enrolled with the scheme would no longer be entitled to Medicare benefits.  Instead, their 
general practice would receive $950 a year for their care, out of a total $1200, to handle all the 
consultation costs for that patient – regardless of whether the treatment was related to their diabetes, 
or another problem. The remaining $250, to be spent on care by allied health workers such as 
physiotherapists and dieticians, would apparently be paid directly to them.  GPs could keep the unspent 
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portion of the $950 and the practice would also receive around $10,800 a year, to be “paid in part on 
the basis of performance in providing better care and improving health outcomes”. DoHA stated that 
the current average cost of Medicare benefits for a diabetic patient was between $490 and $761 a year, 
and that if the $1200 ran out for some patients, GPs could apply to dip into a ‘’contingency fund’’ 
included in the overall cost of the plan. The average cost of admitting a diabetic to hospital is $4300. 
The Government expected 4300 general practices – 60 per cent of all GPs – would join the program by 
2012-13 when it was scheduled to begin, and approximately 260,000 patients with diabetes ( about 25% 
of those diagnosed at that time) will be voluntarily enrolled in the personalised care program by 2013-
14.    
 
The proposal was controversial because it singled out diabetes out as the only chronic illness to receive 
this coordinated care but mostly because of opposition from the AMA who saw it as fee capitation. In 
the face of their opposition, then Minister for Health, Nicola Roxon, backed down. The 2011-12 Budget 
provided $30.2 million / 4 years for a pilot program with the design to be established by the Diabetes 
Advisory Group which now included the AMA as a member. 
The pilot was a cluster randomised controlled trial with two Intervention Groups and a Control Group, 
where current models of care were tested alongside new care components comprised of:  
 An integrated information platform (cdmNET) for GPs, allied health professionals and patients.  
 Continuous quality improvement processes with data feedback. 
 Flexible funding model based on patient risk stratification.  
 Quality improvement support payments linked with a range of patient population outcomes.  
 Dedicated Care Facilitators to work with the care team to provide patient support. 
The project had three arms:  
 A control group that received s usual care. 
 Group 1, which tested improvements through the use of the cdmNet shared care planning tool and 
continuous quality improvement processes. 
 Group 2, which tested all those components along with the new funding options. 
The primary clinical endpoint was the difference in the change in HbA1c levels between treatment 
groups at the end of the project. Secondary outcomes included changes in other biochemical and clinical 
metrics, incidence of diabetes-related complications, health-related quality of life, clinical depression, 
success of tailored care and and economic sustainability. 
The pilot study involved 184 practices (the DoH website says 150) and 7781 patients from urban, rural 
and regional areas of South Australia, Queensland  and Victoria (Vic). It was delivered by a consortium of 
healthcare organisations and experts led by consulting firm McKinsey.87 
The study protocol was published in 2013.88 The actual project ran for just 18 months – arguably 
insufficient time to see downstream impacts such as reduced hospitalisations. 
Very little information was provided by DoH as this study proceeded. 
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Evaluation of the Diabetes Care Project 
The evaluation report, written by McKinsey, was not released until May 2015.89 
The evaluation of the trial found: 
 Group 1 participants did not experience a significant improvement in HbA1c levels or other 
clinical metrics, aside from a small improvement in renal function.  
 Group 2 participants had a statistically significant improvement in HbA1c levels compared to the 
control group and clinically modest secondary outcomes.  
 At baseline, the average total healthcare cost across all groups was $8,647 / person / year, of which 
hospital costs ($3,814) were the largest contributor.  Costs for both Group 1 and Group 2 
participants were higher than the control group – $718 and $203 / person / year respectively. These 
are described as not statistically significant, with hospital costs contributing to the large variation. 
 Even when reduced hospital admissions and other acute care savings were taken into account, the 
new funding arrangement was not cost-effective. This may be because the main benefits lie outside 
of 18-month trial period). 
The evaluation committee made three recommendations arising from the DCP: 
 Change the current chronic disease care funding model to incorporate flexible funding for:  
 Registration with a medical home (ie GP practice, AMS). 
 Payment for quality  
 Funding for (targeted) care facilitation. 
 Continue to develop both eHealth and continuous quality improvement processes 
 Better integration of primary and secondary care to reduce avoidable hospital costs.  
The realistic assessment is that: 
 This was not a well-designed project and it was not allowed to run for a sufficient length of time. 
 The findings are predictable and the recommendations could have been made on the basis of 
current knowledge in 2011. 
 The data on costs is useful and highlights both the need to do more and do it better in this area and 
where efforts should be targeted for maximum returns on the investments. 
The DoH website says that the findings of the report will be used to support primary care research, 
assist the Primary Health Networks to develop their own innovative healthcare approaches, and inform 
the work of the Primary Health Care Advisory Group. The report has also been provided to the National 
Diabetes Strategy Advisory Group, to be considered in the development of the National Diabetes 
Strategy. 
 
National Diabetes Strategy 
In response to the release of the evaluation report the Health Minister will extend the consultation 
period for the promised National Diabetes Strategy (to the end of June?) to allow the public and AIHW 
to review the report. 
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An Advisory Group to develop a National Strategy for Diabetes was established in December 2013. A 
consultation paper was released in April 2015. This has a draft Framework for Action.90 Not surprisingly, 
this paper has a strong emphasis on primary prevention and obesity – sure sticking points for this 
Government. 
 
 
Primary Health Care Research, Evaluation and Development program 
 
The third five-year phase of the Primary Health Care Research, Evaluation and Development (PHCRED) 
program has now ended with no decision about its future.  The program has been positively evaluated 
and apparently DoH and / or the Minister for Health is considering options for investment in future 
primary health care research as part of a Departmental wide approach to the support of research.91   
This failure to reach a timely decision in an important area like primary health care research and 
capacity building laves the fate of the Australian Primary Health Care Research Institute (APHCRI) and 
the Primary Health Care Research Information Service (PHCRIS) and their work in the lurch.   
APHCRI has funds only to December 2015. Although the APHCRI contract ends this year a number of 
commissioned research projects (including Centres of Research Excellence) will not be complete until 
2016/2017, and one will conclude in July 2018.   
At a time when research and implementation studies around primary health care priorities are keenly 
needed, it would be a waste of the substantial investment to date for this program to cease.  This type 
of research does not fit well within the remit of the NHMRC and it seems extremely unlikely that the 
proposed MRFF will address this type of research.  
The PHCRED program was established in 2000 to improve Australia’s capacity to produce high quality 
primary care research involving all stakeholders. This followed the recommendations of the Review of 
the General Practice Strategy in 1998.  The first two phases of this program received total funding of the 
order of $135 million 92 but funding levels for Phase 3 have never been made public, 
As described in the strategic plan the goals of this Strategy are:  
 An expanded pool of primary health care researchers;  
 More research relevant to practice and policy; and  
 In collaboration with other relevant organisations, well informed primary health care practice and 
policy.  
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The major Strategy components are: 
 The Australian Primary Health Care Research Institute (APHCRI) which is tasked with providing 
leadership in primary health care and embedding a research culture in general practice.  APHCRI was 
established at the Australian National University in 2003. 
 The Research Capacity Building Initiative (RCBI), established in 2000, which funds university 
Departments of General Practice and Rural Health to provide training and support in primary health 
care research, particularly among GPs. 
 Primary health care research grants and awards administered through the NHMRC. These programs 
provide research training and experience for early, mid and senior level researchers and include the 
funding of both investigator and priority driven research relevant to both policy and practice.  
 The Primary Health Care Research and Information Service (PHCRIS) established in the Department 
of General Practice at Flinders University to provide support in the area of dissemination and 
knowledge-exchange.  PHCRIS was first established First established in 1995 as the National 
Information Service (NIS) and changed its name in 2001. 
APHCRI on behalf of the network and other stakeholders has developed and submitted a paper outlining 
views on the future of dedicated primary health care research funding.93 
 
The key messages are; 
 Primary health care is a vital part of an integrated and sustainable health system 
 Targeted priority driven primary health care research, firmly embedded with the key stakeholders 
groups, i.e. policymakers, consumers and service providers, is too important to leave to the lottery 
of mainstream academic research funding 
 The model for delivering this targeted research and impact focused program should be based on 
inclusive governance and partnership arrangements between academics and the key stakeholder 
groups 
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Mental Health 
 
Despite the enormous need and the very specific guidance for reform offered by the National Mental 
Health Commission (NHMC) National Review of Mental Health Programs and Services, Contributing lives, 
thriving communities,94 there is nothing in the Health portfolio for mental health, and as far as can be 
determined, there is only one provision in the whole budget: a two-year extension of the access to social 
and mental health services for people in drought -affected communities. 
For five months the Abbott Government stubbornly refused to release the NHMC report from the 
review it commissioned, as an election commitment, to assess the efficiency and effectiveness of 
Australia’s mental health services.  
The Abbott Government’s concern for efficiency in the way federal programs are funded and operated 
apparently does not extend to mental health care.  The Commonwealth currently spends $9.6 billion 
annually on mental health, but the NHMC report found that “by far the biggest inefficiencies in the 
system come from doing the wrong things — from providing acute and crisis response services when 
prevention and early intervention services would have reduced the need for those expensive services, 
maintained people in the community with their families and enabled more people to participate in 
employment and education.” 
The report speaks with urgency about why a reordering of priorities for mental health funding is 
imperative, for both social and economic reasons.  The key point is that mental health funds are not 
spent well.  The outcomes are bad for patients and their families and bad for the budget bottom line.  
 
Almost all (87.5%) of the $9.6 billion of Commonwealth funding is spent on acute care and income 
support programs that are indicators of system failure. An increased focus on prevention and early 
intervention and a strengthening of the primary healthcare sector would increase access to care, reduce 
current pressures on hospital services, and help more people stay functional in their communities. 
 
We understand that hospital admission and disability can be prevented for physical illnesses by 
screening, early intervention and affordable and timely access to community-based medical and support 
services. The idea of late intervention for cancer, heart disease and diabetes is unacceptable, but with 
mental illness this is almost the norm. Why has this been allowed to happen? The average cost of a 
hospital admission for a mental health disorder is $10,000, a sum that could fund community support 
for a year.  
More must be done to close the gaps that mean that people miss out on needed services because of 
where they live, their income, and their ability to navigate a complex and fragmented array of services. 
Mental health problems are dealt with in isolation, leading to poorer physical and mental health 
outcomes.  
The current delivery system is driven more by what providers want than by what patients and their 
families want and need. The review struggled to assess the efficiency and effectiveness of the array of 
services and programs because the data are not there. The data that are collected measure activity but 
not outcomes and ignore patient satisfaction.  
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Tackling suicide must be a national priority. In 2012, more than 2,500 Australians (almost seven people 
ever day) died by suicide and more than 25 times that number attempted to take their own lives. It’s the 
leading cause of death for Australians aged between 15 and 44. The report proposes a target to reduce 
both suicides and suicide attempts by 50% over the next decade with sustainable, comprehensive, 
whole-of-community approaches. 
The situation for Indigenous Australians is far worse; the report describes it as ‘dire’. It’s a dominant 
over-arching theme throughout, and there is a recommendation to make Indigenous mental health a 
national priority and agree an additional COAG Closing the Gap target for mental health. 
 
What emerges from this review is that despite a raft of reports, plans, strategies and commitments, 
Australia lacks a clear destination in mental health and suicide prevention. There is no ‘mental 
health system’ but a collection of services and programs with little evidence of value and with no clarity 
of roles and responsibilities. The voices of the people with lived experience of mental illness – patients, 
families, carers and healthcare professionals – have consistently been ignored, misheard and under-
valued.   
 
The new system architecture that the report proposes – to ‘redesign, redirect, rebalance, repackage’  
offers an immediate starting point for reform, as was promised by the Prime Minister and presents 
these reform opportunities in a context that is suitable for the budgetary times. 
 
The first response from the Heath Minister Sussan Ley was telling: she picked one key recommendation 
(to shift priorities from crisis care to prevention, early intervention and community support), take it out 
of context (present it as cutting hospital services) and announce emphatically that this will not be done.  
Her second response indicated an unwillingness to act in a timely way on the report’s 
recommendations: she announced the establishment of a new COAG working party to work with the 
states and territories, and a new expert reference group to focus on four key areas (suicide prevention; 
prevention of and early intervention in mental illness; primary care; and national leadership, including 
regional service integration). No clear timeline for specific action on the recommendations of the NMHC 
report has been announced. 
In March, amid concern from the sector, the Minister announced a 12-month funding extension, worth 
$300 million, for some 150 contracts for the delivery of mental health services.  The Minister said the 
12-month extension would allow services to continue to be delivered while work continued on the 
current Mental Health Review. The focus is supposedly on frontline services but it is not known which 
services have received funding and what their funding levels are. For the time being, in the absence of 
action on mental health reforms, these community organisations must operate on short-term funding. 
Among the other mental health issues that remain up in the air is the way in which the new Primary 
Health Networks (PHNs) will commission mental health services, the funds that they will have for this, 
and how this will be done in those areas where mental health services and professionals are in short 
supply.   
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Issues in mental health 
 
Government response to the review of mental health services 
The main media release from the Minister for Health, Susan Ley, in response to the Review of Mental 
Health Programs and Services from the NMHC admitted that it “ paints a complex, fragmented, and in 
parts, disturbing picture of Australia’s mental health system.” And continued “ I acknowledge there are 
clear failures within both the mental health sector and governments and we must all share the burden 
of responsibility and work together to rectify the situation.”95 It was also helpful to see her 
acknowledgement of the discontent among mental health stakeholders with the Fourth National Mental 
Health Plan and the National Road Map for Mental Health Reform 2012-2022. 
 
The plans to address this report include: 
 Establishment of an Expert Reference Group to inform the reform process, including the 
development of short, medium and long-term strategies in four key areas”  
 Suicide prevention. 
 Promotion, prevention and early intervention of mental health and illness. 
 The role of primary care in treatment of mental health, including better targeting of services. 
 National leadership, including regional service integration. 
 Efforts to establish a dedicated COAG Working Group on Mental Health Reform to coordinate the 
reform process. 
 
The ERG will be supported by: 
 Stakeholder workshops 
 An NDIS Mental Health working group. 
 An Aboriginal and Torres Strait Islander Mental Health and Suicide Prevention Advisory Group. 
 An inter-governmental approach to ensure Commonwealth agencies respond to the 
       Report’s concerns about fragmentation of payments and services.   
 
There has been a mixed reaction to the membership of the ERG which was announced in June.96 
There are 6 psychiatrists and only one consumer: inevitably many groups – Indigenous, CALD, carers, 
mental health nurses – feel they missed out and that their voices may not be heard 
 
The Terms of Reference indicate that the scope of the ERG “will be weighted towards policy and 
programme changes which are within the role of the Commonwealth to directly implement through its 
current national programmes. It will also consider the broader system leadership role that the 
Commonwealth plays within the National Mental Health Strategy.” 97The Minister has said that advice 
from the Expert Reference Group would help inform discussions she will have with State and Territory 
governments about developing a new National Mental Health Plan with much-improved co-ordination 
between federal, state and local bureaucracies and services. 
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The ERG has been given just four months to report back.  It is not clear of this will be a detailed 
implementation plan, a set of points for the COAG Working Group (yet to be established) or something 
else.  The ToR make it clear that the ERG is not a decision-making body. 
 
There is no indication as to when a 5th National Mental Health Plan will be produced. 
 
Headspace  
The Government has given Headspace funding for 2015-16, but this funding has not been indexed, so 
centres that are already turning away youth in need of treatment must do more with less. Inevitably 
young people will miss out on crucial mental health services. 
The Abbott Government has committed to expand to a total of 100 Headspace services by next year, 
and more than $400 million has been committed to Headspace over the five years from 2013-14. Senate 
Estimates was told that there are currently 82 operational sites and each site gets an average of 
$840,000 / year in addition to Medicare reimbursements. 
There are problems with the Headspace program that must be addressed, even ahead of the 
Government’s response to the NMHC review. To date there is little evidence evidence that after 8 years 
of operation, the program has increased access to treatment for young people, particularly those from 
disadvantaged backgrounds or rural and regional areas. 
The review called the current Headspace system a "collection of often uncoordinated services that have 
accumulated spasmodically over time, with no clarity of roles and responsibilities or strategic approach 
that is reflected in practice" and found that it has become too "overly centralised", with "rigid 
management requirements imposed on local services". It raised the concern that a "one-size-fits-all, 
shopfront-oriented approach" does not meet the needs of some communities or people from diverse 
groups, including those with "more complex or ongoing difficulties". 
Others have been even harsher in their criticism: John Mendoza, former chief executive of the Mental 
Health Council of Australia and a previous chair of a Headspace centre in Queensland, said the original 
intent of the service had been "perverted" and the national head office had become "obsessed with 
brand and marketing".  He spoke about "stifling levels of micro-management" that has left centre 
operators feeling like "fast food franchisees" with no capacity to respond to the unique needs of their 
local areas.98 
In my analysis of the mental health provisions in the 2014-15 Budget, I pointed out that the Headspace 
program appears to be under-funded if it is to be faithful to the model developed by Professor Pat 
McGorry.99 
The NMHC recommended that the PHNs be given the authority and money to manage contracts for 
non-government organisations like Headspace at a local and regional level. While theoretically possible, 
PHNs as currently established would find it difficult to manage the non-clinical aspects of such programs. 
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In March the DoH called for tenders for an independent governance review of the Headspace 
program.100  This is apparently due before the end of the year. 
Mental health and the National Disability Insurance Scheme 
 The access requirements for the NDIS include people with a psychiatric condition who have significant 
and permanent functional impairment. The Scheme will fund supports that assist a person to undertake 
activities of daily living including:  
 Assistance with planning and decision making and household tasks..  
 Assistance to build capacity to live independently and achieve their goals.   
 Supports to engage in community activities such as recreation, education, training and 
employment.101  
 
Since the NDIS was enacted there has been what has been described as a “clash in philosophies” when it 
comes to mental health. The ‘permanent impairment’ requirement is problematic for someone with 
mental illness – most people with psychosocial disability have needs and impairments that change in 
severity and in nature over their lifetimes, sometimes changing very quickly.102 
The ability to solve this problem in a satisfactory way depends upon  the alignment of disability, mental 
health and physical health services – something that is just not possible when the mental health system 
is in disarray, the universal access and affordability of the healthcare system is under attack, and the 
NDIS is still being rolled out.  
One example of problems is those Partners in Recovery programs which have had Medicare Locals as 
part of their operational consortium.  As MLs have disappeared, the PiR consortia have been asked to 
identify new lead agencies.  But this new situation will only apply until the PiR program is rolled into the 
NDIS. All these changes  are happening contrary to the recommendations of the NMHC review, which 
sees the transfer of PiR to NDiS as eroding the existing benefits to individuals in receipt of quality 
services.   
The National Disability Insurance Agency (NDIA) has a Mental Health Sector Reference Group, although 
it appears from the website this has only met once, in December 2014.103  NDIA has commissioned two 
papers around the integration of mental health into the NDIS.104  
 
Medicare Better Access Program 
The Better Access to Mental Health Care initiative (Better Access) with a range of MBS items to improve 
access to mental health services from GPs, psychiatrists, psychologists and allied health professionals 
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was introduced in 2008. Since then the program has undergone many iterations, with changes and 
budget cuts made without any obvious evidence base.  
The success of the program has been contentious. While there has been a significant uptake in services, 
it appears that this has not improved access to mental health care for those most in need and there is 
no evidence to show that those who do get services have improved mental health outcomes. 
A recent paper published in the Medical Journal of Australia confirmed these findings.105 The authors 
found there was considerable inequity in services in more disadvantaged and more rural areas. 
The NMHC review found that Better Access has improved access to psychological treatment in the 
community and recommended its continuation.  However it recommended that work be done to ensure 
the program is targeted to those most in need and that it is rolled up into regional models to address 
community needs in an integrated way (ie a role for PHNs). It noted that concerns have been raised 
about the efficacy of the GP Mental Health Care Plan and the number of sessions available to patients. 
 
Mental Health Nurse Incentive Program 
There were concerns about the fate of this program prior to the Budget.  It was not mentioned in the 
Budget but it has received funding of $41.7 million for the next year.  Since its introduction in July 2007 
this MHN Incentive Program has had funding changes in nearly every Budget.  The funding provision for 
2015-16 appears quite generous, considering the 2014-15 funding was $23.4 million. This program has 
been capped at existing service levels for the past 4 years. 
 
Primary Health Networks 
Among the other mental health issues that remain up in the air is the way in which the new Primary 
Health Networks (PHNs) will commission mental health services, the funds that they will have for this, 
and how this will be done in those areas where mental health services and professionals are in short 
supply.   
Access to Allied Psychological Services 
There are rumours, which were not laid to rest during Senate Estimates, that the ATAPS program will 
not continue.  Even in inner city areas such as Inner West Sydney this program has been so over-
subscribed that there are long waiting times for referral. The SouthWest WA Medical Local recently 
reported that there is a 6 week waiting list for general referrals and the suicide prevention program has 
not been accepting new referrals since February 2015. 
Partners in Recovery 
35 Medicare Locals have been involved in the delivery of the PiR program. The existing PiR consortia 
have been asked to identify new lead agencies in their regions. There are currently 48 PiRs which have 
funding until June 2016 when they will be rolled into the NDIS. 
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At Senate Estimates DoH said that there are 13 PHN regions without a PiR program.  There is no 
intention to establish PiR programs in these regions. 
 
No Contributing Life report card from NMHC in 2014 
The fact that the NHMC was consumed with the review of mental health services and programs meant 
that there was no report card produced in 2014. The NMHC has received funding of $6.5 million for 
2015-16 so it is hoped that the report card will be produced in 2015.  It will likely tell a sad story as 
programs  and services languish awaiting Government action on reform. 
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Dental health 
 
It is painfully clear that the Abbott Government does not see public dental health care as necessary, 
despite all the arguments to support this.  Over the past two Budgets the Government has cut more 
than $550 million from public dental services. 
A recent report from AIHW highlights that Australians' dental health has not improved in recent years. 
There has been a rise in the average number of children's baby teeth affected by decay and an increase 
in the number of adults reporting adverse oral impacts. Nearly half of all children aged 12 years had 
decay in their permanent teeth, over one-third of adults had untreated decay, over 50% of people aged 
65 years and over had gum disease and over 20% of this age group had complete tooth loss.106 
Dental care constitutes around 6.4% of national health spending — to which individuals contributed 58% 
in 2010–11. The federal government, via direct outlays and premium rebates, contributed $1.437 
billion. 
In what the CHF and the AHHA described as ‘bittersweet news’107 this Budget provides funding for the 
NP on Adult Public Dental Services, the commencement of which was deferred for 12 months in the 
2014-15 Budget, but then cuts by nearly 25% the funds previously allocated for 2015-16 (from $200 
million to $155 million).  Moreover there is no certainty provided for future funding. Budget Paper 3 
indicates that “Funding arrangements beyond 2015-16 are subject to negotiations with the states” – the 
usual modus operandi of the Abbott Government.  Yet in opposition the Coalition was critical of the gap 
between the end of the Chronic Disease Dental Scheme and the start of the NP.   
The announcement from the Minister for Health, Sussan Ley, headed “Abbott Government sinks teeth 
into dental reform” ,dated two days before the Budget was released, stated that “more than $200 
million” would be provided in the Budget for dental services in 2015-16.108 Her statement also 
referenced the Government’s White Paper on Reforming the Federation as providing an opportunity to 
greater co-ordination with less duplication. In this political environment that could well be read as the 
Abbott Government looking to divest itself of responsibilities for public dental services. 
There is also concern about the pause in indexation for dental services provided under the Child Dental 
Benefit Scheme and for veterans, as well as reduced support for the dental workforce. Dentists who 
cross-subsidise the cost of providing dental care through these programs will find it harder to maintain 
bulk billing under the indexation pause.  
It’s hard to find recent data about the cost of dental services and who pays.  A 2014 report from AIHW , 
using data from 2011-12 when the Chronic Disease Dental Scheme was in effect (thus blowing out the 
Commonwealth Government contribution over where it is today), found that the Government’s 
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contribution to dental services through the Private Health Insurance then was $528 million, about 50% 
of its direct funding ($1.06 billion)109 (see Table 10). This direct funding includes hospital services, PBS 
drugs and veterans’ care. 
Table 10.  Funding for dental services 2011-12 
Funding source $million % 
Commonwealth Government 1060 12.7 
State, Territory and local governments 718 8.6 
Government payments for PHIR 528 6.3 
Health insurers 1261 15.1 
Individuals 4736 56.8 
Other 34 0.4 
Total 8336 100 
Data from AIHW 2014 
 
Budget provisions 
 
National Partnership Agreement in Adult Public Dental Services 
$155 million is provided in 2015-16 for a one-year agreement; This is $200 million less than initially 
provided in 2014-15.   
 2014-15   
$m 
2015-16   
$m 
2016-17     
$m 
2017-18    
$m 
2018-19    
$m 
DOH - - - - - 
Treasury - - - - - 
 
As is increasingly the case, the Budget Papers are cryptic on the funding of this provision.  It was  
originally funded at $1.3 billion / 4 years and these funds are in the forward estimates, although not 
shown. Funding for future years is dependent on negotiations with the States and Territories. Budget 
Paper 2 refers to this one-year agreement replacing the existing NP on Adults Public Health Services – 
does this indicate that the Abbott Government is pulling back from an agreement already reached, or is 
the intention to state that this new NP replaces the NP on Treating More Public Dental Patients, which 
expired in June 2015? 
In the 2014-15 Budget savings of $390.0 million / 4 years were taken by deferring the commencement 
of the National Partnership Agreement for Adult Public Dental Services from 2014-15 to 2015-16 (see 
Table 11). The savings from this measure were invested in the Medical Research Future Fund. 
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Table 11.  Deferred implementation of NP on Adult Public Health Services 2014-15 Budget 
 
 2013-14 
$m 
2014-15 
$m 
2015-16 
$m 
2016-17 
$m 
2017-18 
$m 
DoH - -0.5 -0.2 -0.1 -0.1 
Treasury - -200.0 -95.0 -95.0 - 
Total - -200.5 -95.2 -95.1 -0.1 
 
 (See also the section on State / Territory and Commonwealth relations) 
 
Child Dental Benefits Schedule - indexation 
Savings of $125.6 million / 4 years are taken by aligning the indexation arrangements for both benefits 
payable and the benefits cap with indexation arrangements for other health care programs. The savings 
will go to fund other health priorities or will be invested in the MRFF. 
 
 2014-15   
$m 
2015-16   
$m 
2016-17     
$m 
2017-18    
$m 
2018-19    
$m 
DoH - -14.9 -25.3 -37.6 -47.7 
 
The CDBS began operating 1 January 2014. It is a means-tested dental benefit for children aged 2 to 17 
funded through Medicare. Benefits are capped at $1,000 over two years, indexed annually. 
Pausing indexation of these services brings the CDBS indexation arrangements in line with the paused 
indexation for other Medicare Benefits Schedule items included in the 2014-15 Budget.   
Senate Estimates gave the estimated expenditure for the CDBS over the forward estimates as $1.91 
billion / 4 years. (see Table 12 ) 
Table 12 :  Estimated expenditure for the Child Dental Benefits Scheme 
 2014-15   
$m 
2015-16   
$m 
2016-17     
$m 
2017-18    
$m 
2018-19    
$m 
DoH - 605 616 630 656 
Senate Estimates was told that 5.6 million services to 1,047, 192 children have been delivered since the 
Scheme started in January 201 and that 95% of these services incurred no out-of- pocket costs. The 
estimated pool of eligible children is 3,062,309.  It appears that about 50% of eligible children have 
accessed the scheme and that each child who does receives 5-6 services.  The estimates expenditure 
does not appear to indicate any substantial increase in the percentage of eligible children accessing the 
scheme in the next 4 years.  This may be due to anticipated increases in out-of-pocket costs as a result 
of the freeze on indexation of reimbursements and a decrease in the number of families who qualify as 
a result of changes in family payments. 
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Continuation of indexation pause for DVA dental and allied health provider fees 
The 2014-15 Budget imposed an indexation pause on DVA dental and allied health provider payments to 
1 July 2016.  This aligned indexation of payments to these providers with those for medical services and 
delivered savings of $35.7 million / 4 years.  The 2015-16 Budget takes further savings of $69.6 million / 
4 years which are achieved by extending the pause on indexation of DVA dental and allied health 
provider payments until 1 July 2018. 
This is discussed further in the section on Provisions in Other Portfolios. 
 
Changes to relocation incentives for dentists 
In Senate Estimates it was elucidated that $30 million will be cut from DRISS through the application of 
the MMM and targeting smaller rural towns. 
 
This is discussed further in the section in rural health. 
 
Closing the dental divide 
 
This is a summary of an article I published in the Medical Journal of Australia.110 
A recent report from the Australian Institute of Health and Welfare highlights that Australians' dental 
health has not improved in recent years. There has been a rise in the average number of children's baby 
teeth affected by decay and an increase in the number of adults reporting adverse oral impacts. Nearly 
half of all children aged 12 years had decay in their permanent teeth, over one-third of adults had 
untreated decay, over 50% of people aged 65 years and over had gum disease and over 20% of this age 
group had complete tooth loss.  
There are consequences for the people involved, the health care system and the economy as a whole. 
The costs are substantial: $7.857 billion was spent on dental treatment in 2010–11 and additional care 
costs exceeded $1 billion. Dental care constitutes around 6.4% of national health spending — to which 
individuals contributed 58% in 2010–11. The federal government, via direct outlays and premium 
rebates, contributed $1.437 billion. 
In the absence of regular dental checks, and when access to dental services is limited by geography, 
affordability and long waiting times for public services, dental problems quickly become medical 
problems. Many patients seek pain relief from general practitioners and emergency departments. In the 
2011–12 financial year there were 63 327 potentially preventable hospitalisations for dental conditions 
and 128 712 separations for dental procedures requiring a general anaesthetic.  
For too many Australians a visit to the dentist — for any reason — is an unaffordable luxury. People who 
have private health insurance are more likely to access dental care, but insurance cover is clearly 
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inadequate, with 78.7% of people with ancillary cover reporting that they paid some of the cost of care, 
and 9.4% of people reporting they paid all of their expenses.  
If we are serious about a focus on effective and efficient health care expenditure, equitable access and 
closing the gaps in health disparities, then it is time to end the dental–medical divide. 
The following initiatives are put forward for consideration in the current political and economic 
environment in which integrating dental care into Medicare is seen as a step too far. Implementing my 
proposals will require concerted action from all stakeholders, but depends more on changes in cultures 
and focus than increased resources. 
1. Make dental and medical professionals partners in delivering health care services and to include 
the mouth as part of the body.  
2. Health promotion activities related to eating well, smoking and substance misuse, breastfeeding 
and better management of chronic conditions and polypharmacy need to include oral health 
information.  
3. Oral hygiene is a critical aspect of care for the frail aged, people with mental illness, people with 
disabilities and those on certain medication regimens.  
4. If private health insurance funds are keen to play a role in primary care to ensure that their 
customers are less likely to need acute care services, then it is time for them to consider their 
role in providing better dental care with reduced costs. 
5. In the absence of universal dental care, the best-value investments for governments are in three 
broad areas: fluoridation, preventive services for children, and preventive and treatment 
services for the poor and those with special needs.  
6. Investment in a “Dental Health Service Corps” made up of dentists and dental staff, doctors, 
nurses, community and Aboriginal health workers and public health professionals to take oral 
health services and education where they are needed.  
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Prevention 
 
The 2014-15 Budget eviscerated preventive health funding, with over $377 million ripped from the 
major federal programs that were addressing alcohol, tobacco and obesity. This came on top of the 
$27.0 million savings made in the 2013-14 MYEFO by scrapping the Healthier Communities – Priority 
Infrastructure Program.  
The 2015-16 Budget makes further cuts in key prevention programs; the exact amount is hidden and 
difficult to estimate.  There are likely a number of prevention programs affected by the cuts to Flexible 
Funds. The only major new funding is $188.2 million / 5 years for immunisation programs, the provision 
of new vaccines and improving coverage rates.  
The Abbott Government’s focus is solely on secondary prevention – issues such as cancer screening and 
immunisation – and, with the exception of tobacco harms, primary prevention is ignored.  Even in the 
space where they are willing to work there are problems: a recent paper calls for new approaches to 
diabetes prevention by tackling dietary risk factors.111 
Some of the new spending on immunisation is directed at efforts to improve coverage rates, and to 
track these by expansion of the National Immunisation Program (NIP) register. When combined with the 
No Jab No Pay policy, these efforts provide a ‘carrot and stick’ approach to encouraging vaccination.It is 
interesting to note that the costings for the No Jab No Pay policy, with savings continuing to grow across 
the forward estimates, seem to assume that these efforts to improve immunisation rates will not be 
effective. 
One of the few new programs to be developed in this area is on the harms of crystal methamphetamine 
(ice). However experts in the area have cautioned against a kneejerk response to this problem, 
highlighting that tackling ice use in individuals and communities presents serious challenges for 
treatment and rehabilitation services and also for police and courts that will require both short term and 
long term responses. To develop the most considered and robust response will take time, community 
consultation and professional consultation.112 The Government’s real commitment to this issue must be 
questioned as they spend $20 million on a public awareness campaign while cutting $8 million from 
treatment programs. 
The Government seems determined to ignore the harms and costs due to alcohol which causes greater 
harm than ice. Every day 430 Australians are hospitalised as a consequences of alcohol abuse, there are 
5500 alcohol-related Australian deaths each year,113 and alcohol is a key contributor to family and 
community violence.  
In April 2008 the Australian Government introduced the ‘alcopops’ tax on ready-to-drink (RTD) 
beverages. The aim of the tax was to reduce harm from binge drinking among young people, as a group 
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which are the primary target market (young females in particular) for RTD beverages. Although there 
has been opposition to the tax from the industry (and initially from the Abbott Government) and mixed 
early reports about its impact, a recent study into the impact of the GST and ‘alcopops’ tax on the 
incidence of alcohol harms found:  
 The GST (whose introduction led to reduce prices for RTDs) was associated with a statistically 
significant increase in Emergency Department (ED) presentations for acute alcohol problems among 
18-24 year old females.  
 The ‘alcopops’ tax (whose introduction increased the price of RTDs) was associated with a 
statistically significant decrease in ED presentations among 15-50 year old males, and 15-65 year old 
females, particularly 18-24 year old females.  
 The alcopops tax was also associated with declining ED presentations in underage drinkers.114 
One of the few areas where the Abbott Government has not acted to undermine Labor initiatives is 
tobacco control. Despite Coalition ties to Big Tobacco and Abbott’s criticism of the previous Labor 
Government’s increase in tobacco excise tax, the Government has kept the strong anti-tobacco 
provisions. The Government will continue to act to protect plain packaging and is using the budget 
deficit as an excuse to keep the increased excise tax.115 
Together these and other anti-smoking efforts have had a real impact on Australian smoking rates which 
continue to decline. In the two years since the plain packaging laws came into effect in December 2012, 
tobacco consumption fell 12.8%.116 The National Drug Strategy’s Household Survey shows that the daily 
smoking rate fell 15% 2010 and December 1 2013, to 12.5%.117  
However there are concerns that provisions in the Trans Pacific Partnership, which is currently being 
negotiated, will undermine Australia’s strong anti-tobacco laws.118 
A serious area of concern is that nothing is being done to tackle the growing and costly epidemic of 
obesity in Australia.  The opportunities that might arise to boost physical activity as a result of the 
inclusion of Sport in the Health Portfolio have to date delivered nothing.  
We cannot afford to drop the ball so dramatically on preventive health and we will pay the price down 
the road. 
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Budget provisions 
 
New and amended listings to National Immunisation Program 
$161.8 million / 5 years is provided for new and amended listings to the National Immunisation 
Program (NIP). 
 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DoH 0.1 6.2 42.8 43.8 37.9 
DHS - 2.3 8.2 5.9 5.4 
Treasury - 0.1 0.7 1.6 1.6 
Total 0.1 8.5 51.6 51.3 44.8 
DHS Capital Expense  - 2.4 2.8 0.4 - 
 
These include: 
 An additional dose of Diptheria, Tetanus and Acellular Pertussis (DTPa) vaccine for children aged 
18 months for extra protection against whooping cough (from 1 Jan 2016). 
 Zostavax vaccine to prevent shingles for 70 year olds, with a catch up program for 71–79 year olds 
(from 1 November 2016). 
In addition, this provision in the Budget states that a vaccination register will be established to record all 
adult vaccines provided under the NIP from 1 September 2016.   
Health professionals have called for the introduction of a whole-of-life register to include adult 
vaccinations. However, as pointed out by the Parliamentary Library,119 the exact nature of the 
Government’s response on this issue is not clear. A media release from the Minister has the 
Government ‘exploring options to capture adult immunisation records.’ 
In 2006 the Government announced $1.2 million for a scoping study to examine ‘the feasibility of 
establishing a whole-of-life immunisation register’, but it appears that study was never done. 
 
Improving immunisation coverage rates 
$26.4 million / 4 years is provided to improve immunisation coverage rates. 
 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DoH - 8.4 4.6 3.1 3.7 
Treasury - - 1.8 1.9 1.9 
Total - 8.4 6.4 6.0 5.6 
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This initiative includes:  
 An incentive payment to doctors and other immunisation providers when they identify a child who 
is overdue for vaccination and call them in for a catch up. 
 Funds for an awareness campaign to promote the NIP and address parents’ concerns regarding 
immunisation. 
 Expansion of the existing National Human Papillomavirus Vaccination Program Register to the 
Australian School Vaccination Register, to include all adolescent vaccinations delivered in schools 
under the NIP. 
Tobacco plain packaging legislation 
The Government will provide funding and continue to defend international legal challenges to the 
Tobacco Plain Packaging Act 2011, which is the subject of dispute proceedings in the World Trade 
Organisation. This funding goes to DoH, the Attorney General’s Department, DFAT and the Australian 
Government Solicitor General; it is not for publication. 
Recent news is that Ukraine will drop its case against Australia which was instigated at the request of 
the American Chamber of Commerce.120 Other cases have been filed by Honduras, Dominican Republic, 
Cuba and Indonesia.  
A leaked chapter of the Trans Pacific Partnership (TPP) contains information about the TPP’s proposed  
investor-state dispute settlement (ISDS) clause. Such clauses give investors direct access to international 
arbitration, where they can bring claims against a government over regulatory measures they think may 
damage their bottom line. This could enable Big Tobacco to contest Australia’s palin packaging laws. The 
leaked chapter has a footnote saying Australia is exempt from ISDS, but that may change ‘subject to 
certain conditions’. The draft doesn’t indicate the exact nature of these conditions, and the footnote 
remains in brackets, indicating the issue has not yet been settled.121 
 
Reforms to National Cervical Screening Program 
The National Cervical Screening Program (NCSP) will be reformed to reflect recommendations deom 
MSAC at a net cost of $13,000 / 4 years. 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DoH - 2.2 2.0 -0.1 -0.6 
DHS - - -0.3 -1.6 -1.6 
Total - 2.2 1.7 -1.7 -2.2 
From 1 May 2017, the current two-yearly Pap test will be replaced by a 5 year HPV test for women aged 
25-74 years. 
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An HPV test every five years is considered more effective at protecting against cervical cancer and just as 
safe as, screening with a Pap test every two years.
122
 HPV vaccinated women will still require cervical 
screening as the HPV vaccine does not protect against all the types of HPV that cause cervical cancer. 
Renewal of National Drugs Campaign 
$20 million / 2 years is provided to renew the National Drugs Campaign. This will be used for a national 
media campaign focused on awareness of the harms caused by methamphetamine (ice). 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DoH - 10.0 10.0 - - 
In the 2010-11 Budget, cuts were made to the National Drugs Campaign, but $21.2 million / 4 years was 
provided to continue a national media campaign to promote the avoidance and cessation of illicit drug 
use. The campaigns were to focus on ecstasy, methamphetamine and cannabis use by young people. No 
further funding was provided in 2014-15. 
In the 2014-15 MYEFO the Abbott Government abolished the Drug and Alcohol Prevention and 
Treatment Advisory Committee. Since then, the Government has chosen to focus solely on the problems 
associated with ice use. This is happening even as $8 million is cut from drug and alcohol programs 
funded through the Flexible Funds. 
In April 2015 the Prime Minister announced a task force to tackle the current ice problems in the 
community and in criminal gangs.123 The taskforce will coordinate local, state and federal efforts against 
the use, sale, manufacture and importation of the drug and develop a national ice action strategy. An 
interim report is due by the middle of the year. 
In May 2015 the Government launched what was described as a $9 million, six-week blitz campaign.124  
(Note that elsewhere the campaign has been described as costing $11 million.) This involved an ad 
almost identical to one first aired in 2007.  The recycling of this ad may explain how funding was 
available for this in 2014-15. 
In 2013 advice was provided to DoH that shock and awe advertising campaigns bout drugs are a turn off 
for young people.125 Despite this, the Abbott government's advertising blitz on ice has adopted a hard-
hitting approach by depicting an ice user violently lashing out in a hospital. 
The National Drug Strategy 2010-2015 expires this year.  
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Indigenous Health 
 
There were no specific Indigenous issues included in the Health budget, and there are questions about 
the future of some programs. 
 
Aboriginal Community Controlled Health Organisations 
 
The Abbott Government has provided $1.4 billion /3 years ($448 million / per year) for Aboriginal 
Community Controlled Health Organisations (ACCHOs). This will include a 1.5% CPI increase over the 3 
year period. This appears to be a reduction from current funding levels.126 NACCHO and Affiliate funding 
of $18 million is provided for 18 months and in that time DoH will commence a review of NACCHO’s role 
and function.127  
 
In addition, NACCHO has secured confirmation of an extension of the exemption from Section 19.2  of 
the Health Insurance Act 1973 which expires on 30 June 2015, which enables ACCHOs to receive 
financial benefit from Medicare rebates in addition to Government funding.  This extension will be 
granted until June 2018. 
The freeze on MBS rebate indexation will have a significant financial impact on ACCHOs as will any 
increase in Medicare and PBS co-payments. 
 
Flexible Funds 
 
In combination the 2014-15 and 2015-16 Budgets will cut $500 million / 4 years from 14 of the 16 DoH 
flexible funds.  There is still no clarity in relation to how these savings are to be achieved, although the 
Aboriginal and Torres Strait Islander Chronic Disease Fund will not be cut.  However cuts to other funds 
such as those that support the provision of essential services in rural, regional and remote Australia, that 
manage responses to communicable diseases and that deliver delivering substance abuse treatment 
services will affect  Indigenous Australians.  
Aboriginal and Torres Strait Islander Chronic Disease Fund 
Within the Health portfolio, the Aboriginal and Torres Strait Islander Chronic Disease Fund supports 
activities to improve the prevention, detection, and management of chronic disease in Indigenous 
Australians and to contribute to the target of closing the gap in life expectancy. The Fund consolidates 
16 existing programs, including the majority of initiatives under the Indigenous Chronic Disease Package, 
into a single flexible fund. The three priority areas targeted are:  
 Tackling chronic disease risk factors  
 Primary health care services that can deliver  
 Fixing the gaps and improving the patient journey.  
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The Fund was established in the 2011 Budget and came into operation on 1 July 2011. The funding is 
$833.27 million / 4 years (from 1 July 2011 to 30 June 2015). The majority of funding has been directly 
allocated to organisations to support activities under the Fund’s Indigenous Chronic Disease Package 
programs.128        
 
At June 2015 Senate Estimates it was confirmed that most, but not all, of the activities under this fund 
were continuing.  Local community campaigns and the chronic disease self-management program were 
named as two programs that were not continued. 
 
Tackling Indigenous Smoking Program  
 
The 2014-15 Budget cut $130 million / 5 years from the Tackling Indigenous Smoking Program, despite 
the fact that 44% of Indigenous people smoke.129    The program was reviewed in 2014 and the DoH 
website says that this review will “provide the Government with options to ensure the program is being 
implemented efficiently and in line with the best available evidence. The outcome of the review will 
inform new funding arrangements from 1 July 2015.”130  However there were no announcements in the 
Budget. 
The redesigned program was announced on 29 May 2015, but with no increase in funding.131 It is not 
clear when or if the review of this program, conducted by the University of Canberra, will be released. 
Funding in 2014-15 was $46.4 million; this is reduced to $35.3 million in 2015-16.  Staffing levels have 
also fallen significantly, from 284 FTEs in May 2014 to 194 FTEs in May 2015. There will be further 
disruption to this important program as current contracts cease at the end of June 2015 and the 49 
organisations that deliver the program must go through the IAS Invitation to Apply Process for further 
funding.  Transitional funding will be available for the next 6 months. 
 
Australian Nurse Family Partnership Program and New Directions: Mothers 
and Babies Services 
 
In the 2014-15 Budget there was additional funding for a Better Start to Life will improve early childhood 
outcomes : 
 $54 million expansion, from 2015-16, of New Directions from 85 to 137 sites (52 additional sites 
overall) to ensure more Indigenous children are able to access effective child and maternal health 
programs. 
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 $40 million expansion, from 2015-16, of the Australian Nurse Family Partnership Program from 3 to 
13 sites (10 additional sites overall) to provide targeted support to high needs Indigenous families in 
areas of identified need. 
 
 In 2015 the Australian Nurse Family Partnership Program will grow from three to five sites and New 
Directions: Mothers and Babies Services will reach an additional 25 services, bringing the total to 110 
services, with an enhanced capacity to identify and manage Fetal Alcohol Spectrum Disorder in affected 
communities.132 
 
Prevention – Shingles vaccine  
 
The Budget provides for the listing of Zostavax vaccine for the prevention of shingles to be listed on the 
National Immunisation Program for 70 year olds from 1 November 2016.  This measure includes a 5-
years program to provide a catch-up program for people aged 71-79. 
There is concern that the 70-79 year old age cohort largely excludes Indigenous people because of their 
lower life expectancy. 
 
Pharmaceutical Benefits Scheme 
 
Close the Gap PBS Co-payment 
 This is an ongoing measure and although it was not mentioned in the Budget, it was stated in Senate 
Estimates that this would continue as currently. 
 
QUMAX Program 
The QUMAX program is a quality use of medicines initiative that aims to improve health outcomes for 
Indigenous people through a range of services provided by participating ACCHO and community 
pharmacies in rural and urban Australia. It commenced in 2008 as a two year pilot. It was later approved 
for a transition year outside the 4th Community Pharmacy Agreement and for a further four years under 
the  5th Community Pharmacy Agreement.133 
NACCHO and the Pharmacy Guild of Australia have been negotiating 1 year transition funding of QUMAX 
to enable development of an Implementation Plan under the 6th Community Pharmacy Agreement.  
NACCHO will seek to expand QUMAX from 76 services to 134 services. 134 
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Medicare provisions 
 
MBS Practice Incentive Program (PIP) Indigenous Health Incentive 
This is an ongoing program (although it may be subject to an indexation freeze).  It is expected to be 
considered as part of the new MBS Review.  
 
Healthy Kids Check 
The Budget cut Medicare funding for the Healthy Kids Check, a consultation with a nurse or GP to assess 
a child’s health and development before they start school, on the basis that this measure is a duplication 
with existing State and Territory based programs.  NACCHO states that this change will not impact 
ACCHOs or Indigenous children as ACCHOs can continue to bill health assessments through a separate 
item (MBS item 715). 
 
Primary care - PHN Funding  
 
The current transition of Medicare Locals (MLs) to Primary Health Networks (PHNs) is proceeding slowly 
and many details relating to specific programs remain unknown, perhaps even undecided.  
To date, 21 of 61 MLs outsource the provision of services for Indigenous Australians directly to ACCHOs. 
The provision of these services will now move to a competitive commissioning process, leading to 
concerns about issues such as cultural safety and sensitivity. 
The Minister for Health, Sussan Ley,  has advised NACCHO that funding for Complementary Care and 
Supplementary Services will transition to the PHNs.135 
 
Mental Health 
 
The Budget has nothing that responds to the National Mental Health Commission’s review of programs 
and services.  The report describes Indigenous mental health as ‘dire’. It’s a dominant over-arching 
theme throughout, and there is a recommendation to make Indigenous mental health a national priority 
and agree an additional COAG Closing the Gap target for mental health.136 
There is a particular need to address the link between incarceration and mental illness. Among 
Indigenous people in prison, the rates of mental illness such as anxiety, depression, substance misuse 
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and psychosis, are very high: 73% overall for Indigenous men and 86% for women according to a 2008 
estimate from Queensland.137    
Despite this, the Government has delayed any action and has established an Expert Reference Group to 
develop implementation strategies.  There is no Indigenous representation on the Reference Group. 
 
Substance and alcohol abuse   
 
Alcohol abuse  
Alcohol abuse has been identified as a major public health concern among Indigenous people, with 
serious physical and social consequences. Indigenous Australians between the ages of 35 and 54 are up 
to eight times more likely to die than their peers, with alcohol abuse the main culprit and alcohol is 
associated with 40% of male and 30% of female Indigenous suicides.138  
Fewer Indigenous people drink alcohol than in the wider community, but those who do drink do so at 
levels harmful to their health. Culturally appropriate intervention approaches are needed and ‘dry 
zones’ are only seen as stop gap measures.  
Cuts made in Flexible Funds will affect Indigenous drug and alcohol programs.  
 
Ice campaign 
This Budget commits $20 million / 2 years for a new stage of the National Drugs Campaign primarily 
aimed at the use of ice. No consultation has been undertaken in the lead up to the announcement of 
this health promotion campaign.  
It almost certainly will not achieve tangible outcomes for Aboriginal people, despite concerns about a 
growing ice epidemic in remote Indigenous communities.139  
 
Opal fuel 
There are 123 petrol stations selling Opal fuel in remote parts of Australia but some retailers in the roll-
out zones don't and there are pockets of sniffing near state borders. In December 2014 it was 
announced that a bulk storage tank for low-aromatic unleaded fuel (LAF or Opal ) is to be installed in 
northern Australia as part of the  roll-out of OPAL in the fight to curb the problem of petrol sniffing.140 
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Rural health 
 
The 2015-16 Budget offered little for rural and remote health. The single major provision that directly 
benefits rural and remote areas is the retargeting of financial incentives to encourage doctors to work in 
small rural towns, but this comes at the expense of larger rural and regional centres and outer 
metropolitan areas, many of which also have serious workforce shortages.  
Rural and remote areas have generally older populations, higher levels of health risks, and higher rates 
of chronic disease. In addition there are the pressures of the problems affecting the social, economic 
and environmental sustainability of their communities. Despite greater levels of need, rural people have 
less access to health services, with substantial shortages of nearly all health professions and of health-
related infrastructure.141  
 
Certain population groups suffer more than others. Around 70% of Indigenous Australians live in 
regional and rural areas and their health and wellbeing is tragically deficient. Men in rural regions face 
distinct health issues: they are more likely than their urban counterparts to experience chronic health 
conditions, have higher mortality rates from injury, cardiovascular disease and diabetes, and report risk 
factors such as  daily smoking and risky drinking behaviour and poor health literacy.142 
 
There is less access to specialised mental health care in rural areas where suicide rates are highest. 
‘Rural stoicism’, resilient attitudes and lower educational levels also influence help-seeking behaviour, 
readiness to engage with mental health services, and adherence to preventive advice. The NHMC report 
on mental health services recommended that the development of Primary Health Networks provides an 
ideal opportunity to harness the existing infrastructure and better target mental health resources to 
meet population needs on a regional basis.143  The big winners from this approach would be those living 
in rural and regional Australia who suffer most from the current lack of effective community and 
professional services in their own local areas. 
 
Some cuts to rural health programs have been made by stealth and remain unknown.  Assistant Minister 
for Health, Fiona Nash, has refused to provide details of funding cuts to the Rural Health Outreach Fund 
and which rural services will be affected.144 
Workforce numbers remain an issue for rural and remote areas.  It’s not clear if proposed changes to 
rural relocation incentives for doctors and dentists will work better than the existing arrangements 
(there has apparently been no modelling done) and the new arrangements have not built in mechanisms 
to address Indigenous needs. 
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The new geographical classification scheme to be introduced is based on the work done by Professor 
John Humphreys at Monash University.145  This is the second geographical classification system to be 
introduced in the past 6 years. In July 2009 the Australian Standard Geographical Classification – 
Remoteness Areas (ASGC-RA), developed by the Australian Bureau of Statistics, was introduced. The 
new scheme seems to be well accepted but there will always be anomalies and so flexibility is needed in 
implementation. 
The Budget Papers this year highlight the Abbott Government’s Partnership for Regional Growth and the 
White Paper on Developing Northern Australia.  The Budget Papers list the following new initiatives as 
particularly relevant to regional Australia: 
 Streamlining health workforce scholarships : a rural return of service obligation will now be 
associated with most scholarships (see Workforce section). 
 Better targeted rural financial incentives for doctors. 
 Consolidated and streamlined dental workforce programs: the Modified Monash Model will be 
applied.  (no further information about this initiative is provided). 
 New MBS items for targeted intraoperative radiotherapy for early-stage invasive breast cancer: this 
will mean that women in rural and remote areas will not need to travel for radiotherapy after 
surgery  (see Medicare section). 
 New MBS listing for remote monitoring of patients with implanted cardiac devices (see Medicare 
section). 
 MBS rebates for optometrist to assist patients during telehealth consultations with 
ophthalmologists (see Medicare section). 
 Positioning the north as a global leader in tropical health. 
 
Budget provisions 
 
Better targeted rural financial incentives for doctors 
Existing medical training programs will be reprioritized to better target rural areas. Exact funding levels 
cannot be ascertained from the Budget Papers. It is not clear what the funding in the table below 
means. 
 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DoH 0.6 2.6 .. -0.1 -0.1 
DHS -0.6 -2.6 .. 0.1 0.1 
Total - - - - - 
 
Funding from the More Doctors for Outer Metropolitan Areas Relocation Incentive Grant and the HECS 
Reimbursement Scheme will be redirected to the GP Rural Incentives Program (GPRIP). The expanded 
GPRIP will be redesigned to a seven step scheme to increase incentives for GPs in smaller rural 
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communities, based on the Modified Monash Model of rural classification.  Incentive payments will be 
adjusted, based on where doctors choose to practise and their years of service. In media release this is 
described as a $113 million (over 4 years?)  program. 
The GPRIP was introduced by Labor in 2010.  The program then was formed by consolidation of the 
Rural Retention Program (RRP) and the Registrars Rural Incentive Payments Scheme.  It was funded at 
$64.3 million / 4 years. According to the Minister’s media release at the time, a GP relocating from a 
major city to a regional centre would receive a $15,000 grant, and doctors who practice in the most 
remote locations would potentially have their maximum retention incentives increased from $25,000 
per year to $47,000 per year. 
 
Indicative modelling by DoH of this new program shows a doctor who stays in a very remote area for 
five years could earn up to $60,000 as an incentive payment, whereas a doctor choosing a less remote 
region and only staying for two years could receive about $4,000 in incentive payments. Research has 
found doctors would only consider relocating to a rural location of 5,000 people or less for an additional 
64% of their current salary, well above the current government incentive payments. 
On 1 December 2014, Minister Nash announced that an Independent Expert Panel would consider the 
application of the Modified Monash Model (MMM) to GPRIP, and also consider pathways for junior 
doctors to rural practice.146  
Not all of the recommendations of the Expert Panel report have been implemented; in particular, the 
recommendation that rural GPs often deliver complex care within their communities and that GPRIP 
payments is not the most efficient mechanism to reward this higher level of community service. The 
Panel strongly recommended that some funds from the existing GPRIP should be redirected to existing 
programs which recognise this more complex work, such as the Practice Incentives Program (PIP) 
Procedural General Practitioner Payments.  
The retargeted money does not include a target for bolstering health services in Indigenous 
communities. 
Changes to relocation incentives for dentists 
In Senate Estimates it was elucidated that $30 million will be cut from DRISS through the application of 
the MMM and targeting smaller rural towns. 
 
 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DOH - 29.2 18.95 19.2 19.4 
Figures provided in Senate Estimates 
It is a signal either that dental care doesn’t rate with this Government or that there is embarrassment 
about cutting a program to deliver more dental care to rural areas, but the application of similar 
principles to those above to the Dental Relocation Incentive Support Scheme (DRISS) is hidden away in 
the Budget under the provisions for the ‘rationalisation and streamlining Health programs’.  
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The DRISS has not been evaluated and the DoH has admitted that Impact of reduced funding and MMM 
on DRISS and actual relocations is not clear. What is known is that 4 rounds of DRISS resulted in 128 
successful allocations for dentist relocation to regional/rural areas.  
 
Supporting the Royal Flying Doctor Service 
Additional funding of $20 million / 2 years is provided to support the Royal Flying Doctor Service (RFDS). 
 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DOH - 9.9 10.1 - - 
 
This additional funding will provide $68 million for each of the next two years.  The Prime Minister has 
also (separately) announced $33.7 million / 4 years for a  Remote Airstrip Upgrade Program.147 
The RFDS has always been funded from budget cycle to budget cycle, with occasional ‘top ups’. The 
2007-08 budget provided additional funding of $156.6 million / 5 years from 2006-07 to 2010-11 and 
this was described as bringing total funding for this period to $274 million.148 The RFDS received several 
funding grantsfrom the Health and Hospitals Fund in the 2012-13 Budget for a new Base building and 
accommodation in Charleville, a hangar and patient transfer facility in Roma, and a new dental health 
project. 
The extent to which the RFDS relies upon federal funding is unknown; it also receives funding from state 
governments and private sources.   
 
Wimmera Health Care Group – Redevelopment of oncology, dialysis and community 
palliative care centre 
$1 million is provided in 2014-5 to the Wimmera Health Care Group for the redevelopment of the 
Oncology, Dialysis and Community Palliative Care Centre in Horsham, Victoria. 
This funding is to supplement the $2 million of privately raised funds that will be needed for the new 
centre.  The Budget Papers state that the cost of this measure will be met from the existing resources of 
the Department of Infrastructure and Regional Development.  This is not reflected in the way the budget 
provision is written. 
 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
Dept Infrastructure and 
Regional Development 
- - - - - 
DoH 1.0 - - - - 
Total 1.0 - - - - 
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This provision was announced by the Prime Minister in March 2015. This funding is clearly to boost 
support for the local member Andrew Broad.  In local media statements this is described only as an 
oncology centre.  Building is apparently not due to start until 2017.  
 
Developing Northern Australia – positioning the north as a leader in tropical health 
$15.3 million / 4 years is provided to invest in research into exotic disease threats.  This includes $6.8 
million to the NHMRC and $8.5 million to establish an Australian Tropical Medicine Commercialisation 
Grants program. 
 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
Aust Trade Commission - 1.4 2.2 2.7 2.3 
NHMRC - 0.9 2.2 2.2 1.5 
Total - 2.3 4.4 4.9 3.8 
 
The Northern Australian Tropical Disease Collaboration Program, funded through the NHMRC, is 
described as supporting innovative research into tropical diseases, building strong collaborations and 
capacity in the health and medical workforce, and promoting effective translation of research into 
health policy and practice. Research will focus in tropical diseases with a high impact on human health 
including: dengue, malaria, melioidosis, Lyssa Hendra and Nipah viruses, chikungunya and Murray Valley 
encephalitis and multi-drug resistant TB.  . 
The Australian Tropical Medicines Commercialisation Grants program will be an Austrade initiative 
delivered by the Department of Industry and Science.  It is described as looking to take advantage of 
business opportunities by establishing targeted funding to translate and commercialise research in new 
therapeutics and diagnostics in tropical medicine. 
It is not clear if these initiatives are targeted specifically at the Australian Institute of Tropical Health and 
Medicine (AITHM) at James Cook University. 
 
Cuts to Rural Health Outreach Flexible Fund 
At Senate Estimates there was information that there would be cuts to this fund but no indication as to 
the extent of those cuts. By extrapolation from the information given, it appears that this fund will be 
cut by $10.7 million.  Given that the total expenditure for this fund is around $31 million / year, this 
could mean a significant impact on the programs run under this Flexible Fund.   
These programs include: 
 Medical Specialist Outreach Assistance Program (MSOAP) 
 MSOAP ophthalmogy 
 MSOAP multi-disciplinary maternity services 
 Rural Women’s GP Service Program 
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 Kimberley Paediatric Outreach Program 
 
These are all valuable programs for people in rural and remote communities, especially women.  Budget 
cuts at any level will have major consequences. 
 
Other issues  
Prevocational training 
The expert panel that provided advice to the Government on the redesign of the GPRIP also  
recommended that the Government re-introduce the Prevocational General Practice Placements 
Program (PGPPP) which provides junior doctors with a rural general practice experience as part of their 
prevocational training. The report recommended “that the Government consider a range of options to 
introduce a program that provides a high quality community medicine and general practice training in 
rural and remote areas through extended placements for junior doctors”. 
 
The PGPPP was discontinued in the 2014-15 Budget. 
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Workforce 
 
The 2014-15 Budget abolished Health Workforce Australia (HWA) and saw its responsibilities subsumed 
into the DoH even as the Department was hit with required efficiency dividends, staff cutbacks and 
multiple restructures.  We will almost certainly pay the price for the loss of a national, coordinated 
approach to health workforce reform.  
One of the last reports published by HWA summed it up succinctly: “The medical workforce is a national 
resource; a resource that is valuable to the community both in terms of the cost of training, which is 
substantially borne by the taxpayer, and in terms of the benefit derived by the community from a well 
trained health workforce. Uncoordinated decision making in the past in the absence of an active 
workforce planning mechanism has seen a “boom and bust” cycle in medical training and resulting 
doctor numbers. This has a cost to the community and a cost to the taxpayer.”149 
 
Review of Rural Practice Incentives. 
A number of changes have been made to rural practice incentives on the basis of a review by an expert 
panel.  The review, to consider the application of the Modified Monash Model (MMM) to the General 
Practice Rural Incentive Program (GPRIP) and also consider pathways for junior doctors to rural practice 
was commissioned on 1 December 2014 by Assistant Health Minister, Fiona Nash.150 
The expert panel reached the following conclusions: 
 There is a reduced need to incentives to attract doctors to larger regional centres and incentives 
should be applied to smaller rural and more remote areas where they are more likely to compensate 
for the negative factors affecting recruitment, retention and support for comprehensive practice.  
 
 Increased numbers alone are not the solution.  The solution needs to be based on community health 
needs and appropriate service delivery models. Small rural communities require access to 
comprehensive primary care, emergency services, hospital care and maternity and procedural 
services. This in turn implies broadly skilled practitioners and teams operating within a training, 
referral and visiting service network as a 'system of care’ 
 
 Doctors in these smaller rural and remote areas are required to possess an advanced skillset 
including procedural and emergency medicine and to have greater workload flexibility to meet the 
needs of the community.  Currently many doctors in these areas are either in-training or completing 
return-of-service obligations and may not have acquired the necessary skills to meet the needs of 
their communities.  
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 Implicit in a viable practice model is sustainable delivery of services in rural and remote 
communities that are comprehensive and continuing across primary care / general practice into 
extended settings. Inherent in the model must be scope for adequate succession planning and 
system solutions that go beyond individual commitment, skills and personalities. 
 
 GPRIP incentives should form part of a range of incentives that recognise the skills and work of rural 
and remote doctors. As a retention incentive, the GPRIP should be made available during critical 
points in a rural doctor’s career path (after 2-3 years of service).  
 
 Rural doctors require greater access to leave provisions to allow for upskilling, recreational leave, 
etc. both during and after their training. 
 
 It is important that essential that junior doctors continue to have access to early and ongoing 
pathways to rural practice that will provide high quality general practice training through extended 
placements in rural locations. This education and training should not be  limited only to those 
doctors who seek to practice in rural or remote areas but be available to  doctors who may seek 
other career paths.  
 
 The development of new training pathways will require key input and support from state 
jurisdictions and educators to ensure a fully integrated and coordinated medical education and 
training pipeline. 
 
Unfortunately the full recommendations of this comprehensive and far-sighted report were ignored by 
Government which chose simply to revamp the GPRIP and similar incentives for dentists.  These 
incentives now carry sufficient economic value that they will likely work in the short-term; but given that 
financial incentives are just one aspect of what attracts and retains well-qualified doctors (and dentists) 
to rural and remote areas, it remains to be seen if the new incentives programs will work long-term. 
The recommendations about skill levels, team work, new practice models and locum relief remain to be 
addressed.  
 
Prevocational training 
 
The review also recommended that the Government re-introduce the Prevocational General Practice 
Placements Program (PGPPP) which provides junior doctors with a rural general practice experience as 
part of their prevocational training as part of a range of options for programs to provide “high quality 
community medicine and general practice training in rural and remote areas through extended 
placements for junior doctors”. 
 
The PGPPP was discontinued in the 2014-15 Budget. The Government’s decision to cease the PGPPP 
from January 2015 came as a shock to the medical profession. 
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A recent study151 which compared general practice rotations with hospital rotations in relation to 
teaching and support, acquisition of skills and knowledge, and role autonomy found that the PGPPP 
rated better than all hospital rotations in 15 out of 20 areas. 
 
GP Training 
 
DoH has finally reached agreement with professional bodies on terms of reference for a profession-led 
GP Training Advisory Committee (GPTAC).152The new body, which will have representation from the 
Royal Australian College of General Practitioners, the Australian College of Rural and Remote Medicine, 
General Practice Registrars Australia, General Practice Supervisors Australian and independent member, 
will have a policy advisory function. 
But until the body is established later this year, GP training governance remains in limbo and  the tender 
period for applicants to run 11 new regional registrar training organisations (RTOs) ends next week. 
In September, a new cohort of 1500 successful applicants for 2016 will add to the 8000-odd already in 
training.  
Under the 2014 federal budget, the functions of GP Education and Training were to be transferred to 
DoH. But negotiations about roles in education and training for the RTO, colleges and DoH have yet to 
conclude. 
 
Budget Provisions 
 
Better targeted rural financial incentives for doctors 
Existing medical training programs will be reprioritized to better target rural areas. Exact funding levels 
cannot be ascertained from the Budget Papers. It is not clear what the funding in the table below 
means. 
 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DoH 0.6 2.6 .. -0.1 -0.1 
DHS -0.6 -2.6 .. 0.1 0.1 
Total - - - - - 
 
Funding from the More Doctors for Outer Metropolitan Areas Relocation Incentive Grant and the HECS 
Reimbursement Scheme will be redirected to the GP Rural Incentives Program (GPRIP). The expanded 
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GPRIP will be redesigned to a seven step scheme to increase incentives for GPs in smaller rural 
communities, based on the Modified Monash Model of rural classification.  Incentive payments will be 
adjusted, based on where doctors choose to practise and their years of service. In media release this is 
described as a $113 million (over 4 years?)  program. 
For further details see section in Rural Health. 
 
Changes to relocation incentives for dentists 
In Senate Estimates it was elucidated that $30 million will be cut from DRISS through the application of 
the MMM and targeting smaller rural towns. 
 
 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DOH - 29.2 18.95 19.2 19.4 
Figures provided in Senate Estimates 
For further details see section in Rural Health. 
 
Interagency transfer from Department of Veterans’ Affairs of Junior Medical Officer Program 
Responsibility for the Junior Medical Officer Program is transferred from the DVA to DoH. 
 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DOH - 10.0 .010, 10.0 10.0 
DVA - -10.0 -10.0 -10.0 -10.0 
Total - - - - - 
 
This program provides training for junior doctors at the Greenslopes Private Hospital in Queensland and 
the Hollywood Private Hospital in Western Australia. 
 
Streamlining health workforce scholarships 
Savings of $72.5 million / 4 years are taken by streamlining 9 health workforce scholarships into a single 
Health Workforce Scholarship Program. It is not clear how the savings are achieved, but savings of this 
order are unlikely to result simply from streamlining.  
These savings are directed to fund other health policy priorities or to the MRFF. 
 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DOH - -14.2 -17.8 -19.0 -21.7 
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A return of service obligation will apply and will require recipients to work in rural or regional areas for 
one year. The Health Portfolio Budget Statement states that this measure, which applies to the current 
range of medical, nursing and allied health scholarships within the Health portfolio,  is aimed at 
producing a more effective program and encourage more students to work in regional and rural areas. 
This measure will not affect the Puggy Hunter scholarships for Indigenous Australians.  
In addition, the 100 places for medical students under the Medical Rural Bonded Scholarships Scheme 
(MRBS Scheme) will be transferred to the Bonded Medical Places Scheme (BMP Scheme). Currently, 
under the MRBS Scheme, medical students must work for six continuous years in rural or remote areas 
after completing their specialist training. Students on the BMP Scheme have greater geographical choice 
in fulfilling their return of service obligation – they must work in a district of workforce shortage area for 
a period of time equal to the length of their medical degree.  
This change will mean that about 28.5% of medical students will be bonded. 
The Mason Review of health workforce programs153 found that there was limited evidence to show 
whether the desired workforce outcomes are actually achieved through scholarship programs. There is 
insufficient Australian academic literature or research on the issue of whether scholarships affect an 
individual’s choice to enter and/or to remain in the health workforce. However there is some evidence 
to suggest that students from rural areas are more likely to practice in rural locations on completion of 
their training and so scholarships targeted to students of rural origin could therefore play an important 
distributional role. 
However the Mason review found that rural bonding is seen as stigmatising rural practice. Many who 
have taken up these scholarships seek release from their obligations. The Mason review, conducted in 
2013, found that in the decade since its introduction, fewer than 50 MRBS Scheme recipients had 
commenced their return of service period. On the other hand, Rural Australia Medical Undergraduate 
Scholarships (RAMUS) scheme is popular and oversubscribed. 
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e-Health 
 
It appears that the Abbott Government about to begin a whole new strategy for e-health but without a 
roadmap to guide them. 
The 2015-16 Budget presents the Government’s response to the Royle Review of the Personally 
Controlled Electronic Health Record.154  This review was commissioned in November 2013 and then 
Minister for Health, Peter Dutton, received the report in December 2013.  However it was not released 
until May 2014 and the response has only come a year later. 
The delay has proved expensive in terms of lost opportunities to improve the operation of the PCEHR, 
build public interest and increase use by healthcare providers and the public, and the money that has 
been spent. 
The PCEHR project was initially funded in the 2010-11 Budget, with the provision of $466.7 million / 2 
years to establish the key components of the PCEHR system.  Access to the online system was promise 
by 2012-13. Progress was slow, perhaps because the project was linked to the introduction of individual 
health care identifiers – always controversial – but also because National e-Health Transition Authority 
(NeHTA) has a costly history of a slow roll-out of overly complicated projects.  
 
Now the PCEHR will be renamed to My Health Record and NeHTA will be closed and responsibility for e-
health records will now be the joint responsibility of the DoH and the new, yet-to-be established 
Australian Commission for e-Health.  
 
What is happening and not happening in e-health exemplifies the modis operandi  of this Government, 
as outlined in the Introduction:  everything on hold for a report that is then not released for 500 days 
and worse, this time is not used to develop a strategy to address the issues highlighted; a pretence that 
new money is provided  when really savings are being taken from funds already in the forward 
estimates; and a small scale pilot program that may not go anywhere because there is no funding for 
anything beyond three years. 
There is no disagreement from any quarter about the need for and the value of e-health records 
(although there is a debate about whether this should be personally controlled) – indeed it’s a national 
priority. Currently, the electronic transfer of healthcare records is fragmented because data stored 
within disparate clinical information systems cannot be easily exchanged and because there are often 
restrictions as to who has access. 
The current version of the PCEHR allows for sharing of clinical documents via a point-to-share 
environment but this can only happen if the patient and their healthcare providers are registered with 
and using the PCEHR service. There is no guarantee that all the health professionals involved in the care 
of a patient will participate and supply information or that the information supplied will be complete, 
especially as the patient has the ability to hide aspects of their record.   
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There is a debate about whether, even with proposed improvements, the PCEHR / My Health Record is 
what is really needed, given the previously noted factors that contribute to its incompleteness. Doctors 
cannot rely on the record and indeed the AMA’s guidelines state that it should only be used as a 
‘memory prompt’ not as a clinical history.155 A submission to the PCEHR review detailed the signifiant 
clinical risks inherent in a patient-controlled record.156  
Still despite these problems and misgivings, the evidence suggests that a revamped PCEHR / My Health 
Record can contribute to improved healthcare and help patients be engaged in their healthcare 
management. 
The major outstanding issues to address the current inadequacies and to support efficient healthcare 
delivery and continuity of care are: 
 The development of an agreed set of standards for the clinical content.  
 Technical requirements to support the cost-effective and safe (appropriate privacy protections) 
point-to-point transfer of patient records.   
 Standards to ensure meaningful and safe clinical use. 
 
However it seems that there will be no rapid changes.  The Portfolio Budget Statement for Outome 7.1 
(e-Health) indicates that  an Implementation Taskforce will be established to oversee and manage the 
transition of governance arrangements and operations from NeHTA to DoH and the Australian 
Commission for eHealth. The Commission will assume responsibility for the governance, operation and 
ongoing delivery of e-Health activities from 1 July 2016. It is not clear if the role of DoH is simply to 
oversee the work of the new Commission or whether it will also be involved in the implementation of e-
Health activities. The recommendation was that the Commission report to COAG. 
The proposed opt-out trials for the My Health Records will begin in 2016, but will not have much to 
show in the way of results for several years – and currently funding for this project effectively ceases in 
June 2018. 
In her media statement the Minister for Health, Sussan Ley, said that, “In addition to improving patient 
health outcomes, it’s also been identified that a fully-functioning national e-health system could save 
taxpayers $2.5 billion per year within a decade by reducing inefficiencies, with an additional $1.6 billion 
in annual savings also delivered to the states.”157  This is a very different figure to the 2010 estimate of 
Booz and Co that annual savings would be $7.6 billion, although this was for a fully implemented system 
with 100% participation.158 
Up-to-date data on PCEHR enrolments are hard to find.  The Minister’s media release stated that less 
than 10% of Australians have an e-health record.  The 2013-14 PCEHR Report states that on 30 June 
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2014 the number of people with a PCEHR was 1,729,846 and the number of healthcare provider 
organisations registered to participate in the PCEHR system was 7,233.  
 
A NeHTA report card with data to July 2013159 showed enrolments from: 
 72 Aboriginal Medical Services 
 7 aged care facilities 
 47 allied health 
 70 community health centre 
 271 community pharmacy 
 3723 general practice (53% of total general practices in Australia ) 
 50 Medicare Local/State/Territory or Area Health Service 
 3 private hospitals 
 8 public hospitals 
 73 specialists 
 175 other or unknown. 
Although this information is now out of date (one report has almost 200 hospitals now with the 
capability to upload PCEHR data160 ), clearly there is much more work to be done to increase enrolments 
of both patients and providers, especially hospitals. 
In 2015-16 the Practice Incentives Program (PIP) e-Health Incentive (e-PIP) will be reviewed in order to 
attract more GP practices to the use of My Health Record.  It is not clear if this review will be done by 
DoH, a contractor, the new Commission on e-Health or the Primary Health Care Advisory Group. 
 
Royle Review of the Personally Controlled Electronic Health Record. 
 
The PCEHR review was undertaken in a very short period of time in late 2013 by a team consisting of 
Executive Director of the Uniting Care Health Group, Mr Richard Royle, AMA President Dr Steve 
Hambleton and Australia Post CIO, Andrew Walduck. 
 
This report was not released until after the Budget (May 19, 2014).161 It makes 38 recommendations to 
address shortcomings of the system and make it more effective for doctors and patients, but also found 
strong support for the PCEHR.  
Key concerns identified in the report include challenges associated with the registration process linked 
to the opt-in nature of the PCEHR system, the limited amount of clinically usable information, 
inadequate governance arrangements and the usability of the system. 
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Recommendations in the report include: 
 Re-naming the PCEHR project to the My Health Record (MyHR) project. 
 Commissioning an external review of the Department of Health’s eHealth functions. 
 Centralising the system operating of the PCEHR platform to the Department of Human Services 
(which is well-regarded from an IT project perspective). 
 Transitioning the project to an ‘opt out’ model for all Australians from 1 January 2015, to maximise 
usage. 
 That the National e-Health Transition Authority be ‘dissolved’ due to governance issues and 
replaced with an Australian Commission for Electronic Health (ACeH), reporting directly to the COAG 
Standing Council on Health. 
 
Budget Provisions 
 
My Health Record 
$485.1 million / 4 years is provided to continue operation of the eHealth system, make key 
improvement s and implement trials of opt-out arrangements. The savings from this measure will be 
redirected to fund other health policy priorities or will be reinvested in the MRFF. 
 
 
 2014-15     
$m 
2015-16   
$m 
2016-17   
$m 
2017-18   
$m 
2018-19   
$m 
Finance - -0.1 -0.1 .. - 
DVA - -0.1 -0.1 - - 
DHS - -12.5 -15.9 -8.6 0.2 
DoH - -39.6 -82.2 -41.0 5.1 
Total - -52.2 -98.3 -49.6 5.3 
Related capital  
DHS 
- -0.7 -2.1 -0.4 - 
Related capital 
DoH 
- -9.5 -6.7 - - 
Total - capital - -10.1 -8.8 -0.4 - 
 
Funding of $699.2 million / 4 years  for the redevelopment of the PCEHR was provisioned for in the 
contingency reserve at the 2014-15 Budget, so this represents a funding cut of $214.1 million.  $426m / 
3 years has been allocated to operating and enhancing the system and educational activities,  $50m is 
for the opt-out trials as well as changes to the governance arrangements underpinning the PCEHR. 
Almost all of the funds provided will be spent over the first 3 years, so the average funding for each year 
is around $160 million. This compares to $140.6 million to the project for 2014-14. Given the nature of 
this program, it is not clear why more long-term funding is not provided.  One possibility is the 
expectation that the opt-out trials will have produced sufficient information by that time to inform 
future policy and budget decisions. 
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DoH has ambitious plans for the trials, looking to include up to a million people at 2-5 sites. The trials are 
set to commence in July 2016 with a recommendation on what model works best made to government 
in 2017. A discussion paper of the necessary changes to legislation to implement the trial has been 
released.162  
 
In order to be successful the trial will need to be matched with the planned review of GP ePIP. To 
comply with the e-health Practice Incentive Payments (e-PIP),  general practices must meet five 
requirements, including, as of May 2013, the ability to participate in the PCEHR system. The e-PIP 
provides quarterly incentive payments (capped at $12,500 per practice per quarter) for joining and using 
the national system.  Currently practices are paid the ePIP if they install PCEHR-compliant software and 
other eHealth tools but GPs are not required to use them.  
At Senate Estimates DoH indicated that it planned to have revamped incentives in place in early 2016 
and it would also look at the PCEHR Teview's recommendations that funding for chronic disease 
planning be tied to use of the PCEHR.  However these incentives apply only to GPs and not to specialists 
and other health professionals.  
 
 
  
                                                          
162
 https://consultations.health.gov.au/ehealth/ehr-and-hi-legislation-discussion-paper-1  
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Miscellaneous 
 
Accelerating growth in organ and tissue donation for transplantation 
$10.2 million / 2 years to improve organ and tissue donation and transplantation rates. 
 
 2014-15     
$m 
2015-16   
$m 
2016-17   
$m 
2017-18   
$m 
2018-19   
$m 
Aust Organ and Tissue 
Donation and 
Transplantation Authority 
- 5.9 2.2 - - 
DoH - 0.6 0.7 - - 
DHS - 1.3 -0.4 - - 
Total = 7.8 2.4 - - 
 
This money is described as: 
 Delivering clinical education to hospitals 
 Developing a new Australian Organ Matching System 
 Enhancing the Australian Organ Donor Register to enable online registration and legal consent.   
 
There is apparently an assumption that the new matching and / or registration systems will deliver small 
savings to DHS in 2016-17 (and beyond?). 
The Supporting Leave for Living Organ Donors Program, which provides minimum wage for up to 9 
weeks to employers of people who have taken leave to donate, will continue. 
The Australian Organ and Tissue Donation Authority (variously abbreviated at AOTDTA and OTA)  is a 
statutory authority established by the Australian Organ and Tissue Donation and Transplantation 
Authority Act 2008. Since its inception, the OTA has been funded at around $48 million/ year.  It works 
with the states and territories to deliver the national reform program on organ and tissue donation and 
leads the DonateLife Network, comprising  8 DonateLife organ and tissue donation agencies and 
hospital based staff in 72 hospitals. 
In 2006, the Howard Government established the National Clinical Taskforce on Organ and Tissue 
Donation.  This Taskforce was charged with providing evidence-based advice to government on how the 
system might be changed to improve the rate of safe, effective and ethical donation for transplantation 
in Australia. The Taskforce submitted its final report in January 2008. 
Some of this report’s recommendations were reflected in the Rudd Government’s national reform 
package, announced on 2 July 2008. This package (variously reported as costing $151 million and $136.4 
million) was endorsed by COAG and had a number of elements: ‘ 
 $67 million to fund dedicated organ donation specialist doctors and other staff in public and 
private hospitals 
 $46 million to establish a new independent national authority to coordinate national organ 
donation initiatives, to be up and running by 1 January, 2009 
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 $17 million in new funding for hospitals to meet additional staffing, bed and infrastructure 
costs associated with organ donation. 
 $13.4 million to continue national public awareness and education 
 $1.9 million for counselling for potential donor families 
 Other significant measures including enhanced professional education programs, consistent 
clinical protocols, ‘clinical trigger' checklists and data collection for organ transplants in 
hospitals.   
In the 2014-15 Budget, the Government announced the merger of OTA and the National Blood 
Authority (NBA) to create a new independent body by 1 July 2015. This was a recommendation of the 
National Commission of Audit on the basis that the creation of a single entity would reduce running 
costs and streamline and consolidate service delivery. However although it may seem that organs, 
tissue and blood can, as bodily parts and fluids, be treated in similar ways, in fact their clinical and 
administrative management is very different. 
A Parliamentary Committee report found that the potential savings would be negligible and the effort 
and disruption required to achieve them unwarranted.163 The Committee reported stated that merging 
the OTA and NBA has the potential to be damaging to the achievement of the aims of the OTA's 
National Reform Program. There does not appear to be any savings in operational costs over the 
forward estimates. 
Prior to the establishment of the OTA in 2009, organ donation levels in Australia were at a record low. 
Since 2009, there has been a substantial increase in the number of organ donors in Australia (378 in 
2014 compared to 247 in 2009) and the number of transplant recipients (1,117 in 2014 compared to 808 
in 2009).164  
 The Australian donation rate was 16.1 donors per million people – although there are substantial 
variations by state and territory.  The reasons for this are not known.  
Specific state donation rates per million population (dpmp)165  
New South Wales:     12.6 dpmp 
Victoria:      20.0 dpmp 
Queensland:      15.0 dpmp 
South Australia:     21.4 dpmp 
Western Australia:     13.6 dpmp 
Tasmania:      17.5 dpmp 
Northern Territory:     28.6 dpmp 
Australian Capital Territory:    18.1 dpmp 
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http://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Health/Health/First%20Interim%20Report/c 
164
 http://www.donatelife.gov.au/discover/facts-and-statistics#sthash.wzOUrnS0.dpuf   
165
 http://www.donatelife.gov.au/discover/facts-and-statistics#sthash.wzOUrnS0.dpuf  
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On May 26, following the Government’s recent budget allocation of $20 million towards improving 
organ donation rates in Australia, Assistant Minister for Health Fiona Nash announced a review of the 
current organ and tissue donation and transplantation program, with a specific focus on the role of the 
Organ and Tissue Authority. The review follows what was described as a ‘short study’ by DoH and will be 
undertaken by Ernst and Young.166 There is no mention of this in the Portfolio Budget Statements and at 
Senare Estimates it emerged that the Assistant Minister had not met with OTA prior to announcing this 
review. 
The rationale given is that organ transplant rates have not increased as quickly as intended. However 
there are other possible reasons, including a drive to an opt-out system of donation, a push to blames 
(state-run) hospitals, and a move to replace DonateLife with a private body. 
Following the announcement, television personality David Koch quit the OTA advisory board in protest 
at “yet another expensive inquiry” into the organ donation system, and accused the Assistant Health 
Minister of bowing to pressure from the community lobby group ShareLife, which is committed to 
increasing donation rates above the current ranking of 19th in the world.  
An ANAO review released in April 2015 found that overall OTA had made reasonable progress in 
implementing most measures of the national reform program, including the introduction of a 
Professional Education Package and National Donor Family Support Service (NDFSS). However, OTA was 
found to not be achieving the targets set for the program’s quantitative performance indicators: donor 
family request rate and donor family consent rate.  OTA advised the Senate Community Affairs 
Legislation Committee in February 2015 that this was partly attributable to the variability of donation 
outcomes between states and territories and also to a lack of consistency between states and territories 
in applying the Family Donation Conversation training, which OTA considered had adversely affected the 
family consent rate.167 
This it seems that the problems lie more with the states and territories than with OTA. Also currently 
while 76% of Australians are registered as tissue and organ donors, their wishes are overturned by 
families 37% of the time. 
 
Consolidation of Bone Marrow Transplant and International Searches Programs 
The Bone Marrow Transplant and the International Searches programs will be consolidated into a e new 
Haematopoietic Progenitor Cells Program. The cost of this measure (not specified) will be met from 
existing DoH resources. 
This consolidation is described as streamlining the application and funding process and providing a 
single set of eligibility criteria, which will reduce the administrative burden for patients, hospital staff 
and the Australian Bone Marrow Donor Registry (ABMDR). 
The Bone Marrow Transplant Program (BMTP), provides financial assistance to eligible individuals 
requiring life saving Haemopoietic stem cells (HSCs) from overseas donors. The assistance can cover 
either the cost of bringing the donor or their HSCs to Australia for transplantation and is intended to 
                                                          
166 http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2015-nash024.htm 
167
 http://www.anao.gov.au/Publications/Audit-Reports/2014-2015/Organ-and-Tissue-Donation-Community-
Awareness-Professional-Education-and-Family-Support/Audit-summary  
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cover costs outside of the Medicare arrangements. HSCs can be sourced through either bone marrow, 
cord blood or peripheral blood stem cells.  Patients requiring this treatment must first find a suitable 
donor. The Australian Bone Marrow Donor Registry coordinates the searches to match donors with 
recipients. If a matched donor is unable to be located within Australia the treating hospital, on behalf of 
the patient, can submit an application for financial assistance under the Bone Marrow Transplant 
Program. 
The ABMDR is funded by the Commonwealth, State and Territory governments through a variety of 
contracts.  It is the only organisation responsible for the recruitment of volunteer bone marrow/blood 
stem cell donors and the administrative management of the National Cord Blood Collection Network of 
public cord blood banks in Australia. 
Currently 175,400 Australians are registered on the ABMDR and the internationally-linked registry 
provides access to a database of more than 10 million potential donors worldwide. One in four 
Australians needing a transplant will be unable to find a donor match within their family and will need to 
access this registry. 
 
Continuation of National Critical Care and Trauma Response Centre 
$63.5 million / 4 years is provided through a new NP with the Northern Territory for the continued 
operation of the National Critical Care and Trauma Response Centre (NCCTRC) at Royal Darwin Hospital.  
The Budget Papers say this funding has already been provided by the Government – meaning it is 
continued funding in the forward estimates. Only about $32 million of this is new funding as the current 
NP provides funding of $31.3 million for 2015-16 and 2016-17. 
The NCCTRC was announced after the 2002 Bali bombings and formally established in 2005.  Its function 
is to ensure enhanced surge capacity for Royal Darwin Hospital to provide a rapid response in the event 
of a mass casualty incident in the region. To achieve this objective the NCCTRC has provided significant 
financial support (around $15 million / year) to Royal Darwin Hospital to enhance the capability of the 
hospital’s surgical and trauma divisions. 
It is not clear why the Government considers it necessary to sign a new 4 year NP when the current NP 
still has 2 years to run. 
 
Amendments to the National Joint Replacement Levy 
An additional $0.6 million / 4 years is provides to support the increased activity of the National Joint 
Replacement Registry (NJRR). 
 
 2014-15     
$m 
2015-16   
$m 
2016-17   
$m 
2017-18   
$m 
2018-19   
$m 
DoH - 0.1 0.1 0.2 0.2 
Revenue DoH - 0.1 0.1 0.2 0.2 
 
However, as indicated, this funding is not provided by the Government but comes from changes in 
calculating the levy imposed on industry (so it is proportional to market share) from 1 July 2015. 
99 
 
The Government has funded the NJRR since 1998.The 2007-08 Budget provided for the expansion of the 
data collected by the National Joint Replacement Registry. At that time its base funding was $5.3 million 
/ 4 years and in 2007-08 an extra $0.8 million / 4 years was added. 
In 2009 the Government announced that that Registry would be funded on a cost recovery basis. These 
costs are recovered from the suppliers of orthopaedic devices which currently have joint replacement 
prostheses listed on the Private Health Insurance (Prostheses) Rules (the Prostheses List). 
 
Reducing the burden of the Industrial Chemicals Regulatory Framework to industry 
$4.2 million / 4 years is provided to amend the Industrial Chemicals (Notification and Assessment) Act 
1989 to focus regulatory assessment on industrial chemicals that pose the greatest risk, develop 
streamlined processes for new and existing chemicals, and using existing international approvals where 
appropriate. 
 
 2014-15     
$m 
2015-16   
$m 
2016-17   
$m 
2017-18   
$m 
2018-19   
$m 
DoH - 2.5 2.5 - 0.4 
Revenue DoH - 2.5 2.5 1.4 1.8 
Related capital DoH - 3.5 3.5 - - 
 
The Budget states that cost of this measure will be met by industry through increased levies between 
2015-16 to 2021-22. It is not clear why this provision is not budget neutral over the forward estimates. 
The regulation of industrial chemicals is the responsibility of the National Industrial Chemicals 
Notification and Assessment Scheme (NICNAS). 
The proposed changes have been welcomed by industry but interestingly, there have been calls for 
more detail on the implementation and costs – a sign that industry was not consulted about the 
changes. 
A discussion paper - Review of the National Industrial Chemicals Notification and Assessment Scheme -  
was released in  June 2012 with calls for submissions and the promise of consultation.168 A draft 
Regulation Impact Statement (RIS) was issued in June 2013.169 This assessed the impact of four options 
for reform and made recommendations regarding a preferred option – which was Option 3: Graduated, 
risk based approach with pre and post-market emphasis based on risk profile of chemicals. Presumably 
the Government has based this provision on this RIS recommendation. 
 
                                                          
168
 http://www.health.gov.au/internet/publications/publishing.nsf/Content/ohp-nicnas-discussion-paper-june-
2012-l  
 
169
 http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-nicnas-draft-regulation-impact-
statement.htm  
100 
 
New and amended listings to Stoma Appliance Scheme 
Savings of $7.6 million / 4 years are taken from the Stoma Appliance Scheme (SAS). These will go to 
other health policy priorities or the MRFF. 
 
 2014-15     
$m 
2015-16   
$m 
2016-17   
$m 
2017-18   
$m 
2018-19   
$m 
DoH - -1.6 -1.8 -2.0 -2.0 
 
The budget paper state that this is due to the listing of 2 new items, amending the price of 21 items, 
deleting 1 item on scheme as recommended by Stoma Product Assessment Panel. These items are 
unspecified. 
Patients pay a small annual administration fee to access the SAS. Approved stoma products are distributed at 
no cost through 22 independently operated stoma associations. Stoma associations submit a claim to 
Medicare Australia for products supplied and Medicare Australian pays these claims. In addition to the costs 
of the product, the stoma associations are paid a handling fee on products. 
 
In recent budgets the SAS taken some substantial cuts: 
 The 2014-15 Budget took savings of $0.2 million / 4 years are achieved through the listing of three 
new items and amendments to the prices of three current items (all unspecified). 
 The 2012‐13 Budget took savings of $14.4 million / 4 years from this program by removing the 
removal of automatic indexation for subsidised products. 
 As part of the 2009‐10 Federal Budget, the Government announced that the SAS would be reviewed 
with the view to establishing a new program framework that supported the Scheme’s future 
sustainability.170 
 
The total cost of the SAS in 2013-14 was $83.2 million. 
Elsewhere in the Budget unspecified savings are expected to be achieved by piloting competitive 
tendering for a subset of products on the SAS (see section on Smaller Government). 
 
 
 
 
 
 
 
 
                                                          
170 http://www.health.gov.au/internet/main/publishing.nsf/Content/7488BFBCC744183CCA257BF0001C9667/$File/T 
he%20Review%20of%20the%20Stoma%20Appliance%20Scheme%20‐%20Dec%202010.pdf 
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Smaller government and across-the-board funding cuts 
 
The Abbott Government is now delivering the fourth phase of its Smaller Government Reform agenda. 
The stated aim is “to ensure the public sector is as streamlined, effective and transparent as possible”.  
Nothing could be further from the truth: in the majority of cases it is not clear what programs are being 
cut and by how much, in other cases there is no evidence that abolishing and amalgamating government 
bodies will achieve either saving or efficiencies. 
In the 2015-16 Budget these savings, which in Health total at least $1.2 billion / 5 years are achieved 
though further reductions in the number of Government bodies, across-the-board efficiencies, staff 
reductions, indexation pauses and program ‘rationalising and streamlining’. 
These come on top of savings of $3.59 billion / 4 years taken last year under the same imprimatur of 
improving efficiency and reducing waste.  
The adverse impacts are already being felt.  In both Health and Indigenous Affairs many organisations 
and programs have waited until the last minute to hear of they have funding for the next financial year. 
This erodes morale and leads to staff leaving – a situation that is not improved when all that is 
forthcoming is a 12-month extension of funding at 2014-15 levels.  
Indexation pauses across Medicare and related services threaten to lower bulk billing rates and will be 
an increased impost on patients as out-of-pocket costs increase.  
Other changes implemented by this Government have costs that are not provided – in particular, 
substantial costs must accrue as programs, agencies, divisions and even whole departments change 
names and focus. 
The loss of DoH and agency staff and expertise shows in large delays in important decision making 
processes, the failure to respond to reports and reviews in appropriate timeframes and  the lack of 
needed detail in policy and program changes that hinder their implementation. 
A fifth phase of the Smaller Government Reform agenda will be included in MYEFO 2015-16 
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Table 13.  Smaller Government Reforms 2014-15 and 2015-16 
 2013-14           
$m 
2014-15       
$m 
2015-16      
$m 
2016-17     
$m 
2017-18     
$m 
2017-18   
$m 
Indexation Pauses       
Administered Program 
Indexation Pause* 
2014-15 
- -15.1 -34.1 -54.9 -60.9  
Administered Program 
Indexation Pause* 
2015-16 
- - - - -8.4 -21.9 
Health Flexible Funds – 
pausing indexation, 
achieving efficiencies 
2014-15 
- - -46.4 -69.7 -81.0  
Health Flexible Funds 
funding cuts 
2015-16 
- - -58.0 -117.0 -181.0 -240.0 
Pausing indexation of 
some MBS fees, 
Medicare Levy 
Surcharge, PHI rebate 
thresholds 
2014-15 
- -131.5 -378.5 -480.1 -597.3  
Consistent indexation 
measures 
2015-16 
- - -14.9 -25.3 -37.6 -41.7 
Smaller Government       
Health Portfolio - -3.2 -14.6 -29.3 -32.8 -33.0 
Rationalisation & 
streamling 
      
Health programs (does 
not include cuts to 
Flexible Funds) 
- -12.0 -63.5 -98.7 -92.3 -97.2 
Total 2015-16 
(direct Health impact  
only) 
- -15.2 -151.0 -270.3 -343.7 -411.9 
From 2014-15 Budget Paper No 2 and 2015-16 Budget Paper No 2   *indicates wider impact than DoH 
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Budget provisions 
 
Rationalising and streamling Department of Health programs 
Savings of $962.8 million / 5 years are achieved across a range of Health programs. These savings go to 
fund other health priorities or to the MRFF. 
 
 2014-15     
$m 
2015-16   
$m 
2016-17   
$m 
2017-18   
$m 
2018-19   
$m 
DHS - .. - --  
DoH -12.0 -121.5 -215.7 -276.3 -337.2 
Total -12.0 -121.5 -215.7 -276.3 -337.2 
 
The areas where these cuts are made are outlined in only general terms in the Budget Papers: 
 Flexible Funds 
 Dental workforce programs 
 Preventive health research 
 GP SuperClinics that have not yet commenced construction 
 Cessation of Inborn Errors of Metabolism Program 
 Piloting competitive tendering for a subset of products on the Stoma Appliance Scheme. 
 
Flexible Funds 
In 2014-15 there were 16 Health Flexible Funds. These fund non-government organisations to deliver a 
range of health and community services in a range of areas.  
The 2014-15 Budget cut $197 million from these.  At Senate Estimates in June 2014, the DoH said that it 
had not yet been determined which of the Flexible Funds would be cut, but did say that some that had 
taken cuts in other ways (such as the Health Workforce Fund and the Indigenous Chronic Disease Fund) 
would be protected from further savings.  There is very little information available about these cuts and 
their impact. 
2015 Senate Estimates revealed cuts of $596 million / 4 years. Thus it appears that the Flexible Funds 
have sustained total cuts of $793 million / 5 years.  
The impact of this year’s cuts over the forward estimates was elicited in Senate Estimates.171   
 2014-15      
$m 
2015-16    
$m 
2016-17    
$m 
2017-18   
$m 
2018-19   
$m 
Flexible funds  ? -58 -117 -181 -240 
 
 
                                                          
171
 Senate Estimates information courtesy of AHHA 
 
104 
 
The Indigenous Health and Medical Indemnity funds are exempt from cuts. 11 Flexible Funds will 
experience cuts in 2015-16 (see Table 14) Senate Estimates was told that decisions had yet to be made 
on the specific program cuts that will be necessary to meet these overall cuts.  Over 2000 grants are 
included in the Flexible Funds. The organisations that are funded to deliver these programs have 
currently received current funding for either 6 months or 12 months (which organisations received 
which period was an arbitrary decision) as an interim decision. It seems very disorganize within DoH and 
that means severe consequences for the organisations and programs relying on this funding. 
 
Table 14  Budget cuts to Flexible Funds 
Fund Scope Budget 
cuts  
2015-16 
Total 
funding 
What is known about 
cuts 
Chronic Disease 
Prevention and Service 
Improvement 
-Prevention  
-Early detection & 
appropriate treatment  
-Integration & continuity 
of prevention & care  
-Self management 
$7.1m $252.81m / 
4 yrs to 
June 2015 
Likely affects primarily 
prevention activities 
Communicable Disease 
Prevention and Service 
Improvement Grants 
-Preventing blood borne 
viruses and STDs  
-Promoting approp 
treatment & management 
$3.0m $43.1m / 4 
yrs to June 
2015 
 
Substance Misuse 
Prevention and Service 
Improvement Grants 
Activities under National 
Drug Strategy 
$7.0m $86.03m /  
4 yrs to 
June 2015 
31 March 2015, Minister 
Nash announced 
continuation of funding 
under NGOTGP at 2014-15 
level for 12 months, 
pending review of drug 
and alcohol treatment 
services. 
Substance Misuse Service 
Delivery Grants Fund 
Substance misuse service, 
incl programs that target 
Indigenous Australians 
$1.2m Not found 
Health Social Surveys -Australian Health Survey  
-National Health Survey 
-Australian Longitudinal 
Study of Women’s Health 
- Australian Longitudinal 
Study on Male Health 
$0.5m $31.83m / 
4 yrs to 
June 2015 
Little room for cuts to 
these programs. 
Single Point of Contact for 
Health Information, 
Advice and Counselling 
 -After Hours GP Helpline - 
video consultation 
Pregnancy, Birth and Baby 
Helpline  
 -National Health Services 
Directory  
 -healthdirect Australia 
(nurse triage services) 
$11.0m $200m /  
4 yrs  from 
2014-2015 
Not clear if video consults 
on AH GP Helpline remain 
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Table 14 continued 
Fund Scope Budget 
cuts  
2015-16 
Total 
funding 
What is known about 
cuts 
Practice Incentives for 
General Practices 
 GP PIPS & payments for: 
 -Asthma  
 -Aged Care Access  
 -Cervical Screening  
 -Diabetes  
 -eHealth   
 -Indigenous Health 
 -Quality Prescribing  
 -Teaching 
 -Procedural GP Payment  
 -Rural loading  
$10.0m $1.055b /  
4 yrs to 
June 2015 
Changes may result from 
recommendations of  
Primary Health Care 
Advisory Group 
Health System Capacity 
Development 
Activities which: 
-Build primary care 
evidence base 
-Support health 
improvements for key 
population groups  
-Provide assistance to 
health support 
organisations  
$6.0m $117 m / 
 4 yrs to 
June 2015 
When applications were 
called was heavily over-
subscribed. 
Health Surveillance Supports a wide range of 
public health monitoring 
and data collection, 
surveillance and reporting 
activities (mostly ongoing) 
$0.8m $78.2 m /    
4 yrs to 
June 2015 
Not clear how contestible 
many of these activities 
are. 
Health Protection Activities to prepare for 
and respond to changing 
health protection 
priorities :  
-National health 
emergencies 
 -Communicable disease 
outbreaks  
-Natural disasters  
-Terrorist attacks 
$0.7m Not found Most of these activities 
are likely to be supported 
in the current political 
environment. Includes 
National Medicines 
Stockpile. 
 Investment in preventive 
health / environmental 
health likely most at risk. 
Rural Health Outreach Supports delivery 
specialist and primary care 
services in rural and 
remote areas. Includes: 
-MSOAP programs 
(specialist eye, maternity 
services)  
-Services by female GPs. 
$10.7m $31 m / yr 
from  
2013-14 
This is a large cut to an 
important program so will 
do real damage. Women 
particularly affected. 
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Dental Workforce Programs 
Although little detail was provided in the Budget Paper, at Senate Estimates it was revealed that some 
$30 million will be cut from the Dental Relocation and Infrastructure Support Scheme (DRISS).  
(see section on Workforce). 
Preventive Health Research 
There are no specifications provided about what will be cut in preventive health research. This could 
refer to cuts in Flexible Funds. It seems that there is an inherent opposition most prevention activities, 
despite their ability to contribute to reduced health costs and improved health outcomes. 
GP SuperClinics 
It is not clear where and how savings will be taken from GP Superclinics.  The  2014-15 Budget made the 
decision not to proceed on three SuperClinics – in Darwin, Rockingham and Wynnum – at a savings of 
$16.5 million.  
At that time the then Minister for Health, Peter Dutton, said the program had been a complete failure. 
He indicated that the Government was looking to retrieve money from SuperClinics where contracts had 
been signed on a case-by-case basis.172 That approach appears to have foundered, likely on legal advice 
and / or the fact that many of these were located in marginal electorates. 
(see section on Primary Care) 
Inborn Errors of Metabolism Program 
The Budget Papers state this this program will cease as key medicines are now listed on the PBS and low 
protein foods are available at much lower cost than when the program was initiated. 
The Inborn Error of Metabolism (IEM) Program provides monthly financial assistance to approved 
grantees with protein metabolic disorders to assist with the purchasing of low protein foods needed for 
strict diets.173  Interestingly, given the reference to medicines in the PBS in the Budget Papers, the IEM 
website states that non-food items, such as medications and supplements, cannot be purchased with 
money provided under the program.  
These Budget cuts will affect many families whose children need expensive special foods, and there 
have been media complaints about the impact.174 The Metabolic Dietary Disorders Association says 904 
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 http://www.abc.net.au/news/2014-04-08/government-moves-to-dismantle-labor-super-clinics-
scheme/5375074 
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 http://www.health.gov.au/internet/main/publishing.nsf/Content/Inborn+Error+of+Metabolism+Programme 
 
174
 See for example http://www.canberratimes.com.au/act-news/heartless-cuts-to-special-diet-kids-20150525-
gh8x9g.html 
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sufferers access the grant, which means the cut, which is effective from the end of this year, will save 
between $15 - $17  million / 5 years. 175 
Competitive Tendering for Products on the Stoma Appliance Scheme 
As part of the 2009‐10 Federal Budget, the Government announced that the SAS would be reviewed 
with the view to establishing a new program framework that supported the Scheme’s future 
sustainability.176 
In recent budgets the SAS taken some substantial cuts: 
 The 2015-16 Budget has savings of $7.6 million / 4 years. 
 The 2014-15 Budget took savings of $0.2 million / 4 years are achieved through the listing of three 
new items and amendments to the prices of three current items (all unspecified). 
 The 2012‐13 Budget took savings of $14.4 million / 4 years from this program by removing the 
removal of automatic indexation for subsidised products. 
 
The total cost of the SAS in 2013-14 was $83.2 million. 
(See also the Miscellaneous Section) 
 
Smaller government in the Health portfolio 
Savings of $113.1 million / 5 years are taken from a variety of activities, programs and agencies. The 
Budget Papers say these are based on a Functional and Efficiency Review of DoH in what is described as 
‘sharpening the scope and focus of government’. 
 2014-15     
$m 
2015-16   
$m 
2016-17   
$m 
2017-18   
$m 
2018-19   
$m 
DoH -3.2 -14.8 -29.3 -32.8 -33.0 
 
The National Lead Clinicians Group is abolished with residual functions to be conducted by the DoH, 
saving $17.1 million / 5 years from 2014-15. 
Savings of $106 million /4 years will be made by; 
 Consolidating the corporate and legal services of the Therapeutic Goods Administration into the 
Department of Health. 
 Removing duplication between the activities of the Department and several agencies. Departmental 
activities in areas covered by IHPA, AOTDTA, NBA, NHPA, ACSQHC, NHMRC and AIHW will cease.  
 Rationalising the structure of the Department to better align to Government priorities. 
 Rationalising business support functions, property costs and contractor expenses.  
                                                          
175
 http://www.canberratimes.com.au/act-news/heartless-cuts-to-special-diet-kids-20150525-gh8x9g.html 
 
176 http://www.health.gov.au/internet/main/publishing.nsf/Content/7488BFBCC744183CCA257BF0001C9667/$File/T 
he%20Review%20of%20the%20Stoma%20Appliance%20Scheme%20‐%20Dec%202010.pdf 
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$10 million of the saving will be reinvested to develop the in-house analytical, economic and research  
capacity of DoH.  This is a welcome move if it results in better analysis of data and improved program 
evaluatations.  It is not clear of this $10 million comes from the $113.1 million saved or is in addition to 
that. 
In the 2014-15 Budget there was a proposal to combine 6 major agencies into a Health Productivity and 
Performance Commission.  Senate Estimates was told that there had been no progress on this, that it 
was ‘under Ministerial consideration’. 
Further consultation on future ownership options for Australian Hearing  
There has been a number of Government scoping studies to assess the optimal arrangements for 
delivery and ownership options of a number of Government businesses and assets. 
Media releases from the Finance Minister in May 2015177 stated that the Government will consult 
further with hearing impaired Australians, their families and other key stakeholders about the findings 
of the scoping study before making a decision on ownership options for Australian Hearing. The 
consultations will also focus on the implications of the full  introduction of the National Disability 
Insurance Scheme for government-funded hearing services.  
It is proposed that the NDIS will open the delivery of Community Service Obligation hearing services to 
competition, to give clients greater choice of providers and the hearing devices, services and support on 
offer. 
A report is due in the second half of the 2015 calendar year. 
Two-year extension of the Administered Program Indexation Pause 
Unknown savings are taken from a number of Health programs by a 2-year extension of the indexation 
pause initiated in the 2014-15 Budget. 
In the 2014-14 Budget, 32 programs in the Health portfolio (including one in sport) were among the 112 
listed for indexation pauses commencing in either July 2015 or July 2015.178  Information provided in 
Senate Estimates for the Finance Portfolio in 2014 -14 revealed these cuts will amount to $29.425 
million / 4 years (see Table 15)179. In this year’s Budget there is a cross-portfolio provision to extend this 
pause for an additional 2 years but only to 78 programs.   
 
 
 
 
                                                          
177
 http://www.financeminister.gov.au/media/2015/0508-further.html  
 
178
 http://www.finance.gov.au/news/administered-programme-indexation-pause/ 
 
179
 The exact programs referred to in this table not always clear. 
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Table 15  Savings in Administered Programs made in 2014-15 Budget 
Program Savings                      
2014-15 to 2017-18          
$m 
When indexation pause 
commences 
National Depression Initiative 1.020 1 July 2015 
National Immunisation Strategy 1.594 1 July 2015 
IPH Drug Strategy 0.276 1 July 2015 
Better Access to Psyschiatrists and GPs 0.873 1 July 2015 
Hospital Accountability and Performance Program 0.382 1 July 2015 
COAG Mental health – additional places 0.913 1 July 2015 
COAG Mental Health – support for children 1.261 1 July 2015 
COAG Mental Health – support for day-to-day living 1.544 1 July 2015 
COAG Mental Health – telephone counselling 1.730 1 July 2015 
Leadership in Mental Health Reform 1.259 1 July 2015 
Mental Health More Option Better Outcomes 9.810 1 July 2015 
National Mental Health Program 0.954 1 July 2015 
NBN Telehealth Pilots 0.000 1 July 2015 
Maternity Peer Support 0.183 1 July 2015 
NIDS – NGO Drug Treatment Services 4.486 1 July 2015 
Front of Pack Labelling 0.000 1 July 2015 
Health Services Provisions Grants 0.214 1 July 2015 
Strengthening the Management of the National Medical 
Stockpile 
0.000 1 July 2015 
Biosecurity Surveillance System 0.133 1 July 2015 
Maintaining Seasonal and Pandemic Influenza 
Surveillance 
0.099 1 July 2015 
Post Market 0.124 1 July 2015 
Strengthening Industry Codes of Conduct 0.022 1 July 2015 
National Nutrition Policy 0.000 1 July 2015 
Tas Assistance Package – TML elements 0.360 1 July 2015 
COAG Mental Health – services in rural and remote 
areas 
1.836 1 July 2015 
Management and IM Capability 0.000 1 July 2015 
COAG Biological Regulation Activity 0.037 1 July 2015 
Health Connect (National Health Information Network) 0.000 1 July 2015 
MBS Evaluations 0.059 1 July 2015 
Pathology Reform Implementation 0.246 1 July 2015 
Telehealth Incentive 0.000 1 July 2015 
Total  29.415  
Medicare indexation 
This year’s budget takes savings of $119.5 million / 4 years in the name of “consistent indexation” of 
Medicare reimbursments.  This comes on top of savings of $1.587 billion / 4 years in the 2014-15 
Budget from freezing  indexation of some MBS fees, Medicare Levy Surcharge and  PHI rebate 
thresholds. 
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Provisions in other Portfolios 
 
There are a number of health-related provisions in other jurisdictions. 
 
Treasury – Revenue Measures 
 
Increasing the Medicare levy low-income thresholds 
The Medicare levy low-income thresholds have been increased to take account of movements in the 
CPI. This measure will have an estimated cost to revenue of $231.0 million / 4 years. 
 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
ATO - -81.0 -50.0 -50.0 -50.0 
 
Increasing these income thresholds is meant to ensure that those on low-incomes remain exempt from 
paying the Medicare Levy. Legislation will be needed to raise these income thresholds.  
 
Relaxing criteria for release of superannuation for terminal medical conditions 
Terminally ill patients will have early access to their superannuation.  This will have a cost to revenue of 
$0.3 million / 4 years. 
 
 
 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
ATO - -0.3 .. .. .. 
 
Currently patients must have two medical practitioners certify that they are likely to die within 1 year to 
gain unrestricted, tax- free access to their superannuation.  From July 1 2015 the likely time to death is 
changed to 2 years. 
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Agriculture 
 
National Food Plan – saving 
Savings of $30.9 million / 4 years have already been taken from uncommitted funding from the Gillard 
Government’s National Food Plan initiatives.  These savings will go to fund initiatives associated with the 
Agricultural Competitiveness White Paper. 
The National Food Plan was Australia’s first ‘whole of government’ food plan, intended to bring together 
all aspects of the federal government’s food-related policy. Its development was announced in 2010 by 
the Gillard Government and the National Food Plan White Paper was released in May 2013.180 The Paper  
has minimal focus on what Australians eat, or food processing in Australia; it is more an export plan, 
particularly for Australian producers. 
The Paper made 16 recommendations for food policy in Australia, some achievable, other more 
visionary. At the time of the Paper’s release, almost $40.0 million in initiatives were announced. These 
included: 
 $28.5 million for the establishment of the Asian Food Markets Research Fund.  
 An additional $5.6 million to build relationships with trading partners in key and emerging markets. 
 A review by the Productivity Commission of the impact of regulatory burdens across the food chain. 
 Support for the skills and workforce needs of the food industry. 
 $2.0 million to develop a brand identity for Australian food and related technology. 
With the election of the Abbott Government nothing further was done with this.  It has effectively been 
replaced by the Agricultural Competitiveness White Paper. 
 
Immediate assistance for drought affected communities 
$20 million is provided in 2015-16 to extend the access to social and mental health services for people 
in drought affected communities provided in the 2014-15 Budget.  This previous measure was funded at 
$10.7 million / 2 years (from 2013-14). 
This assistance is delivered through the Family Support and Targeted Community Care (Mental Health) 
programs within the Social Services portfolio.181 
 
 
 
 
                                                          
180
 http://www.agriculture.gov.au/ag-farm-food/food/publications/national_food_plan/white-paper 
 
181
 https://www.dss.gov.au/our-responsibilities/mental-health/programs-services/targeted-community-care-
mental-health-program  
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Human Services 
 
Efficiencies 
Savings of $55.1 million / 4 years are taken by implementing efficiencies within the Department of 
Human Services.  Some of these savings are achieved by phasing out the option for customers to receive 
Medicare and PBS payments via cheque or credit EFTPOS from July 2016 in favour of payments by 
Electronic Funds Transfer. 
 
 
 
Social Services  
 
No Jab No Pay 
Savings of $508.3 million / 5 years will be achieved by requiring that children’s immunisation 
requirements are fully met before families an access subsidised child care payments or the Family Tax 
Benefit Part A end-of-year supplement. 
  
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DHS 0.3 18.7 7.8 3.0 2.9 
Finance - 0.1 - - - 
DSS - -90.8 -156.3 -149.9 -144.1 
Total  0.3 -72.1 -148.5 -146.9 -141.2 
 
From 1 January 2016, the Government will close off some exemptions from the immunisation 
requirements for eligibility for the FTB-A end-of-year supplement, Child Care Benefit (CCB) and Child 
Care Rebate (CCR) payments and require that all children meet the immunisation schedules if their 
families are to receive these payments.  
A requirement for children to meet immunisation schedules has been attached to childcare payments 
since 1998 and for the FTB-A supplement from 2012.  However exemptions for  medical reasons and for 
conscientious objection to immunisation have been included in the relevant legislation.   
Media reports suggest around 10,000 families will lose eligibility for payments in 2016–17 as a result of 
the measure. It is interesting to note that there does not appear to be any allowance in the budget 
estimates for parents to act to improve the immunisation status of their children on the basis of a 
significant financial incentive. 
113 
 
Some health professionals and researchers have questioned whether imposing financial penalties is an 
effective way of lifting immunisation rates and engaging with parents who are hesitant about 
vaccinations.182  
Redirection of funding from Wound Management Scoping Study 
The Government will not proceed with the Wound Management Scoping Study which was announced in 
the 2013-14 Budget.  This will achieve savings of $0.3 million. 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DSS -0.3 - -= - - 
 
 
This scoping study was part of the former Government’s Supporting Senior Australians package.  There 
are two reasons why these savings are illusionary: firstly, this provision was within the jurisdiction of 
DoH (then the Department of Health and Ageing) when it was introduced, and secondly, the funds for 
this measure were to be met from within the existing resources of DoHA.  
 
Veterans’ Affairs 
Continuation of indexation pause for dental and allied health provider fees 
Savings of $69.6 million / 4 years are achieved by extending the pause on indexation of DVA dental and 
allied health provider payments until 1 July 2018. These savings will be redirected to fund other 
Veterans; policy priorities. 
 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DVA - -0.9 -18.6 -27.4 -22.7 
 
The 2014-15 Budget imposed an indexation pause on DVA dental and allied health provider payments to 
1 July 2016.  This aligned indexation of payments t these providers with those for medical services and 
delivered savings of $35.7 million / 4 years (See Table 16).  These savings were directed to the MRFF. 
 
Table 16  Deferred indexation of dental and allied health provider fees 2014-15 
 2013-14     
$m 
2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
DVA - -4.4 -9.4 -9.0 -12.8 
 
                                                          
182
 http://www.abc.net.au/news/2015-04-13/no-benefits-for-anti-vaccination-parents/6387914  
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The Australian Dental Association (ADA) has made the case that dentists’ customary fees have increased 
over the last seven years at a rate below the Health Index but DVA scales have not kept pace. The result 
is the current discrepancy between the two has reached on average nearly 20%, in some cases the 
discrepancy is as high as 60%.  The ADA states that a freeze on indexation will mean that dentists will 
find it increasingly difficult to service DVA patients.183 
 
Extension of trial for in-home telehealth for veterans 
$3.7 million / 2 years is provided to extend the duration of the current trial of in-home telehealth for 
veterans for a further 18 months to support an effective evaluation of the trial. 
 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DVA - 2.3 1.4 - - 
 
This trial, called the In-Home Telemonitoring for Veterans Trial and is aimed at enhancing services 
provided under the Coordinated Veterans’ Care (CVC) Program, which provides ongoing, planned and 
coordinated care, led by a GP with a nurse coordinator. The trial aims to test if in-home telemonitoring 
is a safe, effective and efficient complement to face-to-face GP consultations, whether telemonitoring 
can improve CVC participants’ quality of life and their ability to live in their own home for longer, and 
reduce unplanned hospital admissions.  
The trial commenced in June 2013 at the first site in the New England region, NSW, and was due to 
finish in June 2015. Other trial sites include the North Coast, NSW, the Darling Downs in Queensland, 
and Bayside, Victoria. The 18 month extension (until December 2016) provided in the 2015-16 Budget 
involves no further recruitment to the trial. There is some information available on the internet about an 
evaluation of this program184 that is described as running for 3 years from 2012. 
In 2012 the Labor Government announced a $20.6 million trial programs to enable older Australians, 
people living with cancer, and people requiring palliative care, especially those in rural and remote 
Australia, to btain medical advice and care via videoconferencing, often in their own home. Seven 
organisations received funding.185  Evaluations for these projects have been announced186 but don’t 
seem to be publicly available. 
While some Australian trials have been evaluated, apparently these later ones have not. 
                                                          
183
 http://www.ada.org.au/App_CmsLib/Media/Lib/1406/M784264_v1_635394781080553038.pdf  
 
184
 http://www.slideshare.net/sharon_Campbell/telehealth-for-dva-veterans-evaluation 
 
185
 http://health.gov.au/ehealth-nbntelehealth 
  
186
 http://www.pulseitmagazine.com.au/index.php?option=com_content&view=article&id=1421:csiro-to-
demonstrate-evidence-for-telehealth-under-nbn-project&catid=16:australian-ehealth&Itemid=327  
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Increased number of case co-ordinators 
$10.0 million / 4 years is provided to fund additional case co-ordinators for veterans and their families. 
 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DVA - 2.5 2.5 2.5 2.5 
 
Case co-ordinators provide support to clients and their families with complex medical, physical and 
social needs. 
No further information on the number and role of case co-ordinators at DVA could be elucidated. 
 
New listings and price amendments for Repatriation Pharmaceutical Benefits Scheme 
The Budget Papers say that $0.2million / 5 years is provided for new listings and price amendments on 
the RPBS.  However the accompanying table clearly shows that cost to be $0.4 million / 5 years. 
 
 2014-15   
$m 
2015-16    
$m 
2016-17   
$m 
2017-18    
$m 
2018-19   
$m 
DVA .. 0.1 0.1 0.1 0. 
 
The new listings and price amendments are not provided. It is assumed that these are for items not 
available on the PBS. 
 
Mental health and substance abuse services 
The Budget media release from the Minister for Veterans’ Affairs, Michael Ronaldson, stated that “The 
DVA Budget for mental health will remain uncapped and be driven by demand from clients. Over the 
past 12 months, the Government has expanded access to the Veterans and Veterans Families 
Counselling Service (VVCS). We have also made it easier for veterans dealing with depression, post-
traumatic stress disorder and anxiety, plus substance and alcohol use disorders, to access free and 
immediate treatment for their conditions regardless of whether they are related to service.”187 
 
 
 
 
                                                          
187
 http://minister.dva.gov.au/media_releases/2015/may/va043.htm 
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